There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
Type | HazMat fee for 500 gram (Estimated) |
Excepted Quantity | USD 0.00 |
Limited Quantity | USD 15-60 |
Inaccessible (Haz class 6.1), Domestic | USD 80+ |
Inaccessible (Haz class 6.1), International | USD 150+ |
Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Busulfan (BU), an alkylating agent that causes DNA damage by cross-linking DNAs and DNA and proteins, induces senescence in normal human diploid WI38 fibroblasts through the extracellular signal-regulated kinase (Erk) and p38 mitogen-activated protein kinase (p38 MAPK) cascade independent of the p53-DNA damage pathway[3]. Busulfan (40 mg/kg, i.p) increases apoptosis and decreases the testis weight in mice. The testes of Busulfan-treated mice exhibits higher level of pRB expression, inhibits Rb phosphorylation and PCNA expression compared to the control[4]. Busulfan (2.5, 5.0 mg/kg, i.p.) causes earlier occurrence of persistent esturs in a dose dependent manner in rats. Busulfan (5.0 mg/kg) also increases the incidence of uterine adenocarcinomas and multiplicity of uterine neoplastic lesions. In addition, Busulfan decreases the serum 17β-estradiol(E2), progesterone and inhibin levels in rats, and elevates the E2/progesterone ratio only at 5.0 mg/kg[5]. IV busulfan is a convenient, safe, and effective conditioning agent used in HSCT (hematopoietic stem cell transplantation) that has a predictable pharmacokinetic profile[6]. |
细胞系 | 浓度 | 检测类型 | 检测时间 | 活动说明 | 数据源 |
Kelly cells | 10-100 μM | Proliferation assay | 72 h | Antiproliferative activity against human Kelly cells at 10 to 100 uM after 72 hrs by MTT assay | 24814532 |
LS cells | 10-100 μM | Proliferation assay | 72 h | Antiproliferative activity against human LS cells at 10 to 100 uM after 72 hrs by MTT assay | 24814532 |
SiMa cells | 10-100 μM | Proliferation assay | 72 h | Antiproliferative activity against human SiMa cells at 10 to 100 uM after 72 hrs by MTT assay | 24814532 |
SK-N-SH cells | 10-100 μM | Proliferation assay | 72 h | Antiproliferative activity against human SK-N-SH cells at 10 to 100 uM after 72 hrs by MTT assay | 24814532 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT02114502 | Myeloma | Phase 2 | Withdrawn | - | - |
NCT00997386 | Hematologic Neoplasms ... 展开 >> Multiple Myeloma Anemia, Aplastic Hemoglobinuria, Paroxysmal Myelofibrosis 收起 << | Phase 2 | Completed | - | United States, Arizona ... 展开 >> University Medical Center and UMC-North Clinic Tucson, Arizona, United States, 85719 收起 << |
NCT01471444 | Disorder Related to Bone Marro... 展开 >>w Transplantation Leukemia Transplantation Infection 收起 << | Phase 3 | Active, not recruiting | November 1, 2020 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
4.06mL 0.81mL 0.41mL |
20.30mL 4.06mL 2.03mL |
40.60mL 8.12mL 4.06mL |
CAS号 | 55-98-1 |
分子式 | C6H14O6S2 |
分子量 | 246.302 |
别名 | 1,4-双甲基硫氧基丁烷 ;Busulphan;NSC-750;14di(methylsulfonyloxy)butane.;14di(methanesulfonyloxy)butane;14butanediol dimethylsulfonate;14bitanediol dimethanesulfonate esters;14bis(methanesulfonoxy)butane;Chemical structure names: ;WR19508;GT41;Code names: CB2041;BUS;Abbreviations: BU;Misulfan;Misulban;Sulfabutin;Myelosan;Myeleukon;methanesulfonic acid tetramethylene ester;glyzophrol;Busulfanum;Bussulfam;NCI C01592;Myleran;Mylecytan;Myeloleukon;Milecitan;Mielosan |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Inert atmosphere,Room Temperature |
溶解度 |
DMSO: 50 mg/mL(203 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |
IP 2% DMSO+2% Tween80+40% PEG300+water 10 mg/mL clear PO 0.5% CMC-Na 44 mg/mL suspension |
Tags: Busulfan | Busulphan;NSC-750;14di(methylsulfonyloxy)butane.;14di(methanesulfonyloxy)butane;14butanediol dimethylsulfonate;14bitanediol dimethanesulfonate esters;14bis(methanesulfonoxy)butane;Chemical structure names: ;WR19508;GT41;Code names: CB2041;BUS;Abbreviations: BU;Misulfan;Misulban;Sulfabutin;Myelosan;Myeleukon;methanesulfonic acid tetramethylene ester;glyzophrol;Busulfanum;Bussulfam;NCI C01592;Myleran;Mylecytan;Myeloleukon;Milecitan;Mielosan | 1,4-双甲基硫氧基丁烷 | DNA Alkylator/Crosslinker | AmBeed-信号通路专用抑制剂 | Busulfan 纯度/质量文件 | Busulfan 生物活性 | Busulfan 细胞研究 | Busulfan 临床数据 | Busulfan 参考文献 | Busulfan 实验方案 | Busulfan 技术信息
请填写此表格索取QC报告。我们很快就会发送到您的邮箱。您的信息在我们这里是安全的。*是必填项.
靶点 | 数值 |
需要的总药量: mg
您需要配制的工作液浓度为:mg/mL
细胞系 | 浓度 | 检测类型 | 检测时间 | 活动说明 | 数据源 |
Kelly cells | 10-100 μM | Proliferation assay | 72 h | Antiproliferative activity against human Kelly cells at 10 to 100 uM after 72 hrs by MTT assay | 24814532 |
LS cells | 10-100 μM | Proliferation assay | 72 h | Antiproliferative activity against human LS cells at 10 to 100 uM after 72 hrs by MTT assay | 24814532 |
SiMa cells | 10-100 μM | Proliferation assay | 72 h | Antiproliferative activity against human SiMa cells at 10 to 100 uM after 72 hrs by MTT assay | 24814532 |
SK-N-SH cells | 10-100 μM | Proliferation assay | 72 h | Antiproliferative activity against human SK-N-SH cells at 10 to 100 uM after 72 hrs by MTT assay | 24814532 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT02114502 | Myeloma | Phase 2 | Withdrawn | - | - |
NCT00997386 | Hematologic Neoplasms ... 展开 >> Multiple Myeloma Anemia, Aplastic Hemoglobinuria, Paroxysmal Myelofibrosis 收起 << | Phase 2 | Completed | - | United States, Arizona ... 展开 >> University Medical Center and UMC-North Clinic Tucson, Arizona, United States, 85719 收起 << |
NCT01471444 | Disorder Related to Bone Marro... 展开 >>w Transplantation Leukemia Transplantation Infection 收起 << | Phase 3 | Active, not recruiting | November 1, 2020 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01237951 | Myeloma | Phase 2 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00857389 | Stem Cell Transplantation ... 展开 >> Leukemia Lymphoma 收起 << | Phase 2 | Active, not recruiting | March 2020 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00534469 | Leukemia | Phase 2 | Active, not recruiting | January 2019 | - |
NCT03235973 | Leukemia, Myeloid, Acute ... 展开 >> Leukemia, Lymphoblastic, Acute 收起 << | Phase 1 | Recruiting | April 2021 | France ... 展开 >> Institut Paoli-Calmettes Recruiting Marseille, Bouches-du-Rhône, France, 13009 Contact: Dominique Genre, MD +33491223778 drci.up@ipc.unicancer.fr Principal Investigator: Raynier Devillier, MD,PhD 收起 << |
NCT01534143 | Refractory Multiple Myeloma ... 展开 >> Stage I Multiple Myeloma Stage II Multiple Myeloma Stage III Multiple Myeloma 收起 << | Phase 2 | Terminated(Data was not collec... 展开 >>ted, because funding was unavailable to continue study.) 收起 << | - | United States, Michigan ... 展开 >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 收起 << |
NCT03311503 | Severe Combined Immunodeficien... 展开 >>cy, X Linked Gene Therapy 收起 << | Phase 1 Phase 2 | Recruiting | January 1, 2023 | United States, California ... 展开 >> Mattel Children's Hospital - UCLA Recruiting Los Angeles, California, United States, 90095 Contact: Donald Kohn, MD 310-825-6708 United States, Massachusetts Boston Childrens Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Sung-Yun Pai, MD 617-919-2191 sung-yun.pai@childrens.harvard.edu 收起 << |
NCT01534143 | - | Terminated(Data was not collec... 展开 >>ted, because funding was unavailable to continue study.) 收起 << | - | - | |
NCT02961816 | Lymphoma | Phase 2 | Withdrawn(Lack of funding) | June 2021 | - |
NCT02861417 | Other Diseases of Blood and Bl... 展开 >>ood-forming Organs Acute Myeloid Leukemia Acute Lymphocytic Leukemia Chronic Myeloid Leukemia Chronic Lymphocytic Leukemia Myelodysplastic Syndrome Myeloproliferative Syndrome Non-Hodgkins Lymphoma Hodgkins Lymphoma Multiple Myeloma 收起 << | Phase 2 | Recruiting | August 2022 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 收起 << |
NCT00003462 | Brain and Central Nervous Syst... 展开 >>em Tumors 收起 << | Phase 1 | Completed | - | United States, North Carolina ... 展开 >> Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 收起 << |
NCT00915811 | Myelodysplastic Syndromes ... 展开 >> Leukemia, Myeloid, Acute 收起 << | Phase 2 | Terminated(FB ATG is now a sta... 展开 >>ndard for sib allo MDS patients) 收起 << | - | United Kingdom ... 展开 >> King's College Hospital NHS Foundation Trust London, United Kingdom, SE5 9RS 收起 << |
NCT01435447 | Lymphoid Malignancies | Phase 2 | Completed | - | China, Shanghai ... 展开 >> Blood and Marrow Transplantation Center, Rui Jin Hospital Shanghai, Shanghai, China, 200025 收起 << |
NCT01786018 | B-cell Lymphoma Refractory | Phase 2 | Unknown | February 2015 | Italy ... 展开 >> Città della Salute e della Scienza di Torino Recruiting Torino, Italy, 10126 Contact: Benedetto Bruno, MD +390116336728 benedetto.bruno@unito.it 收起 << |
NCT01985061 | Myelodysplastic Syndrome ... 展开 >> Acute Myeloid Leukemia 收起 << | Phase 2 | Recruiting | December 2018 | France ... 展开 >> Institut Paoli Calmettes Recruiting Marseille, France, 13009 Contact: Dominique GENRE, MD 33491223778 drci.up@ipc.unicancer.fr Contact: Jihane PAKRADOUNI, PharmD, PhD 33491223778 drci.up@ipc.unicancer.fr Principal Investigator: Didier BLAISE, MD PhD 收起 << |
NCT00556452 | - | Completed | - | - | |
NCT00499889 | Leukemia | Phase 2 | Terminated(Support issue.) | - | United States, Texas ... 展开 >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00092937 | Granulomatous Disease ... 展开 >> Chronic 收起 << | Phase 1 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT00499889 | - | Terminated(Support issue.) | - | - | |
NCT00556452 | Leukemia Hodg... 展开 >>kin Lymphoma Non-Hodgkin Lymphoma Multiple Myeloma Myelodysplastic Syndrome 收起 << | Phase 1 Phase 2 | Completed | - | United States, Michigan ... 展开 >> University of Michigan, Department of Internal Medicine, Blood and Marrow Transplant Program Ann Arbor, Michigan, United States, 48170 收起 << |
NCT00475020 | - | Completed | - | - | |
NCT00475020 | Myelofibrosis | Phase 2 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT02129582 | Acute Myeloid Leukemia ... 展开 >> Hematologic Malignancies Acute Lymphocytic Leukemia Non Hodgkin Lymphoma Hodgkin Lymphoma Multiple Myeloma Myelodysplastic Syndrome Chronic Lymphocytic Leukemia Chronic Myeloid Leukemia Myelofibrosis Myeloproliferative Syndrome 收起 << | Phase 1 | Recruiting | May 2019 | United States, Ohio ... 展开 >> University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44106-5065 Contact: Paolo F. Caimi 216-844-0139 paolo.caimi@case.edu Principal Investigator: Paolo F. Caimi 收起 << |
NCT00836628 | Refractory Brain Tumors | Phase 1 | Withdrawn(slow accrual) | - | - |
NCT00477542 | Hematologic Malignancies | Phase 1 | Completed | - | United States, Indiana ... 展开 >> Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 收起 << |
NCT00534430 | Leukemia Myel... 展开 >>odysplastic Syndromes 收起 << | Phase 2 | Active, not recruiting | August 2019 | - |
NCT00629798 | Acute Myeloid Leukemia ... 展开 >> Advanced Myelodysplastic Syndromes 收起 << | Phase 2 | Active, not recruiting | February 2019 | United States, New York ... 展开 >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 收起 << |
NCT01734850 | Human Immunodeficiency Virus | Phase 1 Phase 2 | Completed | - | United States, California ... 展开 >> UCLA CARE Center Los Angeles, California, United States, 90035 Quest Clinical Research San Francisco, California, United States, 94115 收起 << |
NCT00245037 | - | Completed | - | - | |
NCT00516152 | Chronic Myeloid Leukemia ... 展开 >> Acute Myelogenous Leukemia Myelodysplasia Acute Lymphocytic Leukemia Severe Aplastic Anemia Non-Hodgkin's Lymphoma Lymphoproliferative Disease Multiple Myeloma Advanced Myeloproliferative Disease 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> University of California San Francisco San Francisco, California, United States, 94143 收起 << |
NCT00003875 | Adult Acute Myeloid Leukemia i... 展开 >>n Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Childhood Acute Myeloid Leukemia in Remission Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Myeloid Leukemia 收起 << | Phase 2 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT01605032 | DS Stage I Plasma Cell Myeloma... 展开 >> DS Stage II Plasma Cell Myeloma DS Stage III Plasma Cell Myeloma Refractory Plasma Cell Myeloma 收起 << | Phase 2 | Unknown | - | United States, New Jersey ... 展开 >> Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 United States, New York Albert Einstein College of Medicine Bronx, New York, United States, 10461 NYU Cancer Institute New York, New York, United States, 10016 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 收起 << |
NCT00003875 | - | Completed | - | - | |
NCT01572181 | Hematologic Malignancy | Phase 2 | Completed | - | France ... 展开 >> University Hospital Besançon, France University Hospital Bordeaux, France University Hospital Clermont-Ferrand, France University Hospital Grenoble, France University Hospital Lille, France University Hospital Lyon, France University Hospital Marseille, France University Hospital Montpellier, France University Hospital Nancy, France University Hospital Nantes, France University Hopsital Paris, France University Hospital Paris, France University Hospital Rennes, France University Hopsital Rouen, France University Hospital Strasbourg, France 收起 << |
NCT00245037 | Chronic Myeloproliferative Dis... 展开 >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Precancerous Condition 收起 << | Phase 1 Phase 2 | Completed | - | United States, Oregon ... 展开 >> Knight Cancer Institute at Oregon Health and Science University Portland, Oregon, United States, 97239-3098 收起 << |
NCT02083250 | Acute Lymphoblastic Leukemia i... 展开 >>n Remission Acute Myeloid Leukemia in Remission Allogeneic Hematopoietic Stem Cell Transplantation Recipient Myelodysplastic Syndrome Previously Treated Myelodysplastic Syndrome Recurrent Acute Lymphoblastic Leukemia Recurrent Acute Myeloid Leukemia 收起 << | Phase 1 | Active, not recruiting | March 30, 2021 | United States, Texas ... 展开 >> M D Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00941720 | Multiple Myeloma and Plasma Ce... 展开 >>ll Neoplasm 收起 << | Phase 2 | Active, not recruiting | November 2018 | United States, Ohio ... 展开 >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 收起 << |
NCT00006246 | Brain and Central Nervous Syst... 展开 >>em Tumors Childhood Germ Cell Tumor Leukemia Lymphoma Metastatic Cancer Retinoblastoma Sarcoma 收起 << | Phase 1 | Completed | - | United States, California ... 展开 >> UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States, 94143-0128 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010-2970 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, North Carolina Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104-4318 Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 United States, Washington Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 98105 收起 << |
NCT00156858 | Hematologic Malignancy | Not Applicable | Unknown | - | Canada, Alberta ... 展开 >> Tom Baker Cancer Centre Recruiting Calgary, Alberta, Canada, T2N 4N2 Contact: Rachel Syme, PhD clinical_trials_tbcc@cancerboard.ab.ca Sub-Investigator: Chris Brown Sub-Investigator: Ron Anderson Principal Investigator: James Russell Sub-Investigator: Victor Lewis 收起 << |
NCT00469014 | Acute Myeloid Leukemia ... 展开 >> Myelodysplastic Syndrome Chronic Myeloid Leukemia 收起 << | Phase 2 | Completed | - | United States, Texas ... 展开 >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00943319 | Leukemia Lymp... 展开 >>homa Myeloma 收起 << | Phase 1 Phase 2 | Active, not recruiting | December 2018 | United States, Illinois ... 展开 >> The University of Chicago Chicago, Illinois, United States, 60637 收起 << |
NCT00941720 | - | Active, not recruiting | - | - | |
NCT03121014 | Acute Myeloid Leukemia ... 展开 >> Myelodysplastic Syndromes 收起 << | Phase 2 | Recruiting | April 24, 2024 | United States, Illinois ... 展开 >> University of Illinois at Chicago Recruiting Chicago, Illinois, United States, 60612 Contact: Damiano Rondelli, MD 312-413-3547 drond@uic.edu 收起 << |
NCT01191957 | Acute Myeloid Leukemia (AML) | Phase 3 | Completed | - | Israel ... 展开 >> Chaim Sheba Medical Center Tel Hashomer, Israel Italy Azienda Ospedaliera SS Antonio e Biagio Alessandria, Italy Clinica di Ematologia - Ospedali Riuniti di Ancona Ancona, Italy Policlinico di Bari-Ematologia con trapianti Bari, Italy Ospedali Riuniti di Bergamo Bergamo, Italy, 24128 Ospedale Regionale Generale- Divisione Ematologia Bolzano, Italy AO Spedali Civili di Brescia- USD - TMO Adulti Brescia, Italy Ospedale Ferrarotto - Ematologia Catania, Italy S.C. Ematologia - Azienda Ospedaliera S. Croce e Carle Cuneo, Italy Cattedra di Ematologia - Azienda Ospedaliera di Careggi Firenze, Italy AOU-IRCCS San Martino-IST Ematologia II Genova, Italy Divisione di Ematologia - Istituto Nazionale dei Tumori Milano, Italy U.O. Ematologia I - Centro Trapianti di Midollo - Ospedale Maggiore - Policlinico Mangiagalli e Regina Elena Milano, Italy Cattedra di Medicina Interna ed Ematologia - Ospedale S. Gerardo de' i Tintori - Università degli Studi di Milano Monza, Italy A.O.U. Policlinico Federico II Napoli, Italy AOR Villa Sofia-Cervello - Bone Marrow Transplant Unit Palermo, Italy IRCCS Policlinico S. Matteo Pavia, Italy Dip. di Ematologia - Unità di Terapia Intensiva Ematologica per il Trapianto Emopoietico - Ospedale Civile di Pescara Pescara, Italy Divisione di Ematologia - Istituto di Semeiotica Medica - Policlinico A. Gemelli Roma, Italy Policlinico Universitario Tor Vergata Roma, Italy Sapienza University Roma, Italy Ematologia e Centro Trapianti Midollo Osseo - Ospedale IRCCS Casa Sollievo della Sofferenza S. Giovanni Rotondo (FG), Italy Az. Ospedaliera Universitaria Senese - Divisione Ematologia e Trapianti Siena, Italy AOU Città della Salute e della Scienza Torino, Italy Clinica Ematologica - Policlinico Universitario Udine, Italy Ospedale S. Bortolo-Divisione Ematologia Vicenza, Italy 收起 << |
NCT00410982 | Leukemia Lymp... 展开 >>homa Myeloma 收起 << | Phase 1 | Completed | - | United States, Texas ... 展开 >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01200329 | Lymphoma | Phase 2 | Active, not recruiting | June 2020 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT02859402 | T-cell Non-Hodgkin Lymphoma ... 展开 >> Lymphoma, Extranodal NK-T-Cell 收起 << | Phase 2 | Recruiting | December 2021 | Korea, Republic of ... 展开 >> Dong-A University Recruiting Busan, Korea, Republic of, 602-713 Contact: Ji Hyun Lee, MD., Ph.D. +82-10-9397-5694 hidrleejh@dau.ac.kr Keimyung University Dongsan Medical Center Recruiting Daegu, Korea, Republic of, 700-712 Contact: Young Rok Do, MD., Ph.D. +82-10-3541-1160 dyr1160@dsmc.or.kr 收起 << |
NCT00445744 | - | Completed | - | - | |
NCT00445744 | Adult Acute Myeloid Leukemia i... 展开 >>n Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Childhood Acute Myeloid Leukemia in Remission Childhood Myelodysplastic Syndromes de Novo Myelodysplastic Syndromes Essential Thrombocythemia Myelodysplastic Syndrome With Isolated Del(5q) Polycythemia Vera Previously Treated Myelodysplastic Syndromes Primary Myelofibrosis Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Secondary Myelofibrosis Untreated Adult Acute Myeloid Leukemia Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies 收起 << | Not Applicable | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT00496340 | Hematologic Malignancies | Phase 2 | Completed | - | United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 收起 << |
NCT00496340 | - | Completed | - | - | |
NCT01421173 | Lymphoma | Phase 1 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00815568 | AML MDS ... 展开 >> ALL CML Lymphoma 收起 << | Phase 2 | Unknown | December 2012 | Korea, Republic of ... 展开 >> Dong Hwan Kim Recruiting Seoul, Korea, Republic of, 135-710 收起 << |
NCT00863148 | MDS AML ... 展开 >> ALL BAL 收起 << | Phase 2 | Completed | - | France ... 展开 >> Hôpital Edouard Herriot Lyon, France, 69437 Institut Paoli Calmettes Marseille, France, 13273 Nantes University hospital Nantes, France, 44093 Hôpital Saint Louis Paris, France, 75475 CHU Haut-Lévêque Pessac, France, 33604 CHRU Hautepierre Strasbourg, France, 67098 收起 << |
NCT02349906 | Primary Immunodeficiencies ... 展开 >> Inborn Errors of Metabolism Haemoglobinopathies Bone Marrow Failure Syndromes 收起 << | Phase 2 | Recruiting | December 2019 | Austria ... 展开 >> St. Anna Children's Hospital Withdrawn Vienna, Austria, 1090 Czechia University Hospital Motol, Dep. of Paediatric Haematology and Oncology Recruiting Prague, Czechia Contact: Petr Sedlacek, MD, Prof. +42060672 ext 6550 Germany Department of Pediatric Oncology & Hematology, Charite Berlin Not yet recruiting Berlin, Germany, 13353 Contact: Johannes Schulte, MD, Prof. Duesseldorf University Hospital Withdrawn Duesseldorf, Germany, 40225 University Children's Hospital Essen Pediatric stem cell transplantation Not yet recruiting Essen, Germany, 45122 Contact: Rita Beier, MD University Hospital Frankfurt Recruiting Frankfurt am Main, Germany, 60590 Contact: Peter Bader, MD, Prof. University Medical Center Hamburg-Eppendorf Withdrawn Hamburg, Germany, 20246 Hannover Medical University, Dep. of Paediatrics, Paediatric Haematology and Oncology Recruiting Hannover, Germany Contact: Karl-Walter Sykora, MD, Prof. +49(0)511532 ext 5830 Heidelberg University Hospital Recruiting Heidelberg, Germany, 69120 Contact: Johann Greil, MD, Prof. University of Jena, Department of Pediatrics Not yet recruiting Jena, Germany, 07747 Contact: Bernd Gruhn, MD, Prof. University Hospital Regensburg Withdrawn Regensburg, Germany, 93053 Ulm, University Hospital, Clinic for Children and Adolescents Recruiting Ulm, Germany, 89075 Contact: Ansgar Schulz, MD, Prof. +49(0)731500 ext 57154 University Hospital of Wuerzburg Withdrawn Wuerzburg, Germany, 97080 Italy SC Oncoematologia Pediatrica Ospedale Pediatrico Microcitemico "Antonio Cao" A.O. Brotzu Not yet recruiting Cagliari, Italy, 09121 Contact: Maria Grazia Orofino, MD UOC Ematologia ed Oncologia Pediatrica con TMO AOU Policlinico Vittorio Emanuele Not yet recruiting Catania, Italy, 95123 Contact: Giovanna Russo, MD Reparto Trapianti Midollo Osseo Clinica Pediatrica Universitaria Fondazione MBBM-Ospedale San Gerardo Not yet recruiting Monza, Italy, 20900 Contact: Sonia Bonanomi, MD S.C. Oncoematologia Pediatrica Fondazione IRCCS Policlinico San Matteo Not yet recruiting Pavia, Italy, 27100 Contact: Marco Zecca, MD Oncoematologia Pediatrica A.O. di Perugia Ospedale S. Maria della Misericordia Not yet recruiting Perugia, Italy, 06156 Contact: Maurizio Caniglia, MD U.O. Oncoematologia Pediatrica Azienda Ospedaliero Universitaria Pisana Ospedale S. Chiara Not yet recruiting Pisa, Italy, 56100 Contact: Mariacristina Menconi, MD Ospedale Bambino Gesu Roma Recruiting Rome, Italy, 00165 Contact: Franco Locatelli, MD, Prof. Ospedale Infantile Regina Margherita Torino Recruiting Turin, Italy, 10126 Contact: Franca Fagioli, MD, Prof. U.O.C. Oncoematologia Pediatrica Policlinico "G.B. Rossi" - AOUI Verona Recruiting Verona, Italy, 37134 Contact: Simone Cesaro, MD Poland Szpital Uniwersytecki im. dr Antoniego Jurasza Recruiting Bydgoszcz, Poland, 85-094 Contact: Jan Styczynski, MD, Prof Uniwersytecki Szpital Dzieciecy w Krakowie Recruiting Krakow, Poland, 30-663 Contact: Jolanta Gozdzik, MD Dzieciecy Szpital Kliniczny im. A. Gebali w Lublinie Not yet recruiting Lublin, Poland, 20-093 Contact: Katarzyna Drabko, MD Wroclaw Medical University, Department of Pediatric Hematology/Oncology and BMT Recruiting Wroclaw, Poland, 50-368 Contact: Krzysztof Kałwak, MD, PhD, Prof. (48)-71 ext 7703170 收起 << |
NCT01071486 | Busulfan Pharmacokinetic Analy... 展开 >>sis GST Genetic Polymorphism 收起 << | Phase 4 | Withdrawn(lack of participants... 展开 >>) 收起 << | - | Israel ... 展开 >> Rambam Health Care Campus Haifa, Israel, 31096 收起 << |
NCT02500849 | HIV | Phase 1 | Recruiting | March 2019 | United States, California ... 展开 >> City of Hope Medical Center Not yet recruiting Duarte, California, United States, 91010 Contact: Rodica Stan, PhD 626-218-8330 rstan@coh.org Principal Investigator: Amrita Y. Krishnan, MD UCLA CARE Center Recruiting Los Angeles, California, United States, 90035 Contact: Maricela Gonzalez 310-557-3729 mmgonzalez@mednet.ucla.edu Principal Investigator: Ronald Mitsuyasu, MD Mills Clinical Research Recruiting Los Angeles, California, United States, 90069 Contact: Sandro Antunes 310-550-2271 Sandro.Antunes@millsclinicalresearch.com Principal Investigator: Anthony Mills, MD Quest Clinical Research Recruiting San Francisco, California, United States, 94115 Contact: Grace Gonzaga 415-353-0800 grace@questclinical.com Principal Investigator: Jay Lalezari, MD United States, Connecticut Circle CARE Center, LLC Recruiting Norwalk, Connecticut, United States, 06850 Contact: Greg Ulrich, RN 203-852-9525 gulrich@whcccc.org Contact: Patricia R Garton, APRN 203-852-9525 tgarton@whcccc.org Principal Investigator: David Rubin, MD 收起 << |
NCT00361140 | Myelodysplastic Syndromes ... 展开 >> Myeloproliferative Disorders Leukemia, Lymphocytic Myeloma Lymphoma 收起 << | Phase 4 | Completed | - | United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 收起 << |
NCT00363467 | Acute Myeloid Leukemia (AML) | Not Applicable | Terminated(Low accrual) | - | United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 收起 << |
NCT00363467 | - | Terminated(Low accrual) | - | - | |
NCT00361140 | - | Completed | - | - | |
NCT01131169 | Multiple Myeloma | Phase 2 | Active, not recruiting | May 2019 | United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 收起 << |
NCT00774280 | Leukemia Myel... 展开 >>odysplastic Syndrome 收起 << | Phase 3 | Completed | - | Korea, Republic of ... 展开 >> Asan Medical Center Seoul, Korea, Republic of, 138-736 收起 << |
NCT02250937 | Acute Myeloid Leukemia ... 展开 >> Myelodysplastic Syndrome 收起 << | Phase 2 | Recruiting | October 2020 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 收起 << |
NCT03492749 | - | Active, not recruiting | August 2019 | - | |
NCT00469144 | Myelodysplastic Syndrome ... 展开 >> Leukemia Acute Myeloid Leukemia 收起 << | Phase 3 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00990249 | Leukemia Lymp... 展开 >>homa Allogeneic Haematopoietic Stem Cell Transplantation Acute Lymphoblastic Leukemia 收起 << | Phase 2 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01203020 | Hodgkin's Lymphoma ... 展开 >> Non-Hodgkin's Lymphoma 收起 << | Phase 2 | Recruiting | December 2018 | United States, West Virginia ... 展开 >> West Virginia University Hospitals Mary Babb Randolph Cancer Center Recruiting Morgantown, West Virginia, United States, 26506 Contact: Pam Bunner, MT 304-598-4511 bunnerp@wvuhealthcare.com Contact: Crystal Street, MT 304-598-4512 streetc@wvuhealthcare.com Sub-Investigator: Michael Craig, MD Sub-Investigator: Aaron Cumpston, PharmD Sub-Investigator: William Petros, PharmD 收起 << |
NCT00990249 | - | Completed | - | - | |
NCT01178645 | Non-Hodgkin Lymphoma | Phase 2 | Unknown | - | Korea, Republic of ... 展开 >> Inje University Busan Paik Hospital, Inje University College of Medicine Recruiting Busan, Korea, Republic of, 614-735 Contact: Won Sik Lee +82-51-890-6407 drlee112@hanafos.com Principal Investigator: Won Sik Lee Seoul National University Hospital, Seoul National University College of Medicine Recruiting Seoul, Korea, Republic of, 110-744 Contact: Sung-Soo Yoon +82-2-2072-3079 ssysmc@snu.ac.kr Contact: Ji-Won Kim +82-11-9010-0427 werbinig@gmail.com Sub-Investigator: Byoung Kook Kim Sub-Investigator: Seonyang Park Principal Investigator: Sung-Soo Yoon Sub-Investigator: Inho Kim Severance Hospital, Yonsei University College of Medicine Recruiting Seoul, Korea, Republic of, 120-752 Contact: Jin Seok Kim hemakim@yuhs.ac Principal Investigator: Jin Seok Kim Asan Medical Center, University of Ulsan College of Medicine Recruiting Seoul, Korea, Republic of, 138-736 Contact: Je Hwan Lee jhlee3@amc.seoul.kr Principal Investigator: Je Hwan Lee Ulsan University Hospital, University of Ulsan College of Medicine Recruiting Ulsan, Korea, Republic of, 682-714 Contact: Hawk Kim Principal Investigator: Hawk Kim 收起 << |
NCT03619551 | SCID | Phase 2 | Not yet recruiting | August 1, 2026 | United States, California ... 展开 >> Children's Hospital Los Angeles Not yet recruiting Los Angeles, California, United States, 90027 Contact: Nini Huynh 323-361-5286 huhuynh@chla.usc.edu Principal Investigator: Michael Pulsipher, MD United States, Massachusetts Boston Children's Hospital Not yet recruiting Boston, Massachusetts, United States, 02115 Contact: Sung-Yun Pai, MD 617-919-2508 sung-yun.pai@childrens.harvard.edu 收起 << |
NCT01814475 | Myelofibrosis | Phase 2 | Completed | - | Italy ... 展开 >> Azienda Ospedaliera SS Antonio e Biagio Alessandria, Italy Clinica di Ematologia - Ospedali Riuniti di Ancona Ancona, Italy Divisione di Ematologia - Ospedali Papa Giovanni XXIII Bergamo, Italy AO Spedali Civili di Brescia- USD - TMO Adulti Brescia, Italy Ospedale Ferrarotto - Ematologia Catania, Italy Cattedra di Ematologia - Azienda Ospedaliera di Careggi Firenze, Italy AOU IRCCS San Martino - IST Genova, Italy Ospedale Panico Lecce, Italy Divisione di Ematologia - Istituto Nazionale dei Tumori Milano, Italy Divisione Ematologia - Azienda Ospedaliera Universitaria - Policlinico - Modena, Italy AO Ospedali Riuniti Villa Sofia - Cervello Palermo, Italy Dipartimento Oncologico La Maddalena Palermo, Italy Fondazione IRCCS San Matteo Pavia, Italy, 27100 Dip. di Ematologia - Unità di Terapia Intensiva Ematologica per il Trapianto Emopoietico - Ospedale Civile di Pescara Pescara, Italy Centro Unico Regionale Trapianti di Midollo Osseo - Ospedale Bianchi-Melacino-Morelli Reggio Calabria, Italy Arciospedale S. M. Novella Reggio Emilia, Italy Cattedra di Ematologia - Università La Sapienza Roma, Italy Ematologia e Centro Trapianti Midollo Osseo - Ospedale IRCCS Casa Sollievo della Sofferenza S. Giovanni Rotondo (FG), Italy Ospedale San Giuseppe Moscato Taranto, Italy Ematologia 2 - ASO San Giovanni Battista Torino, Italy A.O. Santa Maria della Misericordia Udine, Italy 收起 << |
NCT02784561 | Leukemia | Phase 4 | Not yet recruiting | July 2020 | - |
NCT01572662 | Leukemia Acut... 展开 >>e Myeloid Leukemia Acute Lymphocytic Leukemia Chronic Myeloid Leukemia Chronic Lymphocytic Leukemia Myeloproliferative Diseases Non-Hodgkins Lymphoma Hodgkins Lymphoma Multiple Myeloma Myelodysplastic Syndrome 收起 << | Phase 2 | Active, not recruiting | April 2019 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01702831 | Multiple Myeloma | Phase 2 | Active, not recruiting | December 2022 | Canada, Alberta ... 展开 >> Cross Cancer Institute 11560 University Ave Edmonton, Alberta, Canada, T6G-1Z2 Canada, British Columbia Vancouver General Hospital, Centennial Pavilion, 6th Floor Vancouver, British Columbia, Canada, V5Z 1M9 Canada, New Brunswick Saint John Regional Hospital, 5DN Research Department, 400 University Ave Saint John, New Brunswick, Canada, E2L 4L2 Canada, Nova Scotia Queen Elizabeth II Health Sciences Centre. Halifax, Nova Scotia, Canada, B3H 2Y9 Canada, Ontario London Regional Cancer Program 790 Commissioners Road East London, Ontario, Canada, N6A 4L6 The Ottawa Hospital Ottawa, Ontario, Canada, K1H 8L6 Princess Margaret Cancer Centre Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Hôpital Maisonneuve-Rosemont, 5415, boul. de l'Assomption Montreal, Quebec, Canada, H1T 2M4 Royal Victoria Hospital, MUHC Glen Site, Cedars Cancer Centre Montreal, Quebec, Canada, H4A 3J1 Canada, Saskatchewan Saskatoon Cancer Centre 20 Campus Drive Saskatoon, Saskatchewan, Canada, S7N 4H4 收起 << |
NCT01455506 | Acute Myeloid Leukemia ... 展开 >> Myelodysplastic Syndrome 收起 << | Phase 1 | Completed | - | United States, New Jersey ... 展开 >> Hackensack University Medical Center - John Theurer Cancer Center Hackensack, New Jersey, United States, 07601 收起 << |
NCT01643668 | Acute Myeloid Leukemia ... 展开 >> Acute Lymphoblastic Leukemia Myelodysplastic Syndrome 收起 << | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 收起 << |
NCT00800839 | Hematologic Diseases ... 展开 >> Leukemia Lymphoma Myeloma 收起 << | Phase 2 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01178658 | Non-Hodgkin Lymphoma | Phase 2 | Unknown | - | Korea, Republic of ... 展开 >> Inje University Busan Paik Hospital, Inje University College of Medicine Recruiting Busan, Korea, Republic of, 614-735 Contact: Won Sik Lee +82-51-890-6407 drlee112@hanafos.com Principal Investigator: Won Sik Lee Seoul National University Hospital, Seoul National University College of Medicine Recruiting Seoul, Korea, Republic of, 110-744 Contact: Sung-Soo Yoon +82-2-2072-3079 ssysmc@snu.ac.kr Contact: Ji-Won Kim +82-11-9010-0427 werbinig@gmail.com Sub-Investigator: Byoung Kook Kim Sub-Investigator: Seonyang Park Principal Investigator: Sung-Soo Yoon Sub-Investigator: Inho Kim Severance Hospital, Yonsei University College of Medicine Recruiting Seoul, Korea, Republic of, 120-752 Contact: Jin Seok Kim hemakim@yuhs.ac Principal Investigator: Jin Seok Kim Asan Medical Center, University of Ulsan College of Medicine Recruiting Seoul, Korea, Republic of, 138-736 Contact: Je Hwan Lee jhlee3@amc.seoul.kr Principal Investigator: Je Hwan Lee Ulsan University Hospital, University of Ulsan College of Medicine Recruiting Ulsan, Korea, Republic of, 682-714 Contact: Hawk Kim Principal Investigator: Hawk Kim 收起 << |
NCT02701673 | Lymphoma | Phase 1 Phase 2 | Withdrawn | - | - |
NCT03613532 | Acute Myeloid Leukemia (AML) ... 展开 >> Myelodysplastic Syndrome (MDS) Chronic Myelomonocytic Leukemia (CMML) MDS/Myeloproliferative Neoplasm-unclassifiable (MDS/MPN-unclassifiable) Hematopoietic Stem Cell Transplant 收起 << | Phase 1 | Recruiting | February 1, 2021 | United States, Massachusetts ... 展开 >> Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Jacqueline S Garcia, MD 617-632-1906 jacqueline_garcia@dfci.harvard.edu Principal Investigator: Jacqueline S Garcia, MD 收起 << |
NCT01413178 | Myeloma | Phase 3 | Active, not recruiting | September 2018 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00804947 | Multiple Myeloma | Phase 2 | Unknown | March 2010 | Spain ... 展开 >> Hospital Insular Canarias Recruiting Las Palmas de Gran Canaria, Las Palmas, Spain Contact: Juan D González, MD jdgonsan@gobiernodecanarias.org Principal Investigator: Juan D González, MD H La Princesa Recruiting Madrid, Spain Contact: Adrián Alegre, MD Adrian.Alegre@telefonica.net Principal Investigator: Adrián Alegre, MD H. 12 de Octubre Recruiting Madrid, Spain Contact: Juan J Lahuerta, MD jjlahuerta@terra.es Principal Investigator: Juan J Lahuerta, MD S. de Hematología. Hospital La Fe Recruiting Valencia, Spain, 46009 Principal Investigator: Javier de la Rubia, MD Sub-Investigator: Guillermo Sanz, MD Sub-Investigator: Isidro Jarque, MD Hospital Clínico Recruiting Valencia, Spain Contact: Carlos Solano, MD carlos.solano@uv.es Principal Investigator: Carlos Solano, MD Hospital Dr. Peset Recruiting Valencia, Spain Contact: Paz Ribas, MD ribas_paz@gva.es Principal Investigator: Paz Ribas, MD 收起 << |
NCT01338675 | Chronic Granulomatous Disease | Phase 1 Phase 2 | Unknown | December 2013 | Korea, Republic of ... 展开 >> Seoul National University Hospital Recruiting Seoul, Daehangno, Jongno-gu, Korea, Republic of Contact: Hyoung Jin Kang, MD, PhD 82 2 2072 3304 kanghj@snu.ac.kr Contact: Ji Won Lee, MD 82 2 2072 0177 agnesjw@hanmail.net 收起 << |
NCT00506857 | Hematologic Malignancies | Phase 1 Phase 2 | Completed | - | United States, Texas ... 展开 >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01779882 | Myeloid Leukemia ... 展开 >> Precursor Myeloid Neoplasms Lymphoid Neoplasms 收起 << | Not Applicable | Completed | - | Switzerland ... 展开 >> University Hospital, Basel Basel, Switzerland, 4031 University Hospital Geneva Geneva, Switzerland, 1205 University Hospital Zurich Zurich, Switzerland, 8091 收起 << |
NCT01643668 | - | Completed | - | - | |
NCT00800839 | - | Completed | - | - | |
NCT00328029 | Signs and Symptoms, Respirator... 展开 >>y 收起 << | Phase 2 | Unknown | June 2012 | France ... 展开 >> Service d'Explorations Fonctionelles Respiratoires - Hôpital Civil Recruiting Strasbourg, France, 67091 Contact: Charloux Anne, MD 3.33.88.11.61.22 anne.charloux@chru-strasbourg.fr Contact: Oswald Monique, MD 3.33.88.11.68.61 monique.oswald@chru-strasbourg.fr Service de Pédiatrie Onco-Hématologie - Hôpital de Hautepierre Recruiting Strasbourg, France, 67098 Contact: Patrick Lutz, MD 3.33.88.12.80.90 patrick.lutz@chru-strasbourg.fr Contact: Natacha Entz-Werle, MD 3.33.88.12.80.99 natacha.entz-werle@chru-strasbourg.fr Principal Investigator: Patrick Lutz, MD Sub-Investigator: Natacha Entz-Werle, MD Sub-Investigator: Nadine COJEAN, MD Sub-Investigator: Sophie BAYART, MD 收起 << |
NCT01701986 | Lymphoma | Phase 1 Phase 2 | Recruiting | October 2020 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 收起 << |
NCT00502905 | Leukemia | Phase 2 | Completed | - | United States, Texas ... 展开 >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01339988 | Acute Leukemias ... 展开 >> Chronic Leukemias Myelodysplastic Syndrome Juvenile Myelomonocytic Leukemia 收起 << | Phase 4 | Not yet recruiting | June 2019 | - |
NCT01274195 | Hematopoietic Stem Cell Transp... 展开 >>lantation 收起 << | Phase 2 | Unknown | December 2013 | Korea, Republic of ... 展开 >> Seoul National University Hospital Recruiting Seoul, Daehangno, Jongno-gu, Korea, Republic of Contact: Hyoung Jin Kang, MD, PhD 82 2 2072 0177 kanghj@snu.ac.kr Contact: Ji Won Lee, MD 82 2 2072 0177 agnesjw@hanmail.net Principal Investigator: Hyo Seop Ahn, MD, PhD 收起 << |
NCT00948090 | Lymphoma | Phase 2 | Completed | - | - |
NCT01366612 | Myeloid Malignancies ... 展开 >> Acute Myelogenous Leukemia Chronic Myelogenous Leukemia Myeloproliferative Disorders Myelodysplastic Syndrome 收起 << | Phase 3 | Recruiting | November 2018 | United States, New Jersey ... 展开 >> John Theurer Cancer Center at Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Mariefel Vendivil, RN 551-996-5828 Mariefel.Vendivil@HackensackMeridian.org Contact: Andrea Ortega, RN 551-996-3923 Andrea.Ortega@HackensackMeridian.org Principal Investigator: Michele Donato, MD Sub-Investigator: Melissa Baker, APN Sub-Investigator: Michele Boonstra, APN Sub-Investigator: Phyllis McKiernan, APN Sub-Investigator: Scott Rowley, MD Sub-Investigator: Alan Skarbnik, MD Sub-Investigator: David Vesole, MD, PhD 收起 << |
NCT02589145 | Lymphoma | Phase 1 Phase 2 | Active, not recruiting | June 2021 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00502905 | - | Completed | - | - | |
NCT03247088 | Acute Myeloid Leukemia | Phase 1 Phase 2 | Recruiting | July 2022 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Clinical Research Operations CR_Study_Registration@mdanderson.org 收起 << |
NCT00506857 | - | Completed | - | - | |
NCT00427765 | - | Completed | - | - | |
NCT00948090 | - | Completed | - | - | |
NCT00113919 | - | Terminated(Due to poor accrual... 展开 >>) 收起 << | - | - | |
NCT00113919 | Multiple Myeloma | Phase 1 Phase 2 | Terminated(Due to poor accrual... 展开 >>) 收起 << | - | United States, Arkansas ... 展开 >> University of Arkansas for Medical Sciences, Myeloma Institute for Research and Therapy Little Rock, Arkansas, United States, 72205 University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 收起 << |
NCT01009840 | Multiple Myeloma | Phase 2 | Completed | - | United States, Arizona ... 展开 >> Arizona Cancer Center Tucson, Arizona, United States, 85724 United States, Georgia Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States, 30342 United States, Illinois Loyola University Medical Center Maywood, Illinois, United States, 60153 United States, Indiana Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, Maryland University of Maryland School of Medicine - Marlene & Stewart Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Pennsylvania University of Pennsylvania -Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 The Western Pennsylvania Hospital Pittsburgh, Pennsylvania, United States, 15224 United States, Texas South Texas Veterans Health Care System San Antonio, Texas, United States, 78229 Texas Transplant Physician Group, PLLC San Antonio, Texas, United States, 78229 United States, Utah Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Canada, Nova Scotia Queen Elizabeth II Health Sciences Centre Halifax, Nova Scotia, Canada, B3H 2Y9 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 收起 << |
NCT02483325 | Hematological Diseases | Phase 2 | Recruiting | September 2018 | France ... 展开 >> Institut Paoli Calmettes Recruiting Marseille, France, 13009 Principal Investigator: FURST Sabine, MD 收起 << |
NCT00427765 | Multiple Myeloma ... 展开 >> Lymphoma 收起 << | Phase 2 | Completed | - | United States, Texas ... 展开 >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01923935 | Multiple Myeloma | Phase 2 | Unknown | December 2015 | Korea, Republic of ... 展开 >> National Cancer Center Recruiting Goyang-si, Gyeonggi, Korea, Republic of, 410-769 Contact: Hyeon Seok Eom, M.D., Ph.D. 82-31-920-2402 hseom@ncc.re.kr Principal Investigator: Hyeon Seok Eom, M.D., Ph.D. Gachon University Gil Hospital Not yet recruiting Namdong-gu, Incheon, Korea, Republic of, 405-760 Contact: Jae Hoon Lee, M.D., Ph.D. 82-32-460-2186 jhlee@gilhospital.com Principal Investigator: Jae Hoon Lee, M.D., Ph.D. Chonnam National University Hwasun Hospital Recruiting Hwasun-gun, Jeollanam-do, Korea, Republic of, 519-763 Contact: Je-Jung Lee, M.D, Ph.D. 82-61-379-7638 f0115@chonnam.ac.kr Contact: Jae-Sook Ahn, M.D, Ph.D. 82-61-379-7635 ahnjaesook@hanmail.net Principal Investigator: Je-Jung Lee, M.D., Ph.D. Sub-Investigator: Deok-Hwan Yang, M.D., Ph.D. Sub-Investigator: Jae-Sook Ahn, M.D., Ph.D. Sub-Investigator: Sung-Hoon Jung, M.D. Samsung Medical Center Not yet recruiting Gangnam-gu, Seoul, Korea, Republic of, 135-710 Contact: Kihyun Kim, M.D., Ph.D. 82-2-3410-3459 kihyunk@skku.edu Principal Investigator: Kihyun Kim, M.D., Ph.D. Seoul National University Hospital Not yet recruiting Jongno-gu, Seoul, Korea, Republic of, 110-744 Contact: Sung Soo Yoon, M.D., Ph.D. 82-2-2072-3079 ssysmc@snu.ac.kr Principal Investigator: Sung Soo Yoon, M.D., Ph.D. Ewha Womans University Mokdong Hospital Not yet recruiting Mokdong, Seoul, Korea, Republic of, 158-710 Contact: Yeung-Chul Mun, M.D., Ph.D. 82-2-2650-2777 yeungchul@ewha.ac.kr Principal Investigator: Yeung-Chul Mun, M.D., Ph.D. Seoul St. Mary's hospital Not yet recruiting Seocho-gu, Seoul, Korea, Republic of, 137-701 Contact: Chang Ki Min, M.D., Ph.D. 82-2-2258-6053 ckmin@catholic.ac.kr Principal Investigator: Chang Ki Min, M.D., Ph.D. Severance Hospital Not yet recruiting Seodaemun-gu, Seoul, Korea, Republic of, 120-752 Contact: Soo Jung Kim, M.D. 82-2-2228-5487 ALVIN97@yuhs.ac Principal Investigator: Soo Jung Kim, M.D., Ph.D. 收起 << |
NCT01959477 | Adult Grade III Lymphomatoid G... 展开 >>ranulomatosis Adult Nasal Type Extranodal NK/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Childhood Burkitt Lymphoma Childhood Diffuse Large Cell Lymphoma Childhood Grade III Lymphomatoid Granulomatosis Childhood Immunoblastic Large Cell Lymphoma Childhood Nasal Type Extranodal NK/T-cell Lymphoma Contiguous Stage II Adult Burkitt Lymphoma Contiguous Stage II Adult Diffuse Large Cell Lymphoma Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma Contiguous Stage II Adult Lymphoblastic Lymphoma Contiguous Stage II Grade 1 Follicular Lymphoma Contiguous Stage II Grade 2 Follicular Lymphoma Contiguous Stage II Grade 3 Follicular Lymphoma Contiguous Stage II Mantle Cell Lymphoma Contiguous Stage II Marginal Zone Lymphoma Contiguous Stage II Small Lymphocytic Lymphoma Cutaneous B-cell Non-Hodgkin Lymphoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma Intraocular Lymphoma Nodal Marginal Zone B-cell Lymphoma Noncontiguous Stage II Adult Burkitt Lymphoma Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma Noncontiguous Stage II Adult Lymphoblastic Lymphoma Noncontiguous Stage II Grade 1 Follicular Lymphoma Noncontiguous Stage II Grade 2 Follicular Lymphoma Noncontiguous Stage II Grade 3 Follicular Lymphoma Noncontiguous Stage II Mantle Cell Lymphoma Noncontiguous Stage II Marginal Zone Lymphoma Noncontiguous Stage II Small Lymphocytic Lymphoma Noncutaneous Extranodal Lymphoma Peripheral T-cell Lymphoma Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Small Noncleaved Cell Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Refractory Hairy Cell Leukemia Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Stage I Adult Burkitt Lymphoma Stage I Adult Diffuse Large Cell Lymphoma Stage I Adult Diffuse Mixed Cell Lymphoma Stage I Adult Diffuse Small Cleaved Cell Lymphoma Stage I Adult Hodgkin Lymphoma Stage I Adult Immunoblastic Large Cell Lymphoma Stage I Adult Lymphoblastic Lymphoma Stage I Adult T-cell Leukemia/Lymphoma Stage I Childhood Anaplastic Large Cell Lymphoma Stage I Childhood Hodgkin Lymphoma Stage I Childhood Large Cell Lymphoma Stage I Childhood Lymphoblastic Lymphoma Stage I Childhood Small Noncleaved Cell Lymphoma Stage I Cutaneous T-cell Non-Hodgkin Lymphoma Stage I Grade 1 Follicular Lymphoma Stage I Grade 2 Follicular Lymphoma Stage I Grade 3 Follicular Lymphoma Stage I Mantle Cell Lymphoma Stage I Marginal Zone Lymphoma Stage I Small Lymphocytic Lymphoma Stage IA Mycosis Fungoides/Sezary Syndrome Stage IB Mycosis Fungoides/Sezary Syndrome Stage II Adult Hodgkin Lymphoma Stage II Adult T-cell Leukemia/Lymphoma Stage II Childhood Anaplastic Large Cell Lymphoma Stage II Childhood Hodgkin Lymphoma Stage II Childhood Large Cell Lymphoma Stage II Childhood Lymphoblastic Lymphoma Stage II Childhood Small Noncleaved Cell Lymphoma Stage II Cutaneous T-cell Non-Hodgkin Lymphoma Stage IIA Mycosis Fungoides/Sezary Syndrome Stage IIB Mycosis Fungoides/Sezary Syndrome Stage III Adult Burkitt Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Diffuse Small Cleaved Cell Lymphoma Stage III Adult Hodgkin Lymphoma Stage III Adult Immunoblastic Large Cell Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage III Adult T-cell Leukemia/Lymphoma Stage III Childhood Anaplastic Large Cell Lymphoma Stage III Childhood Hodgkin Lymphoma Stage III Childhood Large Cell Lymphoma Stage III Childhood Lymphoblastic Lymphoma Stage III Childhood Small Noncleaved Cell Lymphoma Stage III Cutaneous T-cell Non-Hodgkin Lymphoma Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage III Marginal Zone Lymphoma Stage III Small Lymphocytic Lymphoma Stage IIIA Mycosis Fungoides/Sezary Syndrome Stage IIIB Mycosis Fungoides/Sezary Syndrome Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Diffuse Small Cleaved Cell Lymphoma Stage IV Adult Hodgkin Lymphoma Stage IV Adult Immunoblastic Large Cell Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Adult T-cell Leukemia/Lymphoma Stage IV Childhood Anaplastic Large Cell Lymphoma Stage IV Childhood Hodgkin Lymphoma Stage IV Childhood Large Cell Lymphoma Stage IV Childhood Lymphoblastic Lymphoma Stage IV Childhood Small Noncleaved Cell Lymphoma Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Marginal Zone Lymphoma Stage IV Small Lymphocytic Lymphoma Stage IVA Mycosis Fungoides/Sezary Syndrome Stage IVB Mycosis Fungoides/Sezary Syndrome T-cell Large Granular Lymphocyte Leukemia Testicular Lymphoma Waldenström Macroglobulinemia 收起 << | Early Phase 1 | Completed | - | United States, Ohio ... 展开 >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 收起 << |
NCT00852163 | Leukemia Myel... 展开 >>odysplastic Syndrome 收起 << | Phase 2 | Completed | - | United States, Texas ... 展开 >> Baylor University Medical Center Dallas, Texas, United States, 75246 收起 << |
NCT01009840 | - | Completed | - | - | |
NCT01018446 | Hematopoietic Stem Cell Transp... 展开 >>lantation 收起 << | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Seoul National University Hospital Seoul, Daehangno, Jongno-gu, Korea, Republic of, 101 收起 << |
NCT02034630 | Genetic Rare Disease | Phase 1 Phase 2 | Recruiting | December 2018 | Korea, Republic of ... 展开 >> Seoul National University Hospital Recruiting Seoul, Daehangno, Jongno-gu, Korea, Republic of Contact: Hyoung Jin Kang, MD, PhD 82 2 2072 3304 kanghj@snu.ac.kr Contact: Ji Won Lee, MD 82 2 2072 3452 agnesjw@hanmail.net 收起 << |
NCT01257854 | - | Active, not recruiting | December 2018 | Canada, Alberta ... 展开 >> Alberta children's hospital Calgary, Alberta, Canada Canada, Quebec Chu St Justine Montreal, Quebec, Canada, H3T1C5 France Hopital Rebert Debré Paris, France Switzerland Hopital Cantonal de Genève Geneva, Switzerland, 1206 收起 << | |
NCT00934232 | Multiple Myeloma | Phase 1 | Terminated(PI left the institu... 展开 >>tion) 收起 << | - | - |
NCT02047578 | Acute Lymphoblastic Leukemia | Phase 2 | Recruiting | December 2018 | Korea, Republic of ... 展开 >> Seoul National University Hospital Recruiting Seoul, Daehangno, Jongno-gu, Korea, Republic of Contact: Hyoung Jin Kang, MD, PhD 82 2 2072 3304 kanghj@snu.ac.kr Contact: Ji Won Lee, MD 82 2 2072 4192 agnesjw@hanmail.net 收起 << |
NCT01048827 | Acute Myeloid Leukemia | Phase 1 | Completed | - | United States, California ... 展开 >> University of California Med. Center San Francisco, California, United States, 94143 收起 << |
NCT01498016 | Acute Leukemia | Phase 2 | Unknown | June 2017 | China ... 展开 >> Blood & Marrow Transplantation Center, RuiJin Hospital Recruiting Shanghai, China, 200025 Contact: Jiong HU, M.D. 86-21-64370045 ext 601818 hujiong@medmail.com.cn 收起 << |
NCT01800643 | Acute Leukemia ... 展开 >> Chronic Leukemia Lymphoproliferative Disease Myeloproliferative Disease Immunodeficiency 收起 << | Phase 2 Phase 3 | Unknown | December 2014 | Brazil ... 展开 >> Hospital Israelita Albert Einstein Recruiting Sao Paulo, SP, Brazil, 05651901 Contact: Iracema Esteves , Doctor (5511)963010921 iestevesmed@yahoo.com.br Contact: Sandra Saemi Nakashima, Nurse (5511)21511128 sandra.nakashima@einstein.br Sub-Investigator: Fabio R Kerbauy, Doctor Principal Investigator: Nelson Hamerschlak, Doctor Sub-Investigator: Iracema Esteves, Doctor 收起 << |
NCT01622556 | Hematologic Malignancies | Phase 2 | Terminated | January 2017 | United States, Virginia ... 展开 >> University of Virginia Charlottesville, Virginia, United States, 22908 收起 << |
NCT00322101 | - | Completed | - | - | |
NCT02605460 | Acute Myeloid Leukemia ... 展开 >> Acute Lymphoid Leukemia 收起 << | Phase 2 | Recruiting | December 2018 | Mexico ... 展开 >> Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran Recruiting Mexico City, Distrito Federal, Mexico, 14080 Contact: Eucario Leon Rodriguez, M.D. 525554870900 ext 2255 eucarios@hotmail.com Contact: Monica M Rivera Franco, M.D. 525554870900 ext 2254 monrif90d@gmail.com 收起 << |
NCT01359254 | Hematological Disease | Phase 2 | Terminated(did not accrue enou... 展开 >>gh patients.) 收起 << | - | United States, Illinois ... 展开 >> University of Chicago Chicago, Illinois, United States, 60637 收起 << |
NCT01359254 | - | Terminated(did not accrue enou... 展开 >>gh patients.) 收起 << | - | - | |
NCT01505569 | Ewing's Family Tumors ... 展开 >> Renal Tumors Hepatoblastoma Rhabdomyosarcoma Soft Tissue Sarcoma Primary Malignant Brain Neoplasms Retinoblastoma Medulloblastoma Supra-tentorial Primative Neuro-Ectodermal Tumor (PNET) Atypical Teratoid/Rhabdoid Tumor (AT/RT) CNS Tumors Germ Cell Tumors 收起 << | Not Applicable | Recruiting | January 2021 | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Kim Nelson 612-273-2925 knelso62@fairview.org Principal Investigator: Heather Stefanski, MD, PhD 收起 << |
NCT03412409 | Acute Leukemia ... 展开 >> Myelodysplastic Syndromes 收起 << | Phase 2 | Recruiting | March 1, 2020 | China ... 展开 >> Peking University, Institute of Hematolgoy Recruiting Beijing, China Contact: Xiao-Dong Mo 收起 << |
NCT00003972 | Breast Cancer | Phase 3 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 收起 << |
NCT03412266 | Myelodysplastic Syndromes | Phase 2 | Recruiting | March 1, 2020 | China, Beijing ... 展开 >> Peking University Institute of Hematology,Beijing Recruiting Beijing, Beijing, China, 100044 Contact: Xiao-Dong Mo mxd453@163.com Principal Investigator: Xiao-Jun Huang, MD 收起 << |
NCT00782379 | Leukemia Lymp... 展开 >>homa Myelodysplastic Syndromes 收起 << | Phase 2 | Completed | - | United States, Georgia ... 展开 >> Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States, 30342 收起 << |
NCT00322101 | Acute Myeloid Leukemia With Mu... 展开 >>ltilineage Dysplasia Following Myelodysplastic Syndrome Acute Myeloid Leukemia/Transient Myeloproliferative Disorder Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Childhood Acute Myeloid Leukemia in Remission Childhood Myelodysplastic Syndromes de Novo Myelodysplastic Syndromes Myelodysplastic Syndrome With Isolated Del(5q) Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes 收起 << | Phase 3 | Completed | - | United States, Colorado ... 展开 >> HealthOne Presbyterian St. Lukes Medical Center Denver, Colorado, United States United States, Georgia Emory University Altanta, Georgia, United States, 30322 United States, New York Weill Cornell University New York, New York, United States, 10021 United States, Utah University of Utah Salt Lake City, Utah, United States, 84112 United States, Washington Veterans Administration Center-Seattle Seattle, Washington, United States, 98108 Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 United States, Wisconsin Medical College Wisconsin Milwaukee, Wisconsin, United States Germany Technical University Dresden Dresden, Saxony, Germany, 01307 收起 << |
NCT00782379 | - | Completed | - | - | |
NCT02120157 | Myeloablative Conditioning ... 展开 >> HLA-mismatched Bone Marrow Transplantation Graft Survival Transplantion, Bone Marrow 收起 << | Phase 2 | Active, not recruiting | December 2020 | United States, Colorado ... 展开 >> Children's Hospital of Colorado Aurora, Colorado, United States, 80045 United States, Delaware Nemours Alfred I. DuPont Hospital for Children Wilmington, Delaware, United States, 19803 United States, Florida All Children's Hospital Johns Hopkins Medicine Saint Petersburg, Florida, United States, 33701 United States, Maryland Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 United States, Missouri Washington University in St. Louis Saint Louis, Missouri, United States, 63110 United States, North Carolina Levine Cancer Center Charlotte, North Carolina, United States, 28203 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29423 Canada, British Columbia British Columbia Children's Hospital Vancouver, British Columbia, Canada, V6H 3V4 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 收起 << |
NCT00153985 | Hemoglobinopathies ... 展开 >> Sickle Cell Disease Thalassemia 收起 << | Phase 2 | Completed | - | United States, Georgia ... 展开 >> Winship Cancer Institute-Emory University Atlanta, Georgia, United States, 30322 United States, Louisiana Feist-Weiller Cancer Center-LSU Shreveport, Louisiana, United States, 71130 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Boston, Massachusetts, United States, 02115 United States, Ohio Ohio State University College of Medicine Columbus, Ohio, United States, 43210 收起 << |
NCT02410551 | Myeloproliferative Diseases | Phase 2 | Terminated | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00153985 | - | Completed | - | - | |
NCT02022696 | Adenosine Deaminase Deficiency... 展开 >> ADA-SCID 收起 << | Phase 1 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT00357565 | Leukemia Myel... 展开 >>odysplastic Syndromes Childhood Acute Myeloid Leukemia in Remission Recurrent Childhood Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Childhood Acute Lymphoblastic Leukemia in Remission Previously Treated Myelodysplastic Syndrome Secondary Myelodysplastic Syndrome Refractory Anemia With Excess Blasts in Transformation Refractory Anemia With Excess Blasts Refractory Anemia De Novo Myelodysplastic Syndrome Childhood Myelodysplastic Syndrome 收起 << | Phase 2 | Recruiting | February 2019 | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Christen Ebens, MD 612-624-0123 ebens012@umn.edu 收起 << |
NCT02410551 | - | Terminated | - | - | |
NCT00638820 | - | Terminated(Excess toxicity) | - | - | |
NCT00813124 | Stem Cell Transplantation ... 展开 >> Leukemia 收起 << | Phase 2 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00027924 | Leukemia Myel... 展开 >>odysplastic Syndromes 收起 << | Phase 2 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 收起 << |
NCT00598481 | Immunologic Deficiency Syndrom... 展开 >>es 收起 << | Phase 2 | Active, not recruiting | June 30, 2019 | Israel ... 展开 >> GSK Investigational Site Jerusalem, Israel Italy GSK Investigational Site Milano, Lombardia, Italy, 20132 收起 << |
NCT00186810 | Sickle Cell Disease | Phase 2 | Completed | - | United States, Tennessee ... 展开 >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 收起 << |
NCT01050855 | Non Malignant Diseases ... 展开 >> Immunodeficiencies Hemoglobinopathies 收起 << | Phase 2 | Recruiting | December 2018 | United States, Pennsylvania ... 展开 >> The Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Barbara McGlynn 215-590-1303 mcglynn@email.chop.edu Contact: Patricia Hankins, RN 215 590-5168 hankinsp@email.chop.edu Principal Investigator: Nancy J Bunin, MD 收起 << |
NCT00003081 | Sarcoma | Phase 1 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 收起 << |
NCT02626715 | Acute Myeloid Leukemia (AML) ... 展开 >> Myelodysplastic Syndrome (MDS) Hematopoietic Stem Cell Transplant (HSCT) 收起 << | Phase 2 | Recruiting | September 2021 | United States, Pennsylvania ... 展开 >> Children's Hospital of Pittsburgh of UPMC Recruiting Pittsburgh, Pennsylvania, United States, 15224 Contact: Randy Windreich, MD 412-692-5055 收起 << |
NCT00394316 | Chronic Granulomatous Disease | Early Phase 1 | Terminated | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT00638820 | Osteopetrosis | Phase 2 | Terminated(Excess toxicity) | - | United States, Minnesota ... 展开 >> University of MInnesota, Fairview Minneapolis, Minnesota, United States, 55455 收起 << |
NCT00670410 | Neuroblastoma | Phase 1 | Terminated(Poor accrual) | - | United States, New York ... 展开 >> Columbia Presbyterian Medical Center, Morgan Stanley Children's Hospital New York Presbyterian New York, New York, United States, 10032 收起 << |
NCT00005948 | Leukemia | Phase 2 | Completed | - | United States, Colorado ... 展开 >> University of Colorado Cancer Center Denver, Colorado, United States, 80010 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 收起 << |
NCT00002554 | Leukemia | Phase 2 | Completed | - | - |
NCT00003146 | Multiple Myeloma and Plasma Ce... 展开 >>ll Neoplasm 收起 << | Phase 2 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 收起 << |
NCT00578344 | Sickle Cell Disease ... 展开 >> Hemoglobin SC 收起 << | Not Applicable | Terminated(Terminated due to n... 展开 >>o new subject enrollment during the last 3 year period.) 收起 << | - | United States, Texas ... 展开 >> Methodist Hospital Houston, Texas, United States, 77030 Texas Children's Hospital Houston, Texas, United States, 77030 收起 << |
NCT02385955 | Hematologic Malignancy | Phase 2 | Not yet recruiting | April 2019 | - |
NCT01339910 | - | Terminated(Accrual terminated ... 展开 >>as recommended by the data and safety monitoring board.) 收起 << | - | - | |
NCT00446173 | Leukemia | Phase 2 | Withdrawn(Terminated due to lo... 展开 >>w accrual.) 收起 << | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT02727803 | Leukemia Lymp... 展开 >>homa Myeloma Myeloproliferative Diseases 收起 << | Phase 2 | Recruiting | May 2021 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 收起 << |
NCT01339910 | Leukemia, Myelocytic, Acute | Phase 3 | Terminated(Accrual terminated ... 展开 >>as recommended by the data and safety monitoring board.) 收起 << | - | - |
NCT00988013 | Acute Myeloid Leukemia ... 展开 >> Lymphoblastic Leukemia Acute Leukemia Non Hodgkins Lymphoma Chronic Myeloid Leukemia 收起 << | Phase 1 | Unknown | September 2017 | United States, Illinois ... 展开 >> University of Illinois at Chicago Chicago, Illinois, United States, 60612 收起 << |
NCT00176930 | Leukemia, Myeloid, Chronic ... 展开 >> AML Leukemia, Lymphocytic, Acute MDS Leukemia, Lymphocytic, Chronic JMML Hodgkin's Disease Non-hodgkin's Lymphoma Multiple Myeloma 收起 << | Not Applicable | Suspended(Trial re-written as ... 展开 >>MT2015-29) 收起 << | December 2018 | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT02766868 | Lymphoblastic Leukemia, Acute,... 展开 >> Adult 收起 << | Phase 2 | Recruiting | July 2019 | China ... 展开 >> Blood & Marrow Transplantation Center, RuiJin Hospital Recruiting Shanghai, China, 200025 Contact: Ling Wang 86-21-64370045 ext 601818 cclingjar@163.com 收起 << |
NCT00582894 | Hematological Neoplasms ... 展开 >> Hematopoietic Stem Cell Transplantation 收起 << | Not Applicable | Completed | - | United States, Oklahoma ... 展开 >> University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States, 73104 收起 << |
NCT02007863 | - | Completed | - | - | |
NCT02007863 | Leukemia Myel... 展开 >>odysplasia Acute Lymphocytic Leukemia Acute Myelogenous Leukemia 收起 << | Not Applicable | Completed | - | United States, Florida ... 展开 >> Jackson Memorial Hospital Miami, Florida, United States, 33136 University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States, 33136 收起 << |
NCT03315078 | X-Linked Combined Immunodefici... 展开 >>ency Diseases 收起 << | Phase 1 Phase 2 | Recruiting | December 2022 | United States, Maryland ... 展开 >> Laboratory of Host Defenses (LHD), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) Recruiting Bethesda, Maryland, United States, 20892-1456 Contact: Suk See DeRavin, M.D., Ph.D 301-496-6772 收起 << |
NCT01141543 | - | Completed | - | Canada, Ontario ... 展开 >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 收起 << | |
NCT03583294 | Leukemia | Not Applicable | Recruiting | April 1, 2021 | France ... 展开 >> Assistance Publique Hopitaux de Marseille Recruiting Marseille, France, 13354 Contact: Blandine Courbiere, MD/PhD blandine.courdbiere@ap-hm.fr 收起 << |
NCT00005797 | Chronic Myeloproliferative Dis... 展开 >>orders Leukemia Multiple Myeloma and Malignant Plasma Cell Neoplasms Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms 收起 << | Phase 2 | Completed | - | United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States, 33612-9497 收起 << |
NCT03601286 | Severe Combined Immunodeficien... 展开 >>cy, X-Linked 收起 << | Phase 1 | Not yet recruiting | October 2024 | - |
NCT00582894 | - | Completed | - | - | |
NCT00881556 | Epidermolysis Bullosa | Early Phase 1 | Unknown | July 2014 | United States, Colorado ... 展开 >> The Children's Hospital Aurora, Colorado, United States, 80045 United States, Illinois Children's Memorial Hospital Chicago, Illinois, United States, 60614 United States, New York Morgan Stanley Children's Hospital of NYP New York, New York, United States, 10032 收起 << |
NCT00796562 | MDS Leukemias... 展开 >> Lymphomas 收起 << | Phase 2 | Completed | - | United States, Maryland ... 展开 >> Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21231 The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 收起 << |
NCT02025881 | High-risk Medulloblastoma | Phase 1 Phase 2 | Recruiting | September 2022 | France ... 展开 >> Gustave Roussy Recruiting Villejuif, Val de Marne, France, 94805 Contact: Christelle Dufour, MD 0142114247 ext +33 christelle.dufour@gustaveroussy.fr Contact: Perrine Capolino 0142113590 ext +33 perrine.capolino@gustaveroussy.fr Principal Investigator: Christelle Dufour, MD 收起 << |
NCT01156350 | Neuroblastoma | Phase 2 | Unknown | September 2014 | France ... 展开 >> CHU Clermont-Ferrand Not yet recruiting Clermont-Ferrand, France, 63003 Contact: Patrick LACARIN 04 73 75 11 95 placarin@chu-clermontferrand.fr 收起 << |
NCT01410344 | Leukemia Lymp... 展开 >>homa HIV 收起 << | Phase 2 | Active, not recruiting | December 2018 | United States, Arizona ... 展开 >> Mayo Clinic - Phoenix Phoenix, Arizona, United States, 85054 United States, California City of Hope National Medical Center Duarte, California, United States, 91010 University of CA, SF San Francisco, California, United States, 94143-0324 United States, Florida H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33624 United States, Georgia Blood & Marrow Transplant Program at Northside Hospital Atlanta, Georgia, United States, 30342 United States, Maryland Johns Hopkins Baltimore, Maryland, United States, 21231 United States, Minnesota Mayo Clinic - Rochester Rochester, Minnesota, United States, 55905 United States, Pennsylvania University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States, 19104 United States, Texas University of Texas/MD Anderson CRC Houston, Texas, United States, 77030 Texas Transplant Institute San Antonio, Texas, United States, 78229 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53211 收起 << |
NCT01471067 | Blood And Marrow Transplantati... 展开 >>on Leukemia Lymphoma Transplantation Infection Transplantation, Bone Marrow 收起 << | Phase 1 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT02670564 | Acute Lymphoblastic Leukemia | Phase 4 | Recruiting | April 2023 | Switzerland ... 展开 >> Hôpital Cantonal de Genève, Département de Pédiatrie Recruiting Geneva, Cansearch Laboratory, Switzerland, 1211 Contact: Marc Ansari, MD, PD +41 22 382 47 31 Marc.Ansari@hcuge.ch Universitäts-Kinderspital beider Basel (UKBB), Onkologie/Hämatologie Recruiting Basel, Switzerland, 4056 Contact: Nicolas Von der Weid + 41 61 704 12 12 nicolas.vonderweid@ukbb.ch HUG Hôpitaux Universitaire de Genève, Unité d'onco-hématologie pédiatrique Recruiting Geneva, Switzerland, 1211 Contact: Marc Ansari +41 22 372 47 31 Marc.Ansari@hcuge.ch Universitäts-Kinderspital Recruiting Zurich, Switzerland, 8032 Contact: Güngör Tayfun +41 44 266 74 92 tayfun.guengoer@kispi.uzh.ch 收起 << |
NCT00684255 | - | Terminated(inactive) | - | - | |
NCT01795430 | Adult Supratentorial Primitive... 展开 >> Neuroectodermal Tumor (PNET) Ewing Sarcoma of Bone Extraosseous Ewing Sarcoma Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor 收起 << | Not Applicable | Withdrawn(No participants enro... 展开 >>lled.) 收起 << | - | United States, California ... 展开 >> City of Hope Medical Center Duarte, California, United States, 91010 收起 << |
NCT03259503 | Malignant Neoplasms Stated as ... 展开 >>Primary Lymphoid Haematopoietic Lymphoma 收起 << | Phase 1 Phase 2 | Not yet recruiting | May 2019 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact ynieto@mdanderson.org 收起 << |
NCT01410344 | - | Active, not recruiting | - | - | |
NCT01749293 | Hematologic Malignancies | Phase 2 | Terminated(The protocol design... 展开 >> is being reconfigured in order to open a new study.) 收起 << | June 2017 | United States, Illinois ... 展开 >> University of Illinois Cancer Center Chicago, Illinois, United States, 60612 收起 << |
NCT00684255 | Systemic Lupus Erythematosus ... 展开 >> Systemic Sclerosis 收起 << | Phase 1 | Terminated(inactive) | - | United States, New York ... 展开 >> Columbia University Medical Center New York, New York, United States, 10032 收起 << |
NCT00054340 | Chronic Myeloproliferative Dis... 展开 >>orders Graft Versus Host Disease Leukemia Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases 收起 << | Phase 1 Phase 2 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 收起 << |
NCT00176904 | - | Completed | - | - | |
NCT00176917 | - | Completed | - | - | |
NCT00176917 | Mucopolysaccharidosis I ... 展开 >> Mucopolysaccharidosis VI Mannosidosis Mucolipidosis Type II (I-cell Disease) 收起 << | Phase 2 | Completed | - | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT03096782 | Hematopoietic/Lymphoid Cancer | Phase 2 | Recruiting | October 2020 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Clinical Research Operations alolson@mdanderson.org 收起 << |
NCT00003199 | - | Completed | - | - | |
NCT00578643 | Chronic Granulomatous Disease | Phase 2 | Completed | - | United States, Texas ... 展开 >> Texas Children's Hospital Houston, Texas, United States, 77030 收起 << |
NCT00176904 | Adrenoleukodystrophy ... 展开 >> Metachromatic Leukodystrophy Globoid Cell Leukodystrophy Gaucher's Disease Fucosidosis Wolman Disease Niemann-Pick Disease Batten Disease GM1 Gangliosidosis Tay Sachs Disease Sandhoff Disease 收起 << | Phase 2 Phase 3 | Completed | - | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT00968162 | Bone Marrow Transplantation ... 展开 >> Sickle Cell Disease 收起 << | Phase 1 | Completed | - | United States, Alabama ... 展开 >> University of Alabama-Birmingham Birmingham, Alabama, United States United States, District of Columbia Children's National Medical Center Washington, D.C., District of Columbia, United States United States, Florida All Children's Research Institute Inc. Saint Petersburg, Florida, United States, 33701 United States, Georgia Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30322 United States, Louisiana Tulane University New Orleans, Louisiana, United States, 70112 United States, Michigan Wayne State University Detroit, Michigan, United States, 48202 United States, Mississippi University of Mississippi Medical Center Jackson, Mississippi, United States United States, New York Montefiore Medical Center The Bronx, New York, United States United States, North Carolina University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27516 United States, Texas University of Texas Southwestern Dallas, Texas, United States 收起 << |
NCT00578643 | - | Completed | - | - | |
NCT00578435 | Genetic Disorders ... 展开 >> Sickle Cell Anemia 收起 << | Phase 2 | Completed | - | United States, New York ... 展开 >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 收起 << |
NCT00003199 | Estrogen Receptor-negative Bre... 展开 >>ast Cancer Estrogen Receptor-positive Breast Cancer Inflammatory Breast Cancer Male Breast Cancer Progesterone Receptor-negative Breast Cancer Progesterone Receptor-positive Breast Cancer Stage IIIB Breast Cancer Stage IV Breast Cancer 收起 << | Phase 2 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center/Puget Sound Oncology Consortium Seattle, Washington, United States, 98109 收起 << |
NCT00615589 | Multiple Myeloma ... 展开 >> Plasma Cell Leukemia 收起 << | Phase 2 | Terminated(Low accrual) | - | United States, Michigan ... 展开 >> University of Michigan,Department of Internal Med. Hematology- Oncology Ann Arbor, Michigan, United States, 48109 收起 << |
NCT00615589 | - | Terminated(Low accrual) | - | - | |
NCT02531841 | Diffuse Large B-cell-lymphoma | Phase 3 | Recruiting | December 2019 | Germany ... 展开 >> University Hospital Freiburg - Department for Hematology, Oncology and Stem cell Transplantion Recruiting Freiburg, Baden-Wuerttemberg, Germany, 79106 Contact: Juergen Finke, PhD +49761270 ext 34080 juergen.finke@uniklinik-freiburg.de Contact: Elisabeth Schorb, PhD +49761270 ext 33210 elisabeth.schorb@uniklinik-freiburg.de Klinikum Stuttgart, Clinic of Hematology, Oncology and Palliative Care, Stuttgart Cancer Center / Tumor Center Eva Mayr-Stihl Recruiting Stuttgart, Baden-Wuerttemberg, Germany, 70174 Contact: Gerald Illerhaus, PhD +49 711 278 ext 30400 G.Illerhaus@klinikum-stuttgart.de Contact: Kristina Mikesch, PhD +49 711 278 ext 30403 k.mikesch@klinikum-stuttgart.de 收起 << |
NCT01175356 | - | Completed | - | - | |
NCT03385096 | Autologous Hematopoietic Stem ... 展开 >>Cell Transplantation Conditioning Multiple Myeloma 收起 << | Phase 2 Phase 3 | Not yet recruiting | December 2021 | China, Guangdong ... 展开 >> Department of Hematology,Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China, 510515 收起 << |
NCT02171104 | Mucopolysaccharidosis Disorder... 展开 >>s Hurler Syndrome Hunter Syndrome Maroteaux Lamy Syndrome Sly Syndrome Alpha-Mannosidosis Fucosidosis Aspartylglucosaminuria Glycoprotein Metabolic Disorders Sphingolipidoses Recessive Leukodystrophies Globoid Cell Leukodystrophy Metachromatic Leukodystrophy Niemann-Pick B Niemann-Pick C Subtype 2 Sphingomyelin Deficiency Peroxisomal Disorders Adrenoleukodystrophy With Cerebral Involvement Zellweger Syndrome Neonatal Adrenoleukodystrophy Infantile Refsum Disease Acyl-CoA Oxidase Deficiency D-Bifunctional Enzyme Deficiency Multifunctional Enzyme Deficiency Alpha-methylacyl-CoA Racmase Deficiency Mitochondrial Neurogastrointestingal Encephalopathy Severe Osteopetrosis Hereditary Leukoencephalopathy With Axonal Spheroids (HDLS; CSF1R Mutation) Inherited Metabolic Disorders 收起 << | Phase 2 | Recruiting | September 2019 | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Kim Nelson 612-273-2925 knelso62@fairview.org 收起 << |
NCT01175356 | Disseminated Neuroblastoma ... 展开 >> Ganglioneuroblastoma Localized Resectable Neuroblastoma Localized Unresectable Neuroblastoma Regional Neuroblastoma Stage 4S Neuroblastoma 收起 << | Not Applicable | Completed | - | - |
NCT00623935 | - | Completed | - | - | |
NCT00623935 | Acute Myelogenous Leukemia | Phase 2 | Completed | - | United States, Michigan ... 展开 >> University of Michigan Cancer Center Ann Arbor, Michigan, United States, 48109 收起 << |
NCT00627666 | Leukemia Myel... 展开 >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms 收起 << | Phase 2 | Completed | - | Korea, Republic of ... 展开 >> Asan Medical Center - University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 收起 << |
NCT00436761 | Unspecified Childhood Solid Tu... 展开 >>mor, Protocol Specific 收起 << | Phase 1 | Unknown | - | United States, Pennsylvania ... 展开 >> Penn State Cancer Institute at Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 收起 << |
NCT03515707 | Acute Myeloid Leukemia ... 展开 >> Minimal Residual Disease Negativity 收起 << | Phase 2 | Recruiting | July 30, 2022 | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Leona A. Holmberg 206-667-6447 Principal Investigator: Leona A. Holmberg 收起 << |
NCT00014469 | Graft Versus Host Disease ... 展开 >> Leukemia Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms 收起 << | Phase 2 | Completed | - | United States, New York ... 展开 >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 收起 << |
NCT00043810 | Acute Myelogenous Leukemia ... 展开 >> Myelodysplastic Syndrome 收起 << | Phase 1 Phase 2 | Terminated | - | United States, Texas ... 展开 >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01823198 | Leukemia | Phase 1 Phase 2 | Recruiting | June 2021 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 收起 << |
NCT00179764 | Tumors Malign... 展开 >>ant Melanoma Hematological Malignancies Myelogenous Leukemia, Chronic Leukemia, Lymphoblastic, Acute 收起 << | Phase 2 | Unknown | December 2016 | United States, Illinois ... 展开 >> Children's Memorial Hospital Recruiting Chicago, Illinois, United States, 60614 Principal Investigator: Morris Kletzel, M.D. 收起 << |
NCT02221310 | Acute Myelogenous Leukemia ... 展开 >> Myelodysplastic Syndrome 收起 << | Phase 2 | Recruiting | June 2021 | United States, New York ... 展开 >> New York Medical College Recruiting Valhalla, New York, United States, 10595 Contact: Sandra Fabricatore, RN, PNP 914-594-2152 sandra.fabricatore@wmchealth.org Contact: Erin Morris, RN 714-964-5359 erin_morris@nymc.edu Principal Investigator: Mitchell S Cairo, MD 收起 << |
NCT00003116 | Leukemia Lymp... 展开 >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases 收起 << | Phase 2 | Completed | - | United States, Ohio ... 展开 >> Ireland Cancer Center at University Hosptials Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 收起 << |
NCT00416598 | - | Active, not recruiting | - | - | |
NCT00416598 | Acute Myeloid Leukemia ... 展开 >> Acute Myeloid Leukemia With Myelodysplasia-Related Changes Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1 Adult Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A Untreated Adult Acute Myeloid Leukemia 收起 << | Phase 2 | Active, not recruiting | - | - |
NCT00794508 | Severe Combined Immunodeficien... 展开 >>cy 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> University of California, Los Angeles Los Angeles, California, United States, 90095 收起 << |
NCT01082133 | Fanconi Anemia | Phase 2 | Completed | - | United States, Ohio ... 展开 >> Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 收起 << |
NCT01306019 | X-linked Severe Combined Immun... 展开 >>odeficiency XSCID SCID-X1 Gamma C-Deficient SCID 收起 << | Phase 1 Phase 2 | Recruiting | December 31, 2025 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 ext TTY8664111010 prpl@cc.nih.gov 收起 << |
NCT01499147 | - | Completed | - | - | |
NCT00794508 | - | Completed | - | - | |
NCT00301951 | Leukemia Lymp... 展开 >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes 收起 << | Phase 1 | Completed | - | United States, California ... 展开 >> UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143-0324 收起 << |
NCT01499147 | Acute Myeloid Leukemia ... 展开 >> Acute Leukemia Chronic Myelogenous Leukemia Malignant Lymphoma Hodgkin's Disease Multiple Myeloma Lymphocytic Leukemia Myeloproliferative Disorder Polycythemia Vera Myelofibrosis Aplastic Anemia 收起 << | Not Applicable | Completed | - | United States, Illinois ... 展开 >> University of Illinois at Chicago Medical Center Chicago, Illinois, United States, 60612 收起 << |
NCT02469974 | Myelofibrosis ... 展开 >> MF 收起 << | Not Applicable | Withdrawn(no enrollments) | - | - |
NCT01182415 | Non-Hodgkin's Lymphoma ... 展开 >> CNS Lymphoma 收起 << | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 << |
NCT01666080 | Hematologic Disorders ... 展开 >> Hemoglobinopathies Immunodeficiencies 收起 << | Not Applicable | Recruiting | June 2019 | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Weston P. Miller, M.D. 612-626-2778 mill4991@umn.eud Principal Investigator: Weston P. Miller, M.D. 收起 << |
NCT00448201 | - | Completed | - | - | |
NCT00907582 | Acute Promyelocytic Leukemia ... 展开 >> Relapse 收起 << | Phase 2 | Terminated(slow recruitment) | - | China ... 展开 >> Rui Jin Hospital, Shanghai JiaoTong University School of Medicine Shanghai, China, 200025 收起 << |
NCT01639690 | Confirmed Diagnosis of ß-thala... 展开 >>ssemia Major 收起 << | Phase 1 | Active, not recruiting | July 2019 | United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 收起 << |
NCT01182415 | - | Completed | - | - | |
NCT00305708 | Congenital Amegakaryocytic Thr... 展开 >>ombocytopenia Diamond-blackfan Anemia Fanconi Anemia Leukemia Severe Congenital Neutropenia Thrombocytopenia 收起 << | Phase 1 Phase 2 | Completed | - | United States, California ... 展开 >> UCSF Comprehensive Cancer Center San Francisco, California, United States, 94115 收起 << |
NCT00034528 | Hemoglobinopathies ... 展开 >> Anemia, Sickle Cell Hemoglobin SC Disease Thalassemia Thalassemia Major 收起 << | Phase 2 | Terminated(Due to slow recruit... 展开 >>ment) 收起 << | - | United States, Massachusetts ... 展开 >> Dana-Farber Cancer Institute/Harvard Cancer Center, Brigham and Women's Hospital and Massachusetts General Hospital Boston, Massachusetts, United States, 02115 收起 << |
NCT00448201 | Chronic Myeloproliferative Dis... 展开 >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes 收起 << | Phase 2 | Completed | - | United States, North Carolina ... 展开 >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 收起 << |
NCT03602131 | Hodgkin Lymphoma ... 展开 >> Non-hodgkin Lymphoma 收起 << | Phase 2 | Not yet recruiting | March 30, 2021 | - |
NCT00802568 | Multiple Myeloma and Plasma Ce... 展开 >>ll Neoplasm 收起 << | Phase 2 | Completed | - | France ... 展开 >> Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Marseille, France, 13273 收起 << |
NCT00579111 | - | Terminated(slow accrual) | - | - | |
NCT00579111 | Myelodysplastic and Myeloproli... 展开 >>ferative Disorders Acute Myelogenous Leukemia Acute Lymphoblastic Leukemia Chronic Myelogenous Leukemia Multiple Myeloma Plasma Cell Dyscrasia Lymphoproliferative Disorders Hematologic Diseases 收起 << | Phase 1 Phase 2 | Terminated(slow accrual) | - | United States, Texas ... 展开 >> Texas Children's Hospital Houston, Texas, United States, 77030 The Methodist Hospital Houston, Texas, United States, 77030 收起 << |
NCT00950846 | Congenital Pediatric Disorders | Not Applicable | Recruiting | January 2025 | United States, Texas ... 展开 >> Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Caridad A Martinez, MD 832-824-4692 camartin@txch.org Contact: Marlen Dinu 832-824-4881 mxdinu@txch.org 收起 << |
NCT01071239 | Fanconi Anemia | Phase 2 | Completed | - | United States, Wisconsin ... 展开 >> Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 收起 << |
NCT01135329 | Lymphoma Leuk... 展开 >>emia Myelodysplastic Syndrome 收起 << | Phase 2 | Terminated(The stopping rule w... 展开 >>as met and hence the study was closed) 收起 << | - | United States, Maryland ... 展开 >> The Sydney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21231 收起 << |
NCT00841724 | Hematological Malignancies | Phase 2 | Completed | - | France ... 展开 >> Institut Paoli Calmettes Marseille, France, 13273 CHU de Nantes Nantes, France, 44093 CHU de Bordeaux Pessac, France, 33604 收起 << |
NCT03653247 | Sickle Cell Disease | Phase 1 Phase 2 | Not yet recruiting | September 2022 | - |
NCT00806767 | Chronic Myeloproliferative Dis... 展开 >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms 收起 << | Phase 2 | Completed | - | France ... 展开 >> Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Marseille, France, 13273 收起 << |
NCT00226512 | Acute Myeloid Leukemia ... 展开 >> Myelodysplastic Syndrome 收起 << | Phase 3 | Withdrawn(the PI is no longer ... 展开 >>work at Hadassah) 收起 << | - | Israel ... 展开 >> Hadassah Medical Organization Jerusalem, Israel, 91120 收起 << |
NCT01135329 | - | Terminated(The stopping rule w... 展开 >>as met and hence the study was closed) 收起 << | - | - | |
NCT02577926 | Polycythemia Vera (PV) ... 展开 >> Essential Thrombocythemia (ET) 收起 << | Phase 2 | Recruiting | December 2022 | Germany ... 展开 >> Universitätsmedizin Mannheim III. Medizinische Klinik Hämatologie und Internistische Onkologie Recruiting Mannheim, Baden-Württemberg, Germany, 68167 Contact: Eva Langfelder, Prof. Dr. +49 (0)621 383 41 31 eva.lengfelder@umm.de Universitätsklinikum Ulm Klinik für Innere Medizin III Recruiting Ulm, Baden-Württemberg, Germany, 89081 Contact: Konstanz Döhner, Prof. Dr. +49 (0)731 500 45543 konstanze.doehner@uniklinik-ulm.de Rems-Murr Klinikum Winnenden Recruiting Winnenden, Baden-Württemberg, Germany, 71364 Contact: Stefani Parmentier, Dr. stefani.parmentier@rems-murr-kliniken.de Contact: Markus Schaich, Dr. markus.schaich@rems-murr-kliniken.de Studienzentrum Aschaffenburg Recruiting Aschaffenburg, Bayern, Germany, 63739 Contact: Martine Klausmann, Dr. mk@klausmann.de III. Medizinischen Klinik des Klinikums rechts der Isar der TU München Recruiting Müchen, Bayern, Germany, 81675 Contact: Philipp Jost, Dr. med. philipp.jost@tum.de Klinikum Nürnberg Nord Medizinische Klinik 5 Recruiting Nürnberg, Bayern, Germany, 90419 Contact: Marinela Augustin, Dr. +49 (0) 911 398 3085 Marinela.Augustin@klinikum-nuernberg.de Universitätsmedizin Mainz III. Medizinische Klinik und Poliklinik Recruiting Mainz, Hessen, Germany, 55131 Contact: Thomas Kindler, PD Dr. +49 (0)6131 17-5046 thomas.kindler@unimedizin-mainz.de Universitätsklinikum Bonn Medizinische Klinik und Poliklinik III Recruiting Bonn, Nordrhein-Westfalen, Germany, 53105 Contact: Dominik Wolf, Prof. Dr. +49 (0)228 287 17233 dominik.wolf@ukb.uni-bonn.de Johanniter-Krankenhaus Rheinhausen GmbH Hämatologie / Internistische Onkologie / Tagesklinik Recruiting Duisburg, Nordrhein-Westfalen, Germany, 47228 Contact: Jan Sebastian Balleisen, Dr. med. s.balleisen@johanniter-rheinhausen.de Universitätsklinikum Düsseldorf Klinik für Hämatologie, Onkologie und Klinische Immunologie Recruiting Düsseldorf, Nordrhein-Westfalen, Germany, 40225 Contact: Norbert Gattermann, Prof. Dr. gattermann@med.uni-duesseldorf.de Universitätsklinikum Essen Klinik für Hämatologie Recruiting Essen, Nordrhein-Westfalen, Germany, 45122 Contact: Göthert Joachim, Dr. joachim.goethert@uk-essen.de Mühlenkreiskliniken Johannes Wesling Klinikum Minden Klinik für Hämatologie, Onkologie und Palliativmedizin Recruiting Minden, Nordrhein-Westfalen, Germany, 32429 Contact: Martin Griesshammer, Prof. Dr. +49 (0)571 790 4201 Martin.Griesshammer@muehlenkreiskliniken.de Zentralklinikum Medizinische Klinik A Hämatologie, Hämostaseologie, Onkologie und Pneumologie Recruiting Münster, Nordrhein-Westfalen, Germany, 48149 Contact: Tim Sauer, Dr. +49 (0) 251 83 52818 tim.sauer@ukmuenster.de Marienhospital Recruiting Düsseldorf, North Rhine Westphalia, Germany, 40479 Contact: Aristoteles Giagounidis, Prof +49 2 11 44 00 -25 01 aristoteles.giagounidis@vkkd-kliniken.de Principal Investigator: Aristoteles Giagounidis, Prof Zentrum für ambulante Hämatologie und Onkologie (ZAHO) Not yet recruiting Siegburg, North Rhine Westphalia, Germany, 53721 Contact: Stefan Fronhoffs, Dr. +49 2241/59540 SFronhoffs@zaho-rheinland.de Uniklinik RWTH Aachen Recruiting Aachen, NRW, Germany, 52074 Contact: Steffen Koschmieder, Prof. Dr. 00492418036102 skoschmieder@ukaachen.de Contact: Susanne Isfort, Dr. 00492418037411 sisfort@ukaachen.de Universitätsklinikum Magdeburg Recruiting Magdeburg, Sachesen-Anhalt, Germany, 39120 Contact: Denise Wolleschak, Dr. 0049 391 6713271 denise.wolleschak@med.ovgu.de Universitätsklinikum Halle (Saale) Recruiting Halle (Saale), Sachsen-Anhalt, Germany, 06120 Contact: Haifa K. Al-Ali, PD Dr. med. 0345 5574959 innere4@uk-halle.de Klinikum Chemnitz gGmbH Klinik für Innere Medizin III Recruiting Chemnitz, Sachsen, Germany, 09113 Contact: Hänel Mathias, PD Dr. +49 (0)371 333 43045 m.haenel@skc.de Universitätsklinikum Dresden Medizinische Klinik und Poliklinik I Recruiting Dresden, Sachsen, Germany, 01307 Contact: Uwe Platzbecker, Prof. Dr. +49 (0)351 - 458 2583 uwe.platzbecker@uniklinikum-dresden.de Charité Universitätsmedizin Berlin Med. Klinik m.S. Hämatologie, Onkologie und Tumorimmunologie Recruiting Berlin, Germany, 13353 Contact: Philipp LeCoutre, PD Dr. +49 30 450 665 307 philipp.lecoutre@charite.de Universitätsklinikum Freiburg - Klinik für Innere Medizin I Recruiting Freiburg, Germany, 79106 Contact: Nikolas von Bubnoff, Prof. Dr. +49 (0) 761 270-33210 nikolas.bubnoff@uniklinik-freiburg.de Universitätsklinikum Hamburg Eppendorf Klinik und Poliklinik für Onkologie, Hämatologie und KMT mit Sektion Pneumologie Recruiting Hamburg, Germany, 20246 Contact: Philippe Schafhausen, PD Dr. +49n (0)40 7410 57122 schafhausen@uke.de Universitätsklinik Jena - Klinik für Innere Medizin II Recruiting Jena, Germany, 07705 Contact: Florian Heidel, Prof. Dr. +49 3641 9-324210 Florian.Heidel@med.uni-jena.de 收起 << |
NCT01119066 | Acute Lymphoblastic Leukemia ... 展开 >> Acute Myelogenous Leukemia Myelodysplastic Syndrome Multiple Myeloma 收起 << | Phase 2 | Recruiting | May 2019 | United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Richard O'Reilly, MD 212-639-5957 Contact: Sergio Giralt, MD 212-639-3859 Principal Investigator: Richard O'Reilly, MD 收起 << |
NCT00881933 | Aplastic Anemia | Phase 1 Phase 2 | Unknown | September 2012 | Korea, Republic of ... 展开 >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 110-744 Contact: Hyo Seop Ahn, M.D, Ph.D 82 2 2072 3625 hsahn@snu.ac.kr 收起 << |
NCT01044745 | Accelerated Phase Chronic Myel... 展开 >>ogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Nasal Type Extranodal NK/T-cell Lymphoma Blastic Phase Chronic Myelogenous Leukemia Contiguous Stage II Adult Burkitt Lymphoma Contiguous Stage II Adult Diffuse Large Cell Lymphoma Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma Contiguous Stage II Adult Lymphoblastic Lymphoma Contiguous Stage II Grade 1 Follicular Lymphoma Contiguous Stage II Grade 2 Follicular Lymphoma Contiguous Stage II Grade 3 Follicular Lymphoma Contiguous Stage II Mantle Cell Lymphoma Contiguous Stage II Marginal Zone Lymphoma Contiguous Stage II Small Lymphocytic Lymphoma de Novo Myelodysplastic Syndromes Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Graft Versus Host Disease Nodal Marginal Zone B-cell Lymphoma Noncontiguous Stage II Adult Burkitt Lymphoma Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma Noncontiguous Stage II Adult Lymphoblastic Lymphoma Noncontiguous Stage II Grade 1 Follicular Lymphoma Noncontiguous Stage II Grade 2 Follicular Lymphoma Noncontiguous Stage II Grade 3 Follicular Lymphoma Noncontiguous Stage II Mantle Cell Lymphoma Noncontiguous Stage II Marginal Zone Lymphoma Noncontiguous Stage II Small Lymphocytic Lymphoma Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Relapsing Chronic Myelogenous Leukemia Secondary Myelodysplastic Syndromes Splenic Marginal Zone Lymphoma Stage I Adult Burkitt Lymphoma Stage I Adult Diffuse Large Cell Lymphoma Stage I Adult Diffuse Mixed Cell Lymphoma Stage I Adult Diffuse Small Cleaved Cell Lymphoma Stage I Adult Immunoblastic Large Cell Lymphoma Stage I Adult Lymphoblastic Lymphoma Stage I Adult T-cell Leukemia/Lymphoma Stage I Chronic Lymphocytic Leukemia Stage I Cutaneous T-cell Non-Hodgkin Lymphoma Stage I Grade 1 Follicular Lymphoma Stage I Grade 2 Follicular Lymphoma Stage I Grade 3 Follicular Lymphoma Stage I Mantle Cell Lymphoma Stage I Marginal Zone Lymphoma Stage I Mycosis Fungoides/Sezary Syndrome Stage I Small Lymphocytic Lymphoma Stage II Adult T-cell Leukemia/Lymphoma Stage II Chronic Lymphocytic Leukemia Stage II Cutaneous T-cell Non-Hodgkin Lymphoma Stage II Mycosis Fungoides/Sezary Syndrome Stage III Adult Burkitt Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Diffuse Small Cleaved Cell Lymphoma Stage III Adult Immunoblastic Large Cell Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage III Adult T-cell Leukemia/Lymphoma Stage III Chronic Lymphocytic Leukemia Stage III Cutaneous T-cell Non-Hodgkin Lymphoma Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage III Marginal Zone Lymphoma Stage III Mycosis Fungoides/Sezary Syndrome Stage III Small Lymphocytic Lymphoma Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Diffuse Small Cleaved Cell Lymphoma Stage IV Adult Immunoblastic Large Cell Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Adult T-cell Leukemia/Lymphoma Stage IV Chronic Lymphocytic Leukemia Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Marginal Zone Lymphoma Stage IV Mycosis Fungoides/Sezary Syndrome Stage IV Small Lymphocytic Lymphoma Untreated Adult Acute Lymphoblastic Leukemia Untreated Adult Acute Myeloid Leukemia Waldenström Macroglobulinemia 收起 << | Phase 2 | Active, not recruiting | March 2018 | United States, Nebraska ... 展开 >> University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-7830 收起 << |
NCT01707004 | Acute Myeloid Leukemia With Mu... 展开 >>ltilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) de Novo Myelodysplastic Syndromes Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia 收起 << | Phase 2 | Completed | - | United States, Wisconsin ... 展开 >> University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 收起 << |
NCT01427881 | Accelerated Phase Chronic Myel... 展开 >>ogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Myeloid Leukemia in Remission Adult Erythroleukemia (M6a) Adult Nasal Type Extranodal NK/T-cell Lymphoma Adult Pure Erythroid Leukemia (M6b) Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Blastic Phase Chronic Myelogenous Leukemia Childhood Acute Erythroleukemia (M6) Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Megakaryocytic Leukemia (M7) Childhood Acute Myeloid Leukemia in Remission Childhood Burkitt Lymphoma Childhood Chronic Myelogenous Leukemia Childhood Diffuse Large Cell Lymphoma Childhood Immunoblastic Large Cell Lymphoma Childhood Myelodysplastic Syndromes Childhood Nasal Type Extranodal NK/T-cell Lymphoma Chronic Myelomonocytic Leukemia Chronic Phase Chronic Myelogenous Leukemia Cutaneous B-cell Non-Hodgkin Lymphoma de Novo Myelodysplastic Syndromes Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma Intraocular Lymphoma Nodal Marginal Zone B-cell Lymphoma Noncutaneous Extranodal Lymphoma Peripheral T-cell Lymphoma Philadelphia Chromosome Negative Chronic Myelogenous Leukemia Post-transplant Lymphoproliferative Disorder Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Small Noncleaved Cell Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Relapsing Chronic Myelogenous Leukemia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Stage III Multiple Myeloma Testicular Lymphoma Waldenström Macroglobulinemia 收起 << | Phase 2 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT01427881 | - | Completed | - | - | |
NCT00005824 | Lymphoma | Phase 2 | Completed | - | United States, Maryland ... 展开 >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 United States, Massachusetts Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02129 收起 << |
NCT01565616 | - | Completed | - | - | |
NCT03615105 | Acute Lymphoid Leukemia (ALL) ... 展开 >> Acute Myeloid Leukemia (AML) Chronic Myeloid Leukemia (CML) Hodgkin Lymphoma Non-Hodgkin Lymphoma Chronic Lymphocytic Leukemia 收起 << | Phase 2 | Recruiting | July 2021 | United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Brian Shaffer, MD 212-639-2212 Contact: Miguel-Angel Perales, MD 212-639-8682 Principal Investigator: Brian Shaffer, MD 收起 << |
NCT00004181 | Chronic Myeloproliferative Dis... 展开 >>orders Leukemia Multiple Myeloma and Plasma Cell Neoplasm 收起 << | Phase 2 | Completed | - | United States, Illinois ... 展开 >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611 收起 << |
NCT02793544 | Myelodysplastic Syndrome (MDS)... 展开 >> Chronic Lymphocytic Leukemia (CLL) Chemotherapy-sensitive Lymphoma Acute Lymphoblastic Leukemia (ALL)/T Lymphoblastic Lymphoma Acute Myelogenous Leukemia (AML) Acute Biphenotypic Leukemia (ABL) Acute Undifferentiated Leukemia (AUL) 收起 << | Phase 2 | Recruiting | December 2019 | United States, Florida ... 展开 >> Shands HealthCare & University of Florida Recruiting Gainesville, Florida, United States, 32610 Contact: Maxim Norkin, MD Maxim.Norkin@medicine.ufl.edu Contact: Meghan Vazquez meghan.vazquez@medicine.ufl.edu Principal Investigator: Maxim Norkin, MD University of Miami Recruiting Miami, Florida, United States, 33136 Contact: Antonio Jimenez, MD amjimenez@miami.edu Contact: Kirenia Correa k.correa@med.miami.edu Principal Investigator: Antonio Jimenez, MD H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Contact: Farhad Khimani, MD Farhad.Khimani@moffitt.org Contact: Carmen Patton Carmen.Patton@moffitt.org Principal Investigator: Farhad Khimani, MD United States, Maryland University of Maryland Greenebaum Cancer Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Nancy Hardy, MD nhardy1@umm.edu Contact: Sherri Bauman sphilip1@umm.edu Principal Investigator: Nancy Hardy, MD The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21287 Contact: Javier Bolanos Meade, MD fbolano2@jhmi.edu Contact: Leo Luznik, MD luznile@jhmi.edu Principal Investigator: Javier Bolanos Meade, MD Principal Investigator: Leo Luznik, MD United States, Michigan Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 Contact: Asif Alavi, MD alavia@karmanos.org Contact: Charlotte Brown brownc@karmanos.org Principal Investigator: Asif Alavi, MD United States, New York Memorial Sloan Kettering Cancer Center - Adults Recruiting New York, New York, United States, 10065 Contact: Brian Shaffer, MD shaffeb1@mskcc.org Contact: Stephanie Chinapen chinapes@mskcc.org Principal Investigator: Brian Shaffer, MD United States, North Carolina University of North Carolina Hospitals Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Katarzyna Jamieson, MD katarzyna_jamieson@med.unc.edu Contact: Mary Owen mary_owen@med.unc.edu Principal Investigator: Katarzyna Jamieson, MD United States, Ohio Ohio State Medical Center, James Cancer Center Recruiting Columbus, Ohio, United States, 43210 Contact: Hannah Choe, MD Contact: Nicole Szuminski Nicole.Szuminski@osumc.edu Principal Investigator: Hannah Choe, MD United States, Virginia Virginia Commonwealth University Massey Cancer Center Bone Marrow Transplant Program Recruiting Richmond, Virginia, United States, 23298 Contact: John McCarty, MD john.mccarty@vcuhealth.org Contact: Kathy Candler kcandler@mcvh-vcu.edu Principal Investigator: John McCarty, MD United States, Wisconsin Froedtert Memorial Lutheran Hospital Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Bronwen Shaw, MD, PhD beshaw@mcw.edu Contact: Sharon Yim syim@mcw.edu Principal Investigator: Bronwen Shaw, MD, PhD 收起 << |
NCT01704716 | Neuroblastoma | Phase 3 | Recruiting | September 2024 | - |
NCT00498316 | Myelodysplastic Syndrome ... 展开 >> Leukemia 收起 << | Phase 1 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT03509961 | B-cell Acute Lymphoblastic Leu... 展开 >>kemia 收起 << | Phase 2 | Recruiting | April 1, 2022 | United States, California ... 展开 >> Children's Hospital Los Angeles Recruiting Los Angeles, California, United States, 90027 Contact: Aunsha Williamson 323-361-7551 awilliamson@chla.usc.edu Principal Investigator: Hisham Abdel-Azim, MD United States, Texas Methodist Healthcare System Recruiting San Antonio, Texas, United States, 78229 Contact: Candace Taylor 210-575-7379 Candace.taylor@mhshealth.com Principal Investigator: Troy Quigg, DO 收起 << |
NCT00630565 | Leukemia | Phase 2 Phase 3 | Recruiting | December 2021 | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Timothy Krepski 612-273-2800 tkrepsk1@fairview.org Principal Investigator: Daniel J. Weisdorf, M.D. 收起 << |
NCT01857934 | Neuroblastoma | Phase 2 | Recruiting | July 2021 | United States, Tennessee ... 展开 >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Wayne L. Furman, MD 866-278-5833 referralinfo@stjude.org Principal Investigator: Wayne L. Furman, MD 收起 << |
NCT00143845 | - | Completed | - | - | |
NCT01565616 | Sickle Cell Disease | Phase 2 | Completed | - | United States, California ... 展开 >> Children's Hospital of Oakland Oakland, California, United States, 94609 United States, District of Columbia Children's National Medical Center Washington, D.C., District of Columbia, United States, 20010 United States, Florida University of Miami Miami, Florida, United States, 33136 United States, Georgia Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30322 Emory University Atlanta, Georgia, United States, 30322 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Pennsylvania Chidren's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15224 United States, Virginia Virginia Commonwealth University Richmond, Virginia, United States, 23298 收起 << |
NCT00143845 | Multiple Myeloma ... 展开 >> Lymphocytic Leukemia, Chronic Lymphoma, Low-Grade 收起 << | Phase 2 | Completed | - | United States, Michigan ... 展开 >> The University of Michigan Ann Arbor, Michigan, United States, 48109 收起 << |
NCT00176878 | Diamond-Blackfan Anemia ... 展开 >> Kostmann's Neutropenia Shwachman-Diamond Syndrome 收起 << | Phase 2 Phase 3 | Completed | - | United States, Minnesota ... 展开 >> University of Minnesota Medical Center Minneapolis, Minnesota, United States, 55455 收起 << |
NCT01384513 | Adult Acute Lymphoblastic Leuk... 展开 >>emia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Nasal Type Extranodal NK/T-cell Lymphoma Aplastic Anemia Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Myelodysplastic Syndromes Chronic Eosinophilic Leukemia Chronic Myelomonocytic Leukemia Chronic Neutrophilic Leukemia Essential Thrombocythemia Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Juvenile Myelomonocytic Leukemia Mastocytosis Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Nodal Marginal Zone B-cell Lymphoma Polycythemia Vera Previously Treated Myelodysplastic Syndromes Primary Myelofibrosis Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Refractory Anemia Refractory Anemia With Ringed Sideroblasts Refractory Hairy Cell Leukemia Refractory Multiple Myeloma Secondary Myelodysplastic Syndromes Splenic Marginal Zone Lymphoma T-cell Large Granular Lymphocyte Leukemia Waldenström Macroglobulinemia 收起 << | Phase 2 | Recruiting | July 2020 | United States, Pennsylvania ... 展开 >> Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Dolores Grosso, DNP, CRNP 215-955-8874 Principal Investigator: Dolores Grosso, DNP, CRNP Principal Investigator: Neal Flomenberg, MD Sub-Investigator: S. Onder Alpdogan, MD Sub-Investigator: Matthew Carabasi, MD Sub-Investigator: Joanne Filicko-O'Hara, MD Sub-Investigator: Margaret Kasner, MD Sub-Investigator: Ubaldo Martinez-Outschoorn, MD Sub-Investigator: John L Wagner, MD Sub-Investigator: Mark Weiss, MD Sub-Investigator: Maria Werner-Wasik, MD Sub-Investigator: Wenyin Shi, MD, PhD Sub-Investigator: William O'Hara, PharmD Sub-Investigator: Thomas Klumpp, MD Sub-Investigator: Manish Sharma, MD 收起 << |
NCT02629120 | X-Linked Chronic Granulomatiou... 展开 >>s Disease 收起 << | Early Phase 1 | Suspended | December 31, 2030 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT00176878 | - | Completed | - | - | |
NCT00553202 | - | Unknown | - | - | |
NCT03171831 | Thalassemia Major | Phase 4 | Recruiting | April 1, 2022 | China, Guangxi ... 展开 >> First Affiliated Hospital of Guangxi Medical University Recruiting Nanning, Guangxi, China, 510515 Contact: Yongrong Lai, MD +86(0771)5356510 laiyongrong@hotmail.com 收起 << |
NCT00112645 | Neuroblastoma ... 展开 >> Sarcoma Unspecified Childhood Solid Tumor, Protocol Specific 收起 << | Phase 1 | Completed | - | United States, Pennsylvania ... 展开 >> Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 收起 << |
NCT01118013 | Leukemia Lymp... 展开 >>homa Lymphoproliferative Disorder Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms 收起 << | Phase 2 | Terminated | - | United States, Delaware ... 展开 >> Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States, 19958 CCOP - Christiana Care Health Services Newark, Delaware, United States, 19713 United States, Florida Florida Hospital Cancer Institute at Florida Hospital Orlando Orlando, Florida, United States, 32803-1273 United States, Maryland Greenebaum Cancer Center at University of Maryland Medical Center Baltimore, Maryland, United States, 21201 Union Hospital of Cecil County Elkton MD, Maryland, United States, 21921 United States, Missouri Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis Saint Louis, Missouri, United States, 63110 United States, New Jersey Cancer Institute of New Jersey at Cooper - Voorhees Voorhees, New Jersey, United States, 08043 United States, New York New York Weill Cornell Cancer Center at Cornell University New York, New York, United States, 10021 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210-1240 收起 << |
NCT00053196 | Leukemia Lymp... 展开 >>homa Multiple Myeloma Plasma Cell Neoplasm Myelodysplastic Syndromes Myeloproliferative Neoplasms 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States, 92093-0658 United States, Delaware Beebe Medical Center Lewes, Delaware, United States, 19958 CCOP - Christiana Care Health Services Newark, Delaware, United States, 19713 St. Francis Hospital Wilmington, Delaware, United States, 19805 United States, Maryland Union Hospital Cancer Center at Union Hospital Elkton MD, Maryland, United States, 21921 United States, Missouri Siteman Cancer Center at Barnes-Jewish Hospital St Louis, Missouri, United States, 63110 United States, New Jersey Cancer Institute of New Jersey at the Cooper University Hospital - Voorhees Voorhees, New Jersey, United States, 08043 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Columbus, Ohio, United States, 43210-1240 United States, Pennsylvania Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital Pittsburgh, Pennsylvania, United States, 15224-1791 United States, Virginia Massey Cancer Center at Virginia Commonwealth University Richmond, Virginia, United States, 23298-0037 收起 << |
NCT01118013 | - | Terminated | - | - | |
NCT01773395 | Myelodysplastic Syndrome ... 展开 >> Acute Myeloid Leukemia Chronic Myelomonocytic Leukemia 收起 << | Phase 2 | Recruiting | January 2033 | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Yi-Bin Chen, MD 617-726-5765 YCHEN6@partners.org Principal Investigator: Yi-Bin Chen, MD Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Vincent Ho, MD 617-632-5938 vtho@partners.org Principal Investigator: Vincent Ho, MD Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Vincent Ho, MD 617-632-5938 vtho@partners.org Principal Investigator: Vincent Ho, MD Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Jacalyn Rosenblatt, MD 617-667-9920 jrosenb1@bidmc.harvard.edu Principal Investigator: Jacalyn Rosenblatt, MD 收起 << |
NCT00553202 | Leukemia | Phase 2 | Unknown | - | - |
NCT00296023 | Chronic Myeloproliferative Dis... 展开 >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes 收起 << | Not Applicable | Completed | - | United States, California ... 展开 >> Alta Bates Comprehensive Cancer Center Berkeley, California, United States, 94704 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143-0324 收起 << |
NCT02061800 | Chronic Myeloid Leukemia (CML)... 展开 >> Acute Myelogenous Leukemia (AML) Myelodysplastic Syndrome (MDS) Juvenile Myelomonocytic Leukemia (JMML) Acute Lymphoblastic Leukemia (ALL) Lymphoma (Hodgkin's and Non-Hodgkin's) 收起 << | Phase 1 Phase 2 | Recruiting | December 2018 | United States, New York ... 展开 >> Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Jean Sosna, RN 212-305-2050 Principal Investigator: Diane George, MD 收起 << |
NCT01621477 | Acute Lymphoblastic Leukemia ... 展开 >> Acute Myelocytic Leukemia Chronic Myelocytic Leukemia Juvenile Myelomonocytic Leukemia Myelodysplastic Syndrome Hodgkin or Non-Hodgkin Lymphoma Sarcoma, Myeloid 收起 << | Phase 2 | Terminated(Study was terminate... 展开 >>d in August 2016 due to replacement by a new study.) 收起 << | - | United States, Tennessee ... 展开 >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 收起 << |
NCT03126916 | Childhood Ganglioneuroblastoma... 展开 >> Childhood Neuroblastoma INRG Stage L2 INRG Stage M INRG Stage MS NMYC Gene Amplification Recurrent Neuroblastoma 收起 << | Phase 3 | Recruiting | June 30, 2026 | - |
NCT02248597 | Graft Versus Host Disease ... 展开 >> Hematopoietic/Lymphoid Cancer 收起 << | Phase 2 | Recruiting | January 2019 | United States, North Carolina ... 展开 >> Comprehensive Cancer Center of Wake Forest University Recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Zachariah A. McIver 336-713-5440 zmciver@wakehealth.edu Principal Investigator: Zachariah A. McIver 收起 << |
NCT00740467 | Graft Versus Host Disease ... 展开 >> Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Precancerous Condition 收起 << | Phase 2 | Unknown | - | France ... 展开 >> Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Recruiting Marseille, France, 13273 Contact: Contact Person 33-4-91-22-37-54 收起 << |
NCT00304018 | Leukemia Lymp... 展开 >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes 收起 << | Phase 1 | Completed | - | United States, California ... 展开 >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 收起 << |
NCT00795132 | Acute Leukaemia ... 展开 >> Chronic Disease Leukemia Myelodysplasia Lymphoma 收起 << | Phase 2 | Completed | - | United States, Utah ... 展开 >> Primary Children's Medical Center Salt Lake City, Utah, United States, 84112 收起 << |
NCT01621477 | - | Terminated(Study was terminate... 展开 >>d in August 2016 due to replacement by a new study.) 收起 << | - | - | |
NCT01050036 | Leukemia, Myeloid | Not Applicable | Recruiting | December 2018 | Korea, Republic of ... 展开 >> Wonkwang University Hospital Recruiting Iksan, Chollabuk-do, Korea, Republic of, 570749 Contact: Yeonghui Park, RN 82-63-859-2640 bej02@naver.com Principal Investigator: Hyeok Shim, M.D. & PhD. Gyeongsang National University Hospital Recruiting Jinju, Gyeongsangnam-do, Korea, Republic of, 660702 Contact: Hyeok Choi, RN 82-55-750-9454 hyeau79@yahoo.co.kr Principal Investigator: Gyeong Won Lee, M.D. & PhD. Hallym University Sacred Heart Hospital Recruiting Anyang, Kyeongki-do, Korea, Republic of, 431796 Contact: Hyo Jung Kim, M.D. & PhD. 82-31-380-3704 hemonc@hallym.or.kr Principal Investigator: Dae Young Zang, M.D. & PhD. Sub-Investigator: Hyo Jung Kim, M.D. & PhD. Kosin University, Gospel Hospital Recruiting Busan, Korea, Republic of, 602702 Contact: Aeran Lee, RN 82-51-990-5820 chewon88@paran.com Principal Investigator: Yang Soo Kim, M.D. & PhD. Sub-Investigator: Seong-Hoon Shin, M.D. & PhD. Sub-Investigator: Ho-Sup Lee, M.D. & PhD. Busan Paik Hospital, Inje University College of Medicine Recruiting Busan, Korea, Republic of, 614735 Contact: Hyejung Eum, RN 82-51-890-6987 cake78@nate.com Principal Investigator: Young-Don Joo, M.D. & PhD. Sub-Investigator: Won-Sik Lee, M.D. & PhD. Daegu Fatima Hospital Recruiting Daegu, Korea, Republic of, 701600 Contact: Jung-eun Lee, RN 82-53-940-7687 chachaje@fatima.or.kr Principal Investigator: Jung-lim Lee, M.D. & PhD. Sub-Investigator: Sun-ah Lee, M.D. & PhD. Yeongnam University Hospital Recruiting Daegu, Korea, Republic of, 705717 Contact: Young Mi Chun, RN 82-53-620-3069 jerry1032@hanmail.net Principal Investigator: Myung Soo Hyun, M.D. & PhD. Sub-Investigator: Min Kyoung Kim, M.D. & PhD. Daegu Catholic University Medical Center Recruiting Daegu, Korea, Republic of, 705718 Contact: Hun Mo Ryoo, M.D. & PhD 82-53-650-4034 rhmrhm@cu.ac.kr Contact: Sung Hwa Bae, M.D. & PhD 82-53-650-4388 sunghwa@cu.ac.kr Principal Investigator: Hun Mo Ryoo, M.D. & PhD Sub-Investigator: Sung Hwa Bae, M.D. & PhD Gachon University Gil Hospital Recruiting Inchon, Korea, Republic of, 405-760 Contact: Jin Hee Park, M.D. & PhD. Principal Investigator: Jin Hee Park, M.D. & PhD. Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Mi Ryang Jang, RN 82-2-3010-7084 mrzzang82@naver.com Contact: Mijin Jeon, RN 82-2-3010-6689 mjjeon1982@gmail.com Sub-Investigator: Kyoo-Hyung Lee, M.D. & PhD Sub-Investigator: Je-Hwan Lee, M.D. & PhD Sub-Investigator: Jung-Hee Lee, M.D. & PhD. Principal Investigator: Dae-Young Kim, M.D. Ulsan University Hospital, University of Ulsan College of Medicine Recruiting Ulsan, Korea, Republic of, 682714 Contact: Mi-young Kim, RN 82-52-250-8537 miyoung3798@yahoo.co.kr Contact: Eun-hee Lee, RN, CNS 82-52-250-8516 gival2@uuh.ulsan.kr Principal Investigator: Jae-Hoo Park, M.D. & PhD. Sub-Investigator: Young Joo Min, M.D. & PhD. Sub-Investigator: Hawk Kim, M.D. & PhD. 收起 << |
NCT02544425 | Extranodal NK-T-Cell Lymphoma | Phase 2 | Recruiting | November 2019 | Korea, Republic of ... 展开 >> Samsung Medical Center Recruiting Seoul, Seoul, Korea, Republic Of, Korea, Republic of, 135-710 Contact: WonSeog Kim, M.D, Ph. D 234106548 ext 82 wskimsmc@skku.edu Contact: SeokJin Kim, M.D,Ph. D 234101766 ext 82 seokjin88.kim@samsung.com Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Wonseog Kim, M.D., Ph.D. 82-2-3410-6548 wonseog.kim@samsung.com Contact: Seokjin Kim, M.D., Ph.D. seokjin88.kim@samsung.com Sub-Investigator: Seokjin Kim, M.D., Ph.D. Principal Investigator: Wonseog Kim, M.D. Ph.D 收起 << |
NCT00795132 | - | Completed | - | - | |
NCT02053545 | Leukemia Lymp... 展开 >>homa MDS 收起 << | Phase 1 Phase 2 | Unknown | December 2018 | United States, Illinois ... 展开 >> Ann & Robert H. Lurie Children's Hospital of Chicago Recruiting Chicago, Illinois, United States, 60611 Contact: Joseph Laskowski jlaskowski@luriechildrens.org Principal Investigator: Reggie Duerst 收起 << |
NCT03597594 | Severe Combined Immunodeficien... 展开 >>cy 收起 << | Phase 1 Phase 2 | Recruiting | July 1, 2028 | United States, Tennessee ... 展开 >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Ewelina Mamcarz, MD 866-278-5833 referralinfo@stjude.org 收起 << |
NCT02294552 | Acute Myeloid Leukemia ... 展开 >> Acute Lymphoid Leukemia Lymphoma Myelodysplastic Syndromes Chronic Lymphocytic Leukemia Immune System Diseases 收起 << | Phase 2 | Completed | - | Russian Federation ... 展开 >> First Pavlov State Medical University of St. Petersburg Saint-Petersburg, Russian Federation, 197089 收起 << |
NCT01500161 | Acute Myelogenous Leukemia ... 展开 >> Acute Lymphocytic Leukemia Chronic Lymphocytic Leukemia Chronic Myelogenous Leukemia Hodgkins Disease Non-Hodgkins Lymphoma Aplastic Anemia Multiple Myeloma Myelodysplastic Syndrome 收起 << | Phase 2 | Terminated(Insufficient accrua... 展开 >>ls) 收起 << | - | United States, Texas ... 展开 >> Texas Oncology Amarillo, Texas, United States, 79106 收起 << |
NCT00578292 | Thalassemia | Not Applicable | Terminated(Over the course of ... 展开 >>this study stem cell transplant was determined to be standard of care for this disease and as such the study is no longer relevant.) 收起 << | - | United States, Texas ... 展开 >> Texas Children's Hospital Houston, Texas, United States, 77030 收起 << |
NCT00691015 | Chronic Myeloproliferative Dis... 展开 >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms 收起 << | Phase 2 | Completed | - | United States, Michigan ... 展开 >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 收起 << |
NCT00691015 | - | Completed | - | - | |
NCT02428517 | - | Terminated(The PI resigned the... 展开 >> institute, and the rest investigators at the institute decided to terminate the study.) 收起 << | - | Korea, Republic of ... 展开 >> Inje University Busan Paik Hospital Busan, Korea, Republic of Inje University Haeundae Paik Hospital Busan, Korea, Republic of Asan Medical Center, University of Ulsan College of Medicine Seoul, Korea, Republic of Ulsan University Hospital, University of Ulsan College of Medicine Ulsan, Korea, Republic of 收起 << | |
NCT01625351 | Ewing Sarcoma ... 展开 >> Gastrointestinal Tumor Germ Cell Tumor Hepatic Tumor Lymphoma Wilms Tumor Rhabdoid Tumor Clear Cell Carcinoma Renal Cell Carcinoma Melanoma Neuroblastoma Rhabdomyosarcoma Non-rhabdomyosarcoma 收起 << | Phase 1 | Active, not recruiting | August 19, 2019 | United States, Tennessee ... 展开 >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 收起 << |
NCT01496547 | Acute Leukemia | Phase 2 | Unknown | June 2018 | China ... 展开 >> Blood & Marrow Transplantation Center, RuiJin Hospital Recruiting Shanghai, China, 200025 Contact: Jiong HU, M.D. Principal Investigator: Ling Wang, M.D. 收起 << |
NCT03018223 | Non-Hodgkin's Lymphoma ... 展开 >> Acute Leukemia in Remission Chronic Myeloid Leukemia Primary Myelofibrosis Chronic Myelomonocytic Leukemia Myelodysplastic Syndromes Hodgkin Lymphoma Multiple Myeloma 收起 << | Phase 2 | Active, not recruiting | January 2021 | United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 收起 << |
NCT00623077 | Brain and Central Nervous Syst... 展开 >>em Tumors Kidney Cancer Liver Cancer Retinoblastoma Sarcoma 收起 << | Phase 1 | Terminated(Replaced by another... 展开 >> study) 收起 << | - | United States, Minnesota ... 展开 >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT02472392 | EWINGS SARCOMA | Phase 1 | Completed | - | United States, Kentucky ... 展开 >> University of Louisville Louisville, Kentucky, United States, 40202 收起 << |
NCT01063660 | Acute Myeloid Leukaemia | Phase 2 | Completed | - | Germany ... 展开 >> University of Rostock Rostock, Germany, 18057 收起 << |
NCT00598624 | Leukemia Chro... 展开 >>nic Myeloid Leukemia Myelodysplastic Syndrome Diffuse Large Cell Lymphoma Hodgkin Lymphoma Chronic Lymphocytic Leukemia Multiple Myeloma 收起 << | Phase 2 | Unknown | December 2010 | Italy ... 展开 >> Ematologia, Ospedale Casa Sollievo della Sofferenza Recruiting San Giovanni Rotondo, Foggia, Italy Contact: Angelo Michele Carella, MD am.carella@operapadrepio.it Contact: Marzia Tricarico, DM m.tricarico@operapadrepio.it Principal Investigator: Nicola Cascavilla, MD IRCCS San Raffaele; Unità Operativa di Ematologia Recruiting Milano, MI, Italy, 20100 Contact: Alessandro Crotta, MD +39 0226433903 a.crotta@hsr.it Contact: Stefania Trinca +39 0226434289 stefania.trinca@hsr.it Principal Investigator: Jacopo Peccatori, MD USC Ematologia, Ospedali Riuniti Recruiting Bergamo, Italy Contact: Anna Grassi, MD agrassi@ospedaliriuniti.bergamo.it Contact: Maria Luisa Ferrari, DM mlferrari@ospedaliriuniti.bergamo.it Principal Investigator: Alessandro Rambaldi, MD Ospedale centrale di Bolzano - Reparto di Ematologia Recruiting Bolzano, Italy Contact: Enrico Morello, MD +390471908807 enrico.morello@asbz.it Principal Investigator: Enrico Morello, MD PO "R.Binaghi" - CTMO Recruiting Cagliari, Italy Contact: Adriana Vacca, MD +393285452813 vaadriana@tiscali.it Principal Investigator: Giorgio La Nasa, MD AO "Santa Croce" e Carle - Reparto di Ematologia Recruiting Cuneo, Italy Contact: Laura Bertolotti, Data Manager +390171642229 laura.bertolotti@libero.it Principal Investigator: Andrea Gallamini, MD Istituto Europeo di Oncologia - Divisione di Ematologia Recruiting Milano, Italy Contact: Liliana Calabrese, Data Manager +390257489536 liliana.calabrese@ieo.it Principal Investigator: Giovanni Martinelli, MD Ospedale Civile - UTI ematologia per il trapianto emopoietico Recruiting Pescara, Italy Contact: Paolo Di Bartolomei, MD pescaratmo@virgilio.it Principal Investigator: Paolo Di Bartolomei, MD Arcispedale Santa Maria Nuova - SC di Ematologia Recruiting Reggio Emilia, Italy Contact: Alessandro Bonini, MD bonini.alessandro@asmn.re.it Principal Investigator: Luigi Gugliotta, MD Dipartimento Biotecnologie Cellulari ed Ematologia; Azienda Policlinico Umberto I Recruiting Roma, Italy, 00100 Contact: Emilia Iannella, MD +39 3202233365 emiliaiannella@libero.it Contact: Roberto Ricci +39 3477578735 r.ricci@bce.uniroma1.it Principal Investigator: Roberto Foa, MD AO San Camillo Forlanini - UOC ematologia e trapianto Recruiting Roma, Italy Contact: Beatrice Pinazzi, MD mpinazzi@scamilloforlanini.rm.it Principal Investigator: Ignazio Majolino, MD AOU Santa Maria della Misericordia - Clinica Ematologica Recruiting Udine, Italy Contact: Francesca Patriarca, MD patriarca.francesca@aoud.sanita.fvg.it Principal Investigator: Michela Cerno, MD 收起 << |
NCT02766465 | Sickle Cell Disease | Phase 2 | Recruiting | March 2023 | - |
NCT00619879 | Leukemia, Myelogenous, Chronic... 展开 >> Leukemia, Lymphoblastic, Acute Leukemia, Myelogenous, Acute Myeloproliferative-Myelodysplastic Diseases Lymphoma, Malignant 收起 << | Phase 3 | Recruiting | January 2020 | United States, Illinois ... 展开 >> Children's Memorial Hospital Recruiting Chicago, Illinois, United States, 60614 Principal Investigator: Morris Kletzel, MD 收起 << |
NCT00775931 | Severe Osteopetrosis | Phase 2 Phase 3 | Unknown | October 2015 | United States, Minnesota ... 展开 >> University of MInnesota, Fairview Minneapolis, Minnesota, United States, 55455 收起 << |
NCT02627573 | Leukemia, Chronic Myeloid ... 展开 >> Myelodysplastic Syndromes Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 收起 << | Phase 2 | Suspended | July 2020 | Russian Federation ... 展开 >> First Pavlov State Medical University of St. Petersburg Saint-Petersburg, Russian Federation, 197089 收起 << |
NCT01244906 | Hematologic Neoplasms | Phase 2 | Completed | - | United States, Georgia ... 展开 >> Northside Hospital Atlanta, Georgia, United States, 30342 收起 << |
NCT01062490 | Myelodysplastic Syndrome | Phase 2 | Completed | - | Finland ... 展开 >> Helsinki University Central Hospital Helsinki, Finland, 00029 收起 << |
NCT01244906 | - | Completed | - | - | |
NCT03128359 | Acute Leukemia ... 展开 >> Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Chronic Myelogenous Leukemia, BCR-ABL1 Positive Diffuse Large B-Cell Lymphoma Follicular Lymphoma Graft Versus Host Disease Hodgkin Lymphoma Mantle Cell Lymphoma Marginal Zone Lymphoma Myelodysplastic Syndrome Myeloproliferative Neoplasm Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes Recurrent Plasma Cell Myeloma Refractory Plasma Cell Myeloma Secondary Myelodysplastic Syndrome 收起 << | Phase 2 | Recruiting | June 2019 | United States, California ... 展开 >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Monzr M. Al Malki, MD 626-256-4673 malmalki@coh.org Principal Investigator: Monzr M. Al Malki, MD 收起 << |
NCT00894049 | Allograft All... 展开 >>ogeneic Cell Transplantaion Hematological Malignancy Solid Tumor 收起 << | Phase 2 | Completed | - | France ... 展开 >> CHU Bordeaux Pessac, France CHU Clermont Ferrand, France CHU Lyon, France Institut Paoli-Calmettes Marseille, France CHU Montpellier, France 收起 << |
NCT01087398 | Osteopetrosis | Phase 2 Phase 3 | Unknown | December 2012 | Iran, Islamic Republic of ... 展开 >> Hematology-Oncology & SCT Research Center Recruiting Tehran, Iran, Islamic Republic of, 14114 Contact: Amir Ali Hamidieh, MD 84902645 ext +98-21 aahamidieh@sina.tums.ac.ir Sub-Investigator: Ardeshir Ghavamzadeh, MD Sub-Investigator: Mahdi Jalili, MD 收起 << |
NCT02724163 | Acute Myeloid Leukaemia | Phase 3 | Recruiting | December 2032 | United Kingdom ... 展开 >> Royal Aberdeen Children's Hospital Recruiting Aberdeen, United Kingdom, AB25 2ZG Aberdeen Royal Infirmary, NHS Grampian Recruiting Aberdeen, United Kingdom, AB25 2ZN Belfast City Hospital, Belfast Health and Social Care Trust Not yet recruiting Belfast, United Kingdom, BT9 7AB Birmingham Children's Hospital NHS Foundation Trust Recruiting Birmingham, United Kingdom, B4 6NH University Hospitals Bristol NHS Foundation Trust Recruiting Bristol, United Kingdom, BS1 3NU Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust Recruiting Cambridge, United Kingdom, CB2 0QQ Cardiff and Vale University Health Board, Noah's Ark Children's Hospital for Wales Recruiting Cardiff, United Kingdom, CF14 4XW NHS Lothian, Royal Hospital for Sick Children Recruiting Edinburgh, United Kingdom, EH9 1LF NHS Greater Glasgow and Clyde, The Royal Hospital for Children Recruiting Glasgow, United Kingdom, G51 4TF Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust Recruiting Leeds, United Kingdom, LS9 7TF Alder Hey Children's NHS Foundation Trust Recruiting Liverpool, United Kingdom, L12 2AP University College London Hospitals NHS Foundation Trust Recruiting London, United Kingdom, NW1 2PG The Royal Marsden NHS Foundation Trust Recruiting London, United Kingdom, SW3 6JJ Great Ormond Street Hospital For Children NHS Trust Recruiting London, United Kingdom, WC1N 3JH Royal Manchester Childrens' Hospital , Central Manchester University Hospitals NHS Foundation Trust Recruiting Manchester, United Kingdom, M13 9WL The Christie NHS Foundation Not yet recruiting Manchester, United Kingdom, M20 4BX The Newcastle Upon Tyne Hospitals NHS Foundation Trust Recruiting Newcastle, United Kingdom, NE7 7DN Nottingham University Hospitals NHS Trust Recruiting Nottingham, United Kingdom, NG7 2UH John Radcliffe Hospital, Oxford Radcliffe Hospitals NHS Trust Recruiting Oxford, United Kingdom, OX3 9DU Sheffield Children's NHS Foundation Trust Recruiting Sheffield, United Kingdom, S10 2TH Southampton University Hospitals NHS Trust Recruiting Southampton, United Kingdom, SO16 6YD 收起 << |
NCT00258427 | Fanconi Anemia | Phase 2 | Recruiting | January 2020 | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Timothy Krepski 612-273-2800 tkrepsk1@fairview.org Principal Investigator: Margaret MacMillan, M.D. 收起 << |
NCT01020539 | Acute Myelogenous Leukemia ... 展开 >> Myelodysplastic Syndrome Juvenile Myelomonocytic Leukemia 收起 << | Phase 1 | Active, not recruiting | March 2018 | United States, New York ... 展开 >> Columbia University Medical Center New York, New York, United States, 10032 收起 << |
NCT02750254 | Acute Myeloid Leukemia ... 展开 >> Myelodysplastic Syndrome Acute Lymphocytic Leukemia 收起 << | Phase 1 | Active, not recruiting | October 14, 2020 | United States, Missouri ... 展开 >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 收起 << |
NCT00253487 | Brain and Central Nervous Syst... 展开 >>em Tumors 收起 << | Not Applicable | Completed | - | - |
NCT01019876 | Bone Marrow Failure ... 展开 >> Osteopetrosis Fanconi Anemia Severe Combined Immunodeficiency 收起 << | Phase 2 Phase 3 | Unknown | May 2013 | United States, New York ... 展开 >> Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: James Garvin, MD, PhD 212-305-5872 jhg1@columbia.edu Contact: William A Kim, PhD 212-305-7213 billkim@columbia.edu Principal Investigator: James Garvin, MD, PhD 收起 << |
NCT00966498 | High Risk Solid Tumors ... 展开 >> Recurrent Solid Tumors 收起 << | Not Applicable | Terminated(poor enrollment) | - | United States, Georgia ... 展开 >> Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30322 Emory University Atlanta, Georgia, United States, 30322 收起 << |
NCT00004171 | Lymphoma | Phase 2 | Completed | - | United States, Illinois ... 展开 >> Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611-3013 收起 << |
NCT01079013 | Non Hodgkin Lymphoma ... 展开 >> Hodgkin Lymphoma 收起 << | Phase 2 | Unknown | April 2018 | Israel ... 展开 >> Chaim Sheba Medical Center Tel-Hashomer, Israel, 52621 收起 << |
NCT00491634 | Acute Myeloid Leukemia ... 展开 >> Myelodysplastic Syndrome 收起 << | Phase 2 | Completed | - | Israel ... 展开 >> Chaim Sheba Medical Center Tel-Hashomer, Israel 收起 << |
NCT01203228 | Myelodysplastic Syndromes ... 展开 >> Secondary Acute Myeloid Leukemia 收起 << | Phase 3 | Terminated | - | Germany ... 展开 >> University Hospital Düsseldorf, Germany Martin-Luther-Universität Halle-Wittenberg Halle, Germany University Hospital Eppendorf Hamburg, Germany University Hospital Heidelberg, Germany UKSH Campus Kiel Kiel, Germany University Hospital Köln, Germany University Hospital Leipzig, Germany Universitätsklinikum Munster Munster, Germany University Hospital Tübingen, Germany Italy Santi Antonio e Biagio Alessandria, Italy Ospedale di Careggi Firenze, Italy Ospedale Maggiore di Milano Milano, Italy Netherlands Radboud University MC Nijmegen, Netherlands Russian Federation SPb State I. Pavlov Medical University St. Petersburg, Russian Federation 收起 << |
NCT00667927 | Acute Myeloid Leukemia | Phase 1 | Completed | - | United States, Tennessee ... 展开 >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 收起 << |
NCT03190733 | Chronic Graft-versus-host-dise... 展开 >>ase Leukemia Relapse 收起 << | Phase 4 | Not yet recruiting | September 30, 2021 | - |
NCT00874315 | Neuroblastoma | Phase 2 | Withdrawn(lack of accrual) | - | United States, Illinois ... 展开 >> Children's Memorial Hospital Chicago, Illinois, United States United States, New York Morgan Stanley Children's Hospital of NY New York, New York, United States United States, Ohio Nationwide Children's Hospital Columbus, Ohio, United States, 43205 United States, Wisconsin Children's Hopsital of Wisconsin Milwaukee, Wisconsin, United States 收起 << |
NCT03011528 | Ewing Sarcoma Family of Tumors | Phase 2 | Recruiting | December 2022 | France ... 展开 >> Chr Felix Guyon Not yet recruiting La Réunion, Saint Denis, France, 97400 Principal Investigator: Yves REGUERRE, MD Bordeaux Chu Recruiting Bordeaux, France, 33076 Contact: Cécile VERITE-GOULARD, MD +33(0)556795430 cecile.verite@chu-bordeaux.fr CHU Grenoble Alpes Not yet recruiting Grenoble, France, 38043 Principal Investigator: Dominique PLANTAZ, P LILLE Centre Oscar Lambret Recruiting Lille, France, 59000 Contact: Cyril LERVAT, MD +33(0)320295935 c-lervat@o-lambret.fr LYON Centre Léon Bérard Recruiting Lyon, France, 69000 Contact: Nadège CORRADINI, MD +33(0)469166572 nadege.corradini@lyon-unicancer.fr Marseille Chu Not yet recruiting Marseille, France, 13000 Contact: Jean-Claude GENTET, MD +33(0)491386821 jcgentet@ap-hm.fr CHRU Montpellier - Hôpital A. de Villeneuve Recruiting Montpellier, France, 34295 Principal Investigator: Laure SAUMET, MD Nantes Chu Recruiting Nantes, France, 44000 Contact: Estelle THEBAUD, MD +33(0)240083810 estelle.thebaud@chu-nantes.fr PARIS Institut Curie Recruiting Paris, France, 75005 Contact: Valérie LAURENCE, MD +33(0)1 44 32 42 07 valerie.laurence@curie.fr PARIS Trousseau Recruiting Paris, France, 75012 Contact: Marie-Domnique TABONE, MD +33(0)144736062 marie-dominique.tabone@aphp.fr CHU Hôpital Sud Not yet recruiting Rennes, France, 35056 Principal Investigator: Sophie TAQUE, MD Strasbourg Chu Recruiting Strasbourg, France, 67098 Contact: Natacha ENTZ-WERLE, MD +33(0)388128072 natacha.entz-werle@chu-strasbourg.fr Toulouse Chu Recruiting Toulouse, France, 31059 Contact: Marie-Pierre CASTEX, MD +33(0)534558610 castex.mp@chu-toulouse.fr TOULOUSE Institut Claudius Regaud Recruiting Toulouse, France, 31059 Contact: Christine CHEVREAU, MD +33(0)531155151 chevreau.christine@iuct-oncopole.fr NANCY Institut de Cancérologie de Lorraine Not yet recruiting Vandoeuvre les Nancy, France, 54519 Contact: Maria RIOS, MD +33(0)383598358 m.rios@nancy.unicancer.fr Nancy Chu Recruiting Vandoeuvre-les-Nancy, France, 54511 Contact: Ludovic MANSUY, MD +33(0)383154734 l.mansuy@chu-nancy.fr VILLEJUIF Institut Gustave Roussy Recruiting Villejuif, France, 94805 Contact: Nathalie GASPAR, MD +33(0)142114166 nathalie.gaspar@gustaveroussy.fr 收起 << |
NCT00167219 | Juvenile Myelomonocytic Leukem... 展开 >>ia 收起 << | Phase 1 Phase 2 | Recruiting | December 2020 | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Kim Nelson 612-273-2925 knelso62@fairview.org 收起 << |
NCT01758328 | Multiple Myeloma | Phase 1 | Active, not recruiting | December 2019 | United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 收起 << |
NCT01828619 | - | Unknown | - | China ... 展开 >> Peking University People's Hospital Beijing, China, 100044 收起 << | |
NCT00785330 | Non-Hodgkin's Lymphoma | Phase 2 | Unknown | April 2014 | Germany ... 展开 >> Universitätsklinikum Heidelberg Heidelberg, Baden-Würtenberg, Germany Universitätsklinikum Marburg Marburg, Hessen, Germany Universitätsklinikum und Poliklinik Homburg, Saarland, Germany University Hospital Goettingen Göttingen, Germany, D.37075 Asklepios Klinik St. Georg Hamburg, Germany, D-20099 KMT-Zentrum Medizinische Klinik A Münster, Germany 收起 << |
NCT00916045 | Leukemia, Myeloid, Acute ... 展开 >> Myelodysplastic Syndromes Leukemia, Lymphoblastic, Acute Lymphoma, Non-Hodgkin Hodgkin Disease Chronic Lymphocytic Leukemia 收起 << | Phase 2 | Terminated(Recruitment issues) | - | United Kingdom ... 展开 >> King's College Hosptial NHS Foundation Trust London, United Kingdom, SE5 9RS 收起 << |
NCT01176006 | DOCK8 Deficiency | Phase 2 | Recruiting | December 31, 2022 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office (888) NCI-1937 收起 << |
NCT01043640 | Mucopolysaccharidosis ... 展开 >> Hurler Syndrome Hunter Syndrome Maroteaux-Lamy Syndrome Sly Syndrome Alpha Mannosidosis Fucosidosis Aspartylglucosaminuria Adrenoleukodystrophy (ALD) Krabbe Disease Metachromatic Leukodystrophy (MLD) Sphingolipidoses Peroxisomal Disorders 收起 << | Phase 2 | Completed | - | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT00186342 | Acute Disease ... 展开 >> Myelodysplastic Syndromes Leukemia, Myeloid, Chronic Myeloproliferative Disorders Blood and Marrow Transplant (BMT) Myelodysplastic Syndromes (MDS) Leukemia 收起 << | Not Applicable | Completed | - | United States, California ... 展开 >> Stanford University School of Medicine Stanford, California, United States, 94305 收起 << |
NCT03314974 | Acute Leukemia ... 展开 >> Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Lymphoma Chronic Myelogenous Leukemia Plasma Cell Leukemia Myeloproliferative Neoplasms Myelofibrosis Myelodysplasia Refractory Anemia High Risk Anemia Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Marginal Zone B-Cell Lymphoma Follicular Lymphoma Lymphoplasmacytic Lymphoma Mantle-Cell Lymphoma Prolymphocytic Leukemia Diffuse Large Cell Non Hodgkins Lymphoma Lymphoblastic Lymphoma Burkitt Lymphoma High Grade Non-Hodgkin's Lymphoma, Adult Multiple Myeloma Juvenile Myelomonocytic Leukemia Biphenotypic/Undifferentiated/Prolymphocytic Leukemias MRD Positive Leukemia Natural Killer Cell Malignancies Acquired Bone Marrow Failure Syndromes 收起 << | Phase 2 | Recruiting | November 10, 2023 | United States, Minnesota ... 展开 >> Masonic Cancer Center at University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55337 Contact: Timothy Krepski, RN 612-273-2800 tkrepsk1@Fairview.org 收起 << |
NCT01043640 | - | Completed | - | - | |
NCT02441803 | Leukemia | Phase 2 | Active, not recruiting | September 2023 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00336843 | Non-Hodgkin's Lymphoma | Phase 2 | Completed | - | Korea, Republic of ... 展开 >> Asan Medical Center, Departement of Internal Medicine, Division of Oncology Seoul, Korea, Republic of, 138-736 收起 << |
NCT00179790 | Leukemia Canc... 展开 >>er 收起 << | Phase 1 Phase 2 | Completed | - | United States, Illinois ... 展开 >> Ann & Robert H Lurie Children's Hospital of Chicago Chicago, Illinois, United States, 60625 收起 << |
NCT01015742 | Leukemia, Myeloid, Acute ... 展开 >> Leukemia, Lymphoblastic, Acute Leukemia, Myeloid, Chronic 收起 << | Phase 2 Phase 3 | Unknown | January 2013 | Iran, Islamic Republic of ... 展开 >> Hematology-Oncology & SCT Research Center Recruiting Tehran, Iran, Islamic Republic of, 14114 Contact: Amir Ali Hamidieh, MD 84902645 ext +98-21 aahamidieh@sina.tums.ac.ir Sub-Investigator: Ardeshir Ghavamzadeh, MD Principal Investigator: Amir Ali Hamidieh, MD Sub-Investigator: Omid Modiramani, MD 收起 << |
NCT03687463 | - | Enrolling by invitation | April 10, 2020 | - | |
NCT02354443 | - | Terminated(Business decision) | - | - | |
NCT02328950 | - | Unknown | December 2017 | China, Fujian ... 展开 >> Union Hospital,Fujian Medical University Recruiting Fuzhou, Fujian, China, 350001 Contact: Ting Yang, Prof. +86-591-83357896 ext 8041 yang.hopeting@gmail.com Contact: Jianda Hu, Prof. +86-591-83357896 ext 8041 jdhu@medmail.com.cn Principal Investigator: Jianda Hu, Dr. Sub-Investigator: Ting Yang, Dr. 收起 << | |
NCT03256071 | Acute Myeloid Leukemia ... 展开 >> Allogeneic Hematopoietic Stem Cell Transplantation Conditioning 收起 << | Phase 2 Phase 3 | Recruiting | September 2021 | China, Jiangsu ... 展开 >> The First Affiliated Hospital of Soochow University Recruiting Suzhou, Jiangsu, China, 215000 Contact: Xiaowen Tang, MD +86-512-67781851 xwtang1020@163.com Principal Investigator: Depei Wu, MD 收起 << |
NCT02799147 | Leukemia, Acute Lymphoblastic ... 展开 >> Acute Myeloid Leukemia Mixed-Lineage Acute Leukemias 收起 << | Phase 1 Phase 2 | Recruiting | June 2020 | Russian Federation ... 展开 >> First Pavlov State Medical University of St. Petersburg Recruiting Saint-Petersburg, Russian Federation, 197089 Contact: Ivan S. Moiseev, PhD +79217961951 moisiv@mail.ru Contact: Olga A. Slesarchuk, PhD +79111910003 olga.slesarchuk@gmail.com Sub-Investigator: Olga V. Pirogova, M.S. 收起 << |
NCT01428973 | Graft-Versus-Host Disease ... 展开 >> Hematological Malignancies 收起 << | Phase 2 | Recruiting | September 2020 | Belgium ... 展开 >> Ziekenhuis Netwerk Antwerpen (ZNA) Recruiting Antwerpen,, Antwerpen, Belgium, 2060 Contact: Pierre Zachee, MD; PhD 32-3-2177111 pierre.zachee@zna.be University Hospital, Antwerp Recruiting Edegem, Antwerp, Belgium, 2650 Contact: Wilfried Schroyens, MD; PhD 32-03-2204111 wilfried.schroyens@uza.be Jules Bordet Institute Recruiting Brussels, Brabant, Belgium, 1000 Contact: Philippe Lewalle, MD; PhD 32-02-5417208 plewalle@ulb.ac.be Cliniques universitaires Saint-Luc- Université Catholique de Louvain Recruiting Brussels,, Brussels Region Capital, Belgium, 1200 Contact: Xavier Poiré, MD; PhD 32-02-7641880 xavier.poire@uclouvain.be AZ VUB Jette Recruiting Brussels, Brussels Region Capital, Belgium, 1090 Contact: Rik Schots, MD; PhD 32-02-4763105 Rik.Schots@uzbrussel.be Queen Fabiola Children's University Hospital Recruiting Brussels, Brussels, Region Capital, Belgium, 1020 Contact: Alice Fester, MD 32-02-4772678 afester@ulb.ac.be University Hospital, Gasthuisberg Recruiting Leuven, Flamish Brabant, Belgium, 3000 Contact: Johan Maertens, MD 32-16-33 22 11 johan.maertens@uz.kuleuven.ac.be UZ Gent Recruiting Gent, Flanders Ost, Belgium, 9000 Contact: Lucien Noens, MD; PhD 32-09-332 21 31 Lucien.Noens@Ugent.be Contact: Tessa Kerre, MD; PhD 32-09-3323464 Tessa.Kerre@Ugent.be Jolimont Hospital Haine Saint Paul Recruiting Haine St-Paul, Hainaut, Belgium, 7100 Contact: Nicole Straetmans, MD 32-64-233989 nicole.straetmans@scarlet.be Cliniques Universitaires de Mont-Godinne Recruiting Yvoir, Namur, Belgium, 5530 Contact: Carlos Graux, MD; PhD 32-081-423831 carlos.graux@uclouvain.be AZ Sint-Jan AV Recruiting Brugge, West Flanders, Belgium, 8000 Contact: Dominik Selleslag, MD 32-50-453060 dominik.selleslag@azbrugge.be H.-Hart Hospital Roeselare-Menen Recruiting Roeselare, Western Flanders, Belgium, 8800 Contact: Dries Deeren, MD 32-51-237437 ddeeren@hhr.be CHU Sart Tilman Recruiting Liège, Belgium, 4000 Principal Investigator: Frédéric Baron, MD; PhD Sub-Investigator: Yves Beguin, MD; PhD Sub-Investigator: Evelyne Willems, MD; PhD 收起 << |
NCT02354443 | Metabolic Disorders | Phase 1 | Terminated(Business decision) | - | United States, Massachusetts ... 展开 >> Boston Children's Hospital Boston, Massachusetts, United States, 02115-5450 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27705 收起 << |
NCT01181271 | Diffuse, Large B-Cell, Lymphom... 展开 >>a Lymphoma, Low-Grade T-Cell Lymphoma Mantle-Cell Lymphoma Hodgkin's Lymphoma Chronic Lymphocytic Leukemia Lymphoma, Small Lymphocytic 收起 << | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 << |
NCT00176852 | Sickle Cell Disease ... 展开 >> Thalassemia Severe Congenital Neutropenia Diamond-Blackfan Anemia Shwachman-Diamond Syndrome 收起 << | Phase 2 Phase 3 | Active, not recruiting | January 2019 | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT01181271 | - | Completed | - | - | |
NCT00176852 | - | Active, not recruiting | - | - | |
NCT03339700 | Acute Lymphoblastic Leukemia, ... 展开 >>Adult 收起 << | Early Phase 1 | Recruiting | December 30, 2018 | Mexico ... 展开 >> Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran Recruiting Mexico City, Distrito Federal, Mexico, 14080 Contact: Eucario Leon Rodriguez, M.D. 525554870900 ext 2255 eucarios@hotmail.com Contact: Monica M Rivera Franco, M.D. 525554870900 ext 2719 monrif90d@gmail.com 收起 << |
NCT02215070 | Hematological Malignancies | Phase 2 | Recruiting | January 2020 | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Suspended Boston, Massachusetts, United States, 02114 United States, North Carolina Duke University Medical Center Recruiting Durham, North Carolina, United States, 27705 Contact: Anthony Sung, MD 919-668-5710 anthony.sung@duke.edu 收起 << |
NCT01969942 | Ewing Sarcoma | Phase 1 | Withdrawn(No subjects meeting ... 展开 >>study inclusion were enrolled.) 收起 << | - | United States, Kentucky ... 展开 >> Pediatric Hematology/Oncology University of Louisville Louisville, Kentucky, United States, 40202 收起 << |
NCT00668564 | Hurler's Syndrome ... 展开 >> Maroteaux-Lamy Syndrome Sly Syndrome Alpha Mannosidosis Fucosidosis Aspartylglucosaminuria Sphingolipidoses Krabbe Disease Wolman's Disease Niemann-Pick Disease Type B Niemann-Pick Disease, Type C 收起 << | Phase 2 | Terminated(Replaced by another... 展开 >> study) 收起 << | - | United States, Minnesota ... 展开 >> University of Minnesota, Fairview Minneapolis, Minnesota, United States, 55455 收起 << |
NCT02310997 | Leukaemia Lym... 展开 >>phoma Other Haematological Diseases 收起 << | Phase 2 | Terminated(Trial closed early ... 展开 >>due to poor recruitment) 收起 << | - | United Kingdom ... 展开 >> University College London Hospital London, Greater London, United Kingdom, W1T 4TJ University Hospital Birmingham Birmingham, United Kingdom, B15 2TH Bristol Haematology & Oncology Centre Bristol, United Kingdom, BS2 8ED Addenbrooke's Hospital Cambridge, United Kingdom, CB2 0QQ St James' University Hospital Leeds, United Kingdom, LS9 7TF St Bartholomew's Hospital London, United Kingdom, EC1A 7BE Great Ormond Street Hospital for Children London, United Kingdom, WC1N 3JH Manchester Royal Infirmary Manchester, United Kingdom, M13 9WL Christie Hospital NHS Foundation Trust Manchester, United Kingdom, M20 4BX Nottingham City Hospital Nottingham, United Kingdom, NG5 1PB Royal Hallamshire Hospital Sheffield, United Kingdom, S10 2JF Royal Marsden Hospital Sutton, United Kingdom, SM2 5PT 收起 << |
NCT00668564 | - | Terminated(Replaced by another... 展开 >> study) 收起 << | - | - | |
NCT00984412 | Refractory Acute Leukemia | Phase 1 Phase 2 | Recruiting | November 2020 | Israel ... 展开 >> Hadassah Medical Organization Recruiting Jerusalem, Israel Contact: Arik Tzukert, DMD 00 972 2 6776095 arik@hadassah.org.il Contact: Hadas Lamberg, PhD 00972 2 6777572 Ihadas@hadassah.org.il Principal Investigator: Michael Y Shapira, MD 收起 << |
NCT02277639 | - | Completed | - | - | |
NCT02329080 | Diffuse Large B-cell Lymphoma | Phase 2 | Recruiting | December 2023 | Czechia ... 展开 >> Facultni nemocnice Recruiting Brno, Czechia Contact: Andrea Janikova Principal Investigator: Andrea Janikova FNKV (Facultni Nemocnice Kralovske Vinohrady) Recruiting Praha, Czechia Contact: Heidi Mocikova Principal Investigator: Heidi Mocikova Vseobecna facultni nemocnice v Praze Not yet recruiting Praha, Czechia Contact: Robert Pytlik Principal Investigator: Robert Pytlik Italy Spedali Civili Recruiting Brescia, Italy Contact: Giuseppe Rossi Principal Investigator: Giuseppe Rossi UO Ematologia e CTMO, PO Businco Recruiting Cagliari, Italy Contact: Giuseppina Cabras Principal Investigator: Giuseppina Cabras IRST Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori Recruiting Meldola, Italy Contact: Gerardo Musuraca Principal Investigator: Gerardo Musuraca UO Ematoliga Ospedale dell'Angelo Recruiting Mestre, Italy Contact: Renato Bassan Principal Investigator: Renato Bassan Istituto Nazionale Tumori Recruiting Milano, Italy Principal Investigator: Liliana Devizzi Ospedale Maggiore Policlinico Recruiting Milano, Italy Contact: Maria Cecilia Goldaniga Principal Investigator: Maria Cecilia Goldaniga San Raffaele H Scientific Institute Recruiting Milan, Italy Contact: Andres Ferreri, MD ferreri.andres@hsr.it Principal Investigator: Andrés JM Ferreri, MD AOU Policlinico di Modena Recruiting Modena, Italy Contact: Franco Narni Principal Investigator: Franco Narni SCDU Ematologia Recruiting Novara, Italy Contact: Gianluca Gaidano Principal Investigator: Gianluca Gaidano Ematologia ed Immunologia Clinica - AO di Padova Recruiting Padova, Italy Contact: Renato Zambello Principal Investigator: Renato Zambello UO Oncoematologia Ospedale Tortora Recruiting Pagani, Italy Contact: Catello Califano Principal Investigator: Catello Califano Villa Sofia - Cervello Recruiting Palermo, Italy Contact: Caterina Patti Principal Investigator: Caterina Patti Ematologia AOU Recruiting Parma, Italy Contact: Francesca Re Principal Investigator: Francesca Re Ematologia Ospedale S.Maria delle Croci Recruiting Ravenna, Italy Contact: Claudia Cellini Principal Investigator: Claudia Cellini A.O. Bianchi-Melacrino-Morelli, Divisione di Ematologia Recruiting Reggio Calabria, Italy Contact: Caterina Stelitano, MD Principal Investigator: Caterina Stelitano, MD Arcispedale Santa Maria Nuova, Azienda Ospedaliera di Reggio Emilia Recruiting Reggio Emilia, Italy Contact: Fiorella Ilariucci Principal Investigator: Fiorella Ilariucci Ematologia Università La Sapienza Recruiting Roma, Italy Contact: Maurizio Martelli Principal Investigator: Maurizio Martelli IRCCS Istituto Regina Elena (IFO) Recruiting Roma, Italy Contact: Francesca Palombi Principal Investigator: Francesca Palombi Policlinico Universitario Campus Bio-Medico Recruiting Rome, Italy Contact: Ombretta Annibali Principal Investigator: Ombretta Annibali IRCCS Casa Sollievo Della Sofferenza Recruiting San Giovanni Rotondo, Italy Contact: Nicola Cascavilla Principal Investigator: Nicola Cascavilla AOU Senese Recruiting Siena, Italy Contact: Alberto Fabbri Principal Investigator: Alberto Fabbri AO S.Maria di Terni Recruiting Terni, Italy Contact: Anna Marina Liberati Principal Investigator: Anna Marina Liberati SC Ematologia AO Città della Salute e della Scienza Recruiting Torino, Italy Contact: Barbara Botto Principal Investigator: Barbara Botto UO Ematologia Ospedale Panico Recruiting Tricase, Italy Contact: Vincenzo Pavone Principal Investigator: Vincenzo Pavone AOU Santa Maria della Misericordia Recruiting Udine, Italy Contact: Francesco Zaja Principal Investigator: Francesco Zaja UOC Ematologia Policlinico Rossi Recruiting Verona, Italy Contact: Achille Ambrosetti Principal Investigator: Achille Ambrosetti Ematologia Ospedale S. Bortolo Recruiting Vicenza, Italy Contact: Maurizio Frezzato Principal Investigator: Maurizio Frezzato Netherlands Erasmus MC Recruiting Rotterdam, Netherlands Contact: Jeanette Doorduijn Principal Investigator: Jeanette Doorduijn United Kingdom Beatson Cancer Center Recruiting Glasgow, United Kingdom Contact: Pam Mc Kay Principal Investigator: Pam Mc Kay Liverpool Aintree Recruiting Liverpool, United Kingdom Contact: Jeffery Smith Principal Investigator: Jeffery Smith UCLH University College London Hospitals NHS foundation trust Recruiting London, United Kingdom Contact: Kate Cwynarski Principal Investigator: Kate Cwynarski The Christie Hospital Recruiting Manchester, United Kingdom Contact: Kim Linton Principal Investigator: Kim Linton Southampton General Hospital Not yet recruiting Southampton, United Kingdom Contact: Andrew Davies Principal Investigator: Andrew Davies 收起 << |
NCT02140554 | Sickle Cell Disease | Phase 1 Phase 2 | Recruiting | January 2021 | United States, California ... 展开 >> Recruiting Oakland, California, United States United States, Georgia Children's Healthcare of Atlanta Recruiting Atlanta, Georgia, United States, 30322 United States, Illinois Recruiting Chicago, Illinois, United States United States, Maryland Recruiting Bethesda, Maryland, United States United States, New York Recruiting New York, New York, United States United States, Pennsylvania Recruiting Philadelphia, Pennsylvania, United States United States, South Carolina Recruiting Charleston, South Carolina, United States 收起 << |
NCT01050946 | Leukemia, Lymphocytic, Acute ... 展开 >> Leukemia, Lymphocytic, Chronic Leukemia, Myelocytic, Acute Leukemia, Myeloid, Chronic Lymphoma, Non-Hodgkin Lymphoma, Hodgkins 收起 << | Phase 2 | Terminated(Only one patient wa... 展开 >>s enrolled. Due to low accrual study was terminated) 收起 << | - | - |
NCT00003960 | Leukemia Mult... 展开 >>iple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes 收起 << | Phase 2 | Completed | - | United States, Maryland ... 展开 >> Johns Hopkins Oncology Center Baltimore, Maryland, United States, 21231 United States, South Carolina Center for Cancer Treatment and Research Columbia, South Carolina, United States, 29203 收起 << |
NCT02549586 | Complication of Transplanted O... 展开 >>rgan, Nos 收起 << | Phase 2 | Active, not recruiting | January 2020 | Canada, Ontario ... 展开 >> The Ottawa Hopital Ottawa, Ontario, Canada, K1H 8L6 Multi-Organ Transplant Program, Toronto General Hospital Toronto, Ontario, Canada, M5G 2N2 收起 << |
NCT01814488 | Acute Leukemia | Phase 2 | Completed | - | Italy ... 展开 >> Azienda Ospedaliera SS Antonio e Biagio Alessandria, Italy Policlinico Bari, Italy Divisione di Ematologia - Ospedali Papa Giovanni XXIII Bergamo, Italy Ospedale San Orsola Bologna, Italy Ospedale Regionale Generale- Divisione Ematologia Bolzano, Italy Ospedale Binaghi Cagliari, Italy Ospedale Oncologico Businco Cagliari, Italy Ospedale Ferrarotto - Ematologia Catania, Italy S.C. Ematologia - Azienda Ospedaliera S. Croce e Carle Cuneo, Italy Cattedra di Ematologia - Azienda Ospedaliera di Careggi Firenze, Italy Ospedale Policlinico San Martino - IST Genova, Italy Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano, Italy Ospedale Niguarda Ca' Grande Milano, Italy Ospedale San Raffaele Milano, Italy Divisione Ematologia - Azienda Ospedaliera Universitaria - Policlinico - Modena, Italy Cattedra di Medicina Interna ed Ematologia - Ospedale S. Gerardo de' i Tintori - Università degli Studi di Milano Monza, Italy AO Ospedali Riuniti Villa Sofia - Cervello Palermo, Italy Dipartimento Oncologico La Maddalena Palermo, Italy Fondazione IRCCS San Matteo Pavia, Italy, 27100 Dip. di Ematologia - Unità di Terapia Intensiva Ematologica per il Trapianto Emopoietico - Ospedale Civile di Pescara Pescara, Italy Ospedale G. Da Saliceto di Piacenza Piacenza, Italy Cattedra di Ematologia - Policlinico Roma, Italy Policlinico A. Gemelli Roma, Italy Policlinico Universitario Tor Vergata Roma, Italy U.O. di Ematologia e Trapianti di Midollo Osseo - Azienda Osp. S. Camillo-Forlanini / Padiglione Morgagni Roma, Italy Ematologia e Centro Trapianti Midollo Osseo - Ospedale IRCCS Casa Sollievo della Sofferenza S. Giovanni Rotondo (FG), Italy Ospedale San Giuseppe Moscato Taranto, Italy Azienda ospedaliera Città della Salute e della Scienza Torino, Italy Centro Trapianti Metropolitano Torino, Italy A.O. Santa Maria della Misericordia Udine, Italy 收起 << |
NCT00544115 | Chronic Myeloproliferative Dis... 展开 >>orders Graft Versus Host Disease Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Precancerous/Nonmalignant Condition 收起 << | Phase 2 | Active, not recruiting | - | - |
NCT00536601 | Adult Acute Lymphoblastic Leuk... 展开 >>emia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Nasal Type Extranodal NK/T-cell Lymphoma Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Burkitt Lymphoma Childhood Diffuse Large Cell Lymphoma Childhood Immunoblastic Large Cell Lymphoma Childhood Nasal Type Extranodal NK/T-cell Lymphoma Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor (PNET) Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma Intraocular Lymphoma Nodal Marginal Zone B-cell Lymphoma Peripheral T-cell Lymphoma Plasma Cell Neoplasm Primary Systemic Amyloidosis Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Small Noncleaved Cell Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Malignant Testicular Germ Cell Tumor Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Neuroblastoma Recurrent Small Lymphocytic Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Multiple Myeloma Regional Neuroblastoma Splenic Marginal Zone Lymphoma Testicular Lymphoma Unspecified Adult Solid Tumor, Protocol Specific Unspecified Childhood Solid Tumor, Protocol Specific Waldenström Macroglobulinemia 收起 << | Not Applicable | Completed | - | United States, New York ... 展开 >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 收起 << |
NCT00597714 | - | Completed | - | - | |
NCT00597714 | Hodgkin's Disease ... 展开 >> Non Hodgkin's Lymphoma Myeloma Leukemia Myelodysplasia 收起 << | Phase 2 | Completed | - | United States, North Carolina ... 展开 >> Duke University Health System Durham, North Carolina, United States, 27710 收起 << |
NCT01037764 | Acute Lymphoid Leukemia | Phase 2 | Terminated(The PI resigned the... 展开 >> institute, and the rest investigators at the institute decided to terminate the study.) 收起 << | - | Korea, Republic of ... 展开 >> Inje University Haeundae Paik Hospital Pusan, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of, 138-736 收起 << |
NCT01852071 | ADA-SCID | Phase 1 Phase 2 | Active, not recruiting | September 2018 | United States, California ... 展开 >> Mattel Children's Hospital, UCLA Los Angeles, California, United States, 90095 United States, Maryland Mark O. Hatfield Clinical Research Center, NIH Bethesda, Maryland, United States, 20892 收起 << |
NCT01050946 | - | Terminated(Only one patient wa... 展开 >>s enrolled. Due to low accrual study was terminated) 收起 << | - | - | |
NCT00004907 | Lymphoma | Phase 1 Phase 2 | Completed | - | United States, Illinois ... 展开 >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611 收起 << |
NCT02737384 | Combined Immunodeficiencies | Phase 2 | Terminated | - | France ... 展开 >> Hôpital Necker-Enfants Malades Paris, France, 75015 收起 << |
NCT02623309 | Hematologic Neoplasms | Phase 3 | Recruiting | February 2021 | France ... 展开 >> CHU Amiens Recruiting Amiens, France Contact: Amandine Charbonnier, MD Charbonnier.Amandine@chuamiens.fr Principal Investigator: Amandine Charbonnier, MD CHU Besançon Recruiting Besançon, France Contact: Ana Berceanu, MD aberceanu@chu-besancon.fr Principal Investigator: Ana Berceanu, MD CHU Estaing/Clermont-ferrand Recruiting Clermont-ferrand, France Contact: Eric Hermet, MD Principal Investigator: Eric Hermet, MD Principal Investigator: Jacques-Olivier Bay, MD CHU Albert Michallon Recruiting Grenoble, France Contact: Claude-Eric Bulabois, MD Principal Investigator: Claude-Eric Bulabois, MD CHU Limoges Recruiting Limoges, France Contact: Pascal Turlure, MD Pascal.turlure@chu-limoges.fr Principal Investigator: Pascal Turlure, MD Institut Paoli Calmettes Recruiting Marseille, France, 13009 Contact: Dominique GENRE, MD 33491223778 drci.up@ipc.unicancer.fr Contact: Jihane PAKRADOUNI, PharmD, PhD 33491223778 drci.up@ipc.unicancer.fr Principal Investigator: Didier BLAISE, MD PhD CHRU Montpellier Recruiting Montpellier, France Contact: Patrice CEBALLOS, MD p-ceballos@chu-montpellier.fr Principal Investigator: Patrice CEBALLOS, MD Principal Investigator: Nathalie Fegueux, MD CHU Nantes Recruiting Nantes, France Contact: Patrice Chevallier, MD Patrice.chevallier@chunantes.fr Principal Investigator: Patrice Chevallier, MD Hôpital Necker Recruiting Paris, France Contact: Felipe Suarez, MD felipe.suarez@nck.aphp.fr Principal Investigator: Felipe Suarez Hôpital Saint Antoine Recruiting Paris, France Contact: Mohamad Mohty, MD mohamad.mohty@inserm.fr Principal Investigator: Mohamad Mohty, MD Hôpital Saint Louis Recruiting Paris, France Contact: Regis Peffault de latour, MD regis.peffaultdelatour@sls.aph Principal Investigator: Regis Peffault de latour, MD Hôpital Haut Leveque Recruiting Pessac, France Contact: Reza Tabrizi, MD reza.tabrizi@chu-bordeaux.fr Principal Investigator: Reza Tabrizi, MD Institut de Cancérologie Lucien Neuwirth Recruiting Saint Priest en Jarez, France Contact: Jérôme CORNILLON, MD Jerome.cornillon@icloire.fr Principal Investigator: Jérôme CORNILLON, MD IUCT Recruiting Toulouse, France Contact: Anne Huynh, MD Huynh.Anne@iuct-oncopole.fr Principal Investigator: Anne Huynh, MD 收起 << |
NCT01279616 | Sickle Cell Disease | Phase 2 | Terminated(PI moving to a diff... 展开 >>erent institution.) 收起 << | - | United States, Ohio ... 展开 >> Nationwide Children's Hospital Columbus, Ohio, United States, 43205 收起 << |
NCT00049634 | Chronic Myeloproliferative Dis... 展开 >>orders Leukemia Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases 收起 << | Phase 1 Phase 2 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98104 Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 收起 << |
NCT00966810 | Philadelphia Chromosome-positi... 展开 >>ve Chronic Myelocytic Leukemia 收起 << | Phase 2 Phase 3 | Unknown | January 2011 | Israel ... 展开 >> Rambam Health Care Campus Haifa, Israel, 31096 收起 << |
NCT00547196 | Leukemia Lymp... 展开 >>homa Myelodysplastic Syndromes 收起 << | Not Applicable | Active, not recruiting | September 2019 | United States, Arizona ... 展开 >> Banner Good Samaritan Medical Center Phoenix, Arizona, United States, 85006 United States, California City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 收起 << |
NCT02643589 | Hematopoietic Stem Cell Transp... 展开 >>lantation 收起 << | Not Applicable | Unknown | December 2016 | China, Guangdong ... 展开 >> Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Ren Lin +86-020-62787883 lansinglinren@hotmail.com 收起 << |
NCT00282282 | Graft Versus Host Disease ... 展开 >> GVHD 收起 << | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 << |
NCT02996773 | Acute Lymphoblastic Leukemia ... 展开 >> Acute Myelogenous Leukemia Myelodysplastic Syndromes Chronic Myelogenous Leukemia Juvenile Myelomonocytic Leukemia Lymphoma,Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Follicular Marginal Zone Lymphoma Large Cell Lymphoma Mantle-Cell Lymphoma Gray Zone Lymphoma Burkitt Lymphoma 收起 << | Phase 1 Phase 2 | Recruiting | April 2022 | United States, Arizona ... 展开 >> The University of Arizona Cancer Center Recruiting Tucson, Arizona, United States, 85724 Contact: Olga Ambriz (520) 694-4767 oambriz@email.arizona.edu Principal Investigator: Emmanuel Katsanis, MD Sub-Investigator: Faiz Anwer, MD Sub-Investigator: Daniel Persky, MD Sub-Investigator: Soham Puvvada, MD Sub-Investigator: Ali McBride, PharmD, MS, BCPS Sub-Investigator: Denise J. Roe, DrPH Sub-Investigator: Murali Kodali, MD Sub-Investigator: Lisa Kopp, DO Sub-Investigator: Ravitharan Krishnadasan, MD Sub-Investigator: Sandra Kurtin, NPC Sub-Investigator: Laura McPheeters, NP Sub-Investigator: Jana Montez, NP Sub-Investigator: Lauren Nichols, MD Sub-Investigator: Luz Pelayo-Katsanis, RN, PNP Sub-Investigator: Lauren Sapp, NP Sub-Investigator: Katherine Whitney, NP Sub-Investigator: Andrew Yeager, MD Sub-Investigator: Yi Zeng, MD 收起 << |
NCT01883180 | Hematopoietic Stem Cell Transp... 展开 >>lantation Antithymocyte Globulin Viral Infection 收起 << | Phase 4 | Completed | - | China, Guangdong ... 展开 >> Department of Hematology,Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China, 510515 收起 << |
NCT00282282 | - | Completed | - | - | |
NCT00186966 | Acute Myeloid Leukemia | Phase 3 | Completed | - | United States, Tennessee ... 展开 >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 收起 << |
NCT00049517 | Leukemia | Phase 3 | Active, not recruiting | January 2019 | - |
NCT00002547 | Leukemia Myel... 展开 >>odysplastic Syndromes 收起 << | Phase 2 | Completed | - | United States, Michigan ... 展开 >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 收起 << |
NCT01896102 | Cerebral Adrenoleukodystrophy ... 展开 >>(CALD) 收起 << | Phase 2 Phase 3 | Active, not recruiting | December 2021 | United States, California ... 展开 >> Mattel Children's Hospital UCLA/Ronald Reagan UCLA Medical Center Los Angeles, California, United States, 90095 United States, Massachusetts Boston Children's Hospital/Massachusetts General Hospital Boston, Massachusetts, United States, 02115 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 France Hôpital Bicêtre Le Kremlin-Bicêtre Cedex, France, 94275 United Kingdom Great Ormond Street Hospital for Children NHS Foundation Trust London, United Kingdom, WC1N3JH 收起 << |
NCT00049517 | - | Active, not recruiting | - | - | |
NCT00342316 | Acute Myeloid Leukemia | Phase 3 | Unknown | December 2017 | - |
NCT03270748 | Myeloid Malignancies | Phase 2 | Not yet recruiting | January 1, 2021 | Italy ... 展开 >> Ospedale San Orsola Bologna, Italy AOU-IRCCS San Martino-IST Genova, Italy A.O.U. Citta della Salute e della Scienza Not yet recruiting Torino, Italy Principal Investigator: Benedetto Bruno 收起 << |
NCT00054327 | Leukemia Lymp... 展开 >>homa Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases 收起 << | Phase 2 | Completed | - | United States, Ohio ... 展开 >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 收起 << |
NCT02277639 | Bone Marrow Failure Syndromes ... 展开 >> Immunodeficiencies Immune Dysregulation Syndromes 收起 << | Phase 2 | Completed | - | United States, Pennsylvania ... 展开 >> The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 收起 << |
NCT00423826 | - | - | - | United States, Michigan ... 展开 >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 收起 << | |
NCT00054327 | - | Completed | - | - | |
NCT02386332 | - | Not yet recruiting | March 2020 | - | |
NCT02504047 | Hematologic Neoplasms | Not Applicable | Recruiting | July 2019 | Canada, Alberta ... 展开 >> Foothills Medical Center / Tom Baker Cancer Center Recruiting Calgary, Alberta, Canada, T2N 4N2 Contact: Andrew Daly, MD 4035213706 andrew.daly@albertahealthservices.ca Contact: Mamta Kantharia mamta.kantharia@albertahealthservices.ca Principal Investigator: Andrew Daly, MD Canada, Manitoba Health Sciences Center Recruiting Winnipeg, Manitoba, Canada, R3A 1R9 Contact: Kristjan Paulson, MD kpaulson@cancercare.mb.ca Principal Investigator: Kristjan Paulson, MD Sub-Investigator: Donna Wall, MD Sub-Investigator: David Szwajcer, MD Canada, Ontario Ottawa General Hospital Not yet recruiting Ottawa, Ontario, Canada, K1H 8L6 Contact: Christopher Bredeson, MD cbredeson@toh.on.ca Principal Investigator: Christopher Bredeson, MD Canada, Quebec McGill University Health Centre Not yet recruiting Montreal, Quebec, Canada, H4A 3J1 Contact: Gizelle Popradi, MD gizelle.popradi@mcgill.ca Principal Investigator: Gizelle Popradi, MD Canada, Saskatchewan Royal University Hospital Not yet recruiting Saskatoon, Saskatchewan, Canada, S7N 0W8 Contact: Mark Bosch, MD Mark.Bosch@saskcancer.ca Principal Investigator: Mark Bosch 收起 << |
NCT03392987 | Lysosomal Storage Disease | Phase 3 | Recruiting | August 23, 2028 | Italy ... 展开 >> GSK Investigational Site Recruiting Milan, Italy, 20132 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT00943800 | Leukemia Myel... 展开 >>odysplastic Syndrome Multiple Myeloma Lymphoma 收起 << | Not Applicable | Active, not recruiting | September 2018 | United States, Illinois ... 展开 >> The University of Chicago Chicago, Illinois, United States, 60637 收起 << |
NCT01129544 | Severe Combined Immunodeficien... 展开 >>cy 收起 << | Phase 1 Phase 2 | Active, not recruiting | March 2033 | United States, California ... 展开 >> Mattel Children's Hospital - UCLA Los Angeles, California, United States, 90095 United States, Massachusetts Children's Hospital Boston Boston, Massachusetts, United States, 02116 United States, Ohio Cincinnati Children's Medical Center Cincinnati, Ohio, United States, 45229 收起 << |
NCT01188174 | AML | Phase 2 | Completed | - | France ... 展开 >> CHU de Bordeaux Bordeaux, France CHU Caen Caen, France CHRU lille Lille, France Hôpital Edouard Herriot Lyon, France Institut Paoli Calmette Marseille, France Nantes University hospital Nantes, France, 44200 Paris saint Louis Paris, France CHRU de Strasbourg Strasbourg, France CHU Toulouse Toulouse, France 收起 << |
NCT03016806 | Acute Leukemia ... 展开 >> Immune Deficiency Disorder Congenital Hematological Disorder Metabolism Disorder Aplastic Anemia Myelodysplastic Syndromes Chronic Leukemia Lymphoma Multiple Myeloma Solid Tumor 收起 << | Phase 1 | Recruiting | June 2026 | United States, New York ... 展开 >> Wilmot Cancer Institute Recruiting Rochester, New York, United States, 14642 Contact: Jane L Liesveld, MD 585-275-4099 jane_liesveld@urmc.rochester.edu Contact: Michael W Becker, MD 585-275-4099 michael_becker@urmc.rochester.edu 收起 << |
NCT00275678 | Blood Stem Cell Transplant | Phase 3 | Completed | - | United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT01067300 | Leukemia | Phase 3 | Unknown | January 2016 | France ... 展开 >> Assistance Publique - Hôpitaux de Marseille Marseille, France 收起 << |
NCT00002989 | Leukemia Lymp... 展开 >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes 收起 << | Phase 3 | Unknown | - | Belgium ... 展开 >> Institut Jules Bordet Brussels (Bruxelles), Belgium, 1000 France Hopital Edouard Herriot Lyon, France, 69437 Hotel Dieu de Paris Paris, France, 75181 Institut Gustave Roussy Villejuif, France, F-94805 Germany Eberhard Karls Universitaet Tuebingen, Germany, D-72076 Italy Ospedale San Eugenio Rome, Italy, 00144 Azienda Policlinico Umberto Primo Rome, Italy, 00161 Netherlands Leiden University Medical Center Leiden, Netherlands, 2300 CA University Medical Center Nijmegen Nijmegen, Netherlands, NL-6500 HB 收起 << |
NCT01818479 | High Risk Hematologic Malignan... 展开 >>cies 收起 << | Phase 1 Phase 2 | Recruiting | July 2020 | United States, Utah ... 展开 >> Huntsman Cancer Institute Recruiting Salt Lake City, Utah, United States, 84112 Principal Investigator: Michael Boyer, MD 收起 << |
NCT01966367 | Bone Marrow Failure Syndrome ... 展开 >> Severe Aplastic Anemia Severe Congenital Neutropenia Amegakaryocytic Thrombocytopenia Diamond-Blackfan Anemia Schwachman Diamond Syndrome Primary Immunodeficiency Syndromes Acquired Immunodeficiency Syndromes Histiocytic Syndrome Familial Hemophagocytic Lymphocytosis Lymphohistiocytosis Macrophage Activation Syndrome Langerhans Cell Histiocytosis (LCH) Hemoglobinopathies Sickle Cell Disease Sickle Cell-beta-thalassemia 收起 << | Early Phase 1 | Recruiting | December 2019 | United States, New York ... 展开 >> Morgan Stanley Children's Hospital, New York-Presbyterian, Columbia University Recruiting New York, New York, United States, 10032 Contact: Jean Sosna, RN js4403@columbia.edu Contact: Danielle Dietzen, CPNP 212-305-8443 dad9025@nyp.org Principal Investigator: Diane George, MD 收起 << |
NCT01663766 | GVHD (Acute or Chronic) ... 展开 >> Acute Myeloid or Lymphoblastic Leukemia (AML or ALL) Myelodysplastic Syndrome Chronic Myelogenous Leukemia (CML) Multiple Myeloma (MM) Non-Hodgekin Lymphoma (NHL-both Follicular & Diffuse Large Cell) Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia (CLL or SLL) 收起 << | Phase 1 | Unknown | January 2017 | United States, Ohio ... 展开 >> Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 收起 << |
NCT02906202 | Beta-Thalassemia | Phase 3 | Recruiting | January 2020 | United States, California ... 展开 >> Recruiting Oakland, California, United States United States, Illinois Recruiting Chicago, Illinois, United States United States, Pennsylvania Recruiting Philadelphia, Pennsylvania, United States France Recruiting Marseille, France Germany Recruiting Hannover, Germany Greece Withdrawn Thessaloniki, Greece Italy Recruiting Rome, Italy Thailand Recruiting Bangkok, Thailand United Kingdom Recruiting London, United Kingdom 收起 << |
NCT03246178 | Severe Aplastic Anemia | Not Applicable | Enrolling by invitation | December 1, 2020 | China ... 展开 >> Department of Hematology, 304th Clinical Division, Chinese PLA General Hospital Beijing, China, 100048 收起 << |
NCT00020566 | Sarcoma | Phase 3 | Unknown | - | - |
NCT02660281 | Hematological Disease ... 展开 >> Immune Deficiencies Solid Tumors Myelofibrosis Multiple Myeloma Lymphoma 收起 << | Phase 1 | Recruiting | October 2026 | United States, New York ... 展开 >> Wilmot Cancer Institute Recruiting Rochester, New York, United States, 14642 Contact: Jeffrey Andolina, MD 585-275-2981 jeffrey_andolina@urmc.rochester.edu Contact: Jessica Mavor 585-275-9680 jessica_mavor@urmc.rochester.edu 收起 << |
NCT01461837 | Sickle Cell Disease | Phase 2 | Recruiting | April 2019 | United States, California ... 展开 >> University of California Los Angeles (UCLA) Recruiting Los Angeles, California, United States, 90095 Contact: Theodore Moore, MD 310-825-6708 tbmoore@mednet.ucla.edu Contact: LaMarr Taylor, CCRP 310-794-8929 LaMarrTaylor@mednet.ucla.edu Principal Investigator: Theodore Moore, MD Children's Hospital and Research Center Oakland Completed Oakland, California, United States, 94609 United States, Illinois Lurie Children's Hospital Completed Chicago, Illinois, United States, 60611-2605 United States, Missouri Washington University/St. Louis Children's Hospital Recruiting Saint Louis, Missouri, United States, 63110 Contact: Shalini Shenoy, MD 314-454-6018 Shenoy@kids.wustl.edu Contact: Megan Holtmann 314-454-6018 Principal Investigator: Shalini Shenoy, MD United States, New York New York Medical College Recruiting Valhalla, New York, United States, 10595 Contact: Mitchell S Cairo, MD 914-594-2150 mitchell_cairo@nymc.edu Contact: Sandi Fabricatore, RN, PNP 914-594-2152 Fabricatores@wcmc.com Principal Investigator: Mitchell S Cairo, MD United States, Ohio Cincinnati Children's Hospital Withdrawn Cincinnati, Ohio, United States, 45229 United States, Wisconsin Medical College of Wisconsin/Children's Hospital of Wisconsin Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Julie Talano, MD 414-955-4185 jtalano@mcw.edu Contact: Kathy Jodarski 414-266-2681 kjodarski@chw.org Principal Investigator: Julie Talano, MD 收起 << |
NCT03207009 | Beta-Thalassemia | Phase 3 | Recruiting | April 2021 | United States, California ... 展开 >> UCSF Benioff Children's Hospital Oakland Recruiting Oakland, California, United States, 94609 United States, Illinois Ann & Robert H. Lurie Children's Hospital of Chicago Recruiting Chicago, Illinois, United States, 60611 United States, Pennsylvania Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 France Hopital d'enfants de la Timone Recruiting Marseille, France, 13385 Germany Hannover Medical School Recruiting Hannover, Germany, 30625 University of Heidelberg Recruiting Heidelberg, Germany, 69120 Greece General Hospital of Thessaloniki 'G.Papanikolaou' Recruiting Thessaloníki, Greece Italy IRCCS Ospedale Pediatrico Babino Gesu Recruiting Rome, Italy United Kingdom University College London Hospital Recruiting London, United Kingdom 收起 << |
NCT00507780 | Ovarian Function ... 展开 >> Preservation of Ovarian Function 收起 << | Phase 4 | Withdrawn | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT00130754 | Stem Cell Transplantation ... 展开 >> Graft Vs Host Disease 收起 << | Phase 3 | Completed | - | Israel ... 展开 >> Hadassah Medical Organization Jerusalem, Israel, 91120 收起 << |
NCT01719341 | - | Unknown | - | Singapore ... 展开 >> National University Hospital Recruiting Singapore, Singapore, 119074 Contact: Zi Yi Lim, MB ChB 65 6779 5555 Zi_Yi_Lim@nuhs.edu.sg Principal Investigator: Zi Yi Lim, MB ChB 收起 << | |
NCT00084695 | Childhood Langerhans Cell Hist... 展开 >>iocytosis Fanconi Anemia Leukemia Lymphoma Myelodysplastic Syndromes Neuroblastoma Sarcoma Unspecified Childhood Solid Tumor, Protocol Specific 收起 << | Phase 2 | Unknown | - | United States, Pennsylvania ... 展开 >> Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center Recruiting Hershey, Pennsylvania, United States, 17033-0850 Contact: Kenneth G. Lucas, MD 717-531-6012 klucas@psu.edu 收起 << |
NCT02928991 | Bone Marrow Failure Syndromes | Early Phase 1 | Recruiting | April 2020 | United States, Pennsylvania ... 展开 >> Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Timothy Olson, MD, PhD OLSONT@email.chop.edu Contact: Barbara McGlynn, RN, BSN MCGLYNN@email.chop.edu Principal Investigator: Timothy Olson, MD 收起 << |
NCT00001561 | Graft vs Host Disease ... 展开 >> Multiple Myeloma 收起 << | Phase 3 | Completed | - | United States, Maryland ... 展开 >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 收起 << |
NCT03432364 | Transfusion Dependent Beta-tha... 展开 >>lassemia 收起 << | Phase 1 Phase 2 | Recruiting | May 2022 | United States, California ... 展开 >> University of California, Los Angeles Recruiting Los Angeles, California, United States, 90095-1678 Contact: Nikki Alimi, ANP-BC 310-794-0242 NAlimi@mednet.ucla.edu Contact: Bruck Habtemariam 310-794-0242 bhabtemariam@mednet.ucla.edu Principal Investigator: Gary Schiller, M.D. UCSF Benioff Children's Hospital Oakland Recruiting Oakland, California, United States, 94609 Contact: Julie Decaris 510-428-3885 ext 2739 jdecaris@mail.cho.org Principal Investigator: Mark Walters, MD United States, Massachusetts Dana-Farber Boston Children's Cancer and Blood Disorders Center Recruiting Boston, Massachusetts, United States, 02116 Contact: Colleen Dansereau, M.S.N., R.N. 617-919-7008 colleen.dansereau@childrens.harvard.edu Principal Investigator: David A Williams, M.D. United States, Minnesota University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Angela Smith, M.D., M.S. 612-625-7253 smith719@umn.edu Contact: Jennifer Braun, R.N., BSN 612-625-0084 danie659@umn.edu Principal Investigator: Angela Smith, M.D., M.S. 收起 << |
NCT03279133 | Hematopoietic Stem Cell Transp... 展开 >>lantation 收起 << | Phase 4 | Withdrawn(Unable to find eligi... 展开 >>ble patients with untreated hepatitis C virus.) 收起 << | - | United States, California ... 展开 >> City of Hope Duarte, California, United States, 91010 Kaiser Permanente Los Angeles Medical Center Los Angeles, California, United States, 90027 收起 << |
NCT00002592 | Leukemia | Phase 2 | Completed | - | United States, Pennsylvania ... 展开 >> University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States, 19104-4283 收起 << |
NCT03745287 | Sickle Cell Disease ... 展开 >> Hematological Diseases Hemoglobinopathies 收起 << | Phase 1 Phase 2 | Recruiting | May 2022 | United States, Tennessee ... 展开 >> Research Site Recruiting Nashville, Tennessee, United States, 37203 收起 << |
NCT00274794 | Lymphoma | Not Applicable | Completed | - | United States, Ohio ... 展开 >> Cleveland Clinic Taussig Cancer Institute Cleveland, Ohio, United States, 44195 收起 << |
NCT03655678 | Beta-Thalassemia ... 展开 >> Thalassemia Genetic Diseases, Inborn Hematologic Diseases Hemoglobinopathies 收起 << | Phase 1 Phase 2 | Recruiting | May 2022 | Germany ... 展开 >> Research site Recruiting Regensburg, Germany Research Site Recruiting Tuebingen, Germany United Kingdom Research Site Recruiting London, United Kingdom 收起 << |
NCT00453206 | - | Completed | - | - | |
NCT00453206 | Chronic Myeloproliferative Dis... 展开 >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes 收起 << | Not Applicable | Completed | - | United States, North Carolina ... 展开 >> Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 收起 << |
NCT00245115 | Leukemia | Phase 1 | Terminated(Expiration of study... 展开 >> supply) 收起 << | - | United States, Maryland ... 展开 >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 收起 << |
NCT02577094 | Lymphocyte B CD22 Positive Acu... 展开 >>te Lymphoblastic Leukemia 收起 << | Phase 1 Phase 2 | Withdrawn | - | - |
NCT01336712 | Chronic Leukemia ... 展开 >> Acute Leukemia Hodgkin's Disease Non-Hodgkin's Lymphoma Myelodysplastic Syndrome 收起 << | Phase 2 | Completed | - | United States, Georgia ... 展开 >> Northside Hospital Atlanta, Georgia, United States, 30342 收起 << |
NCT01790295 | Primary Myelofibrosis ... 展开 >> Post Polycythemia Vera Myelofibrosis Post Essential Thrombocythemia Myelofibrosis 收起 << | Phase 2 | Active, not recruiting | February 2021 | United States, Georgia ... 展开 >> Emory Hospital Atlanta, Georgia, United States, 30322 United States, Illinois Northwestern University, Robert h. Lurie Comprehensive Cancer Center Chicago, Illinois, United States, 60611 United States, Kansas University of Kansas Cancer Center Westwood, Kansas, United States, 66205 United States, New York Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 United States, North Carolina Wake Forest Baptist Medical Center Winston-Salem, North Carolina, United States, 27103 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210 Canada Princess Margaret Cancer Centre, University of Toronto Toronto, Canada, M5G 2M9 United Kingdom University of Oxford Oxford, United Kingdom, OX3 9DS 收起 << |
NCT00006367 | Chronic Myeloproliferative Dis... 展开 >>orders 收起 << | Phase 2 | Completed | - | United States, Alaska ... 展开 >> Katmai Oncology Group Anchorage, Alaska, United States, 99508-4627 United States, Florida H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612-9497 United States, Illinois University of Illinois College of Medicine Chicago, Illinois, United States, 60612 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, Missouri Washington University Siteman Cancer Center Saint Louis, Missouri, United States, 63110 United States, New York New York Presbyterian Hospital - Cornell Campus New York, New York, United States, 10021 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 France Hopital Saint-Louis Paris, France, 75475 United Kingdom Addenbrooke's NHS Trust Cambridge, England, United Kingdom, CB2 2QQ 收起 << |
NCT02416206 | Multiple Myeloma | Phase 2 | Recruiting | May 2020 | United States, Georgia ... 展开 >> Blood and Marrow Transplant Group of Georgia Recruiting Atlanta, Georgia, United States, 30342 Contact: Scott R. Solomon, MD 404-255-1930 收起 << |
NCT01432873 | Mucositis Hem... 展开 >>atopoietic Stem Cell Transplantation 收起 << | Phase 1 Phase 2 | Unknown | December 2012 | Iran, Islamic Republic of ... 展开 >> Hematology-Oncology & SCT Research Center Recruiting Tehran, Iran, Islamic Republic of Contact: Molouk Hadjibabaie, Pharma D. +989122838464 Principal Investigator: Molouk Hadjibabaie, Pharma D Sub-Investigator: Zahra Jahangard rafsanjani, Pharma D 收起 << |
NCT01015183 | Mucositis Bon... 展开 >>e Marrow Transplantation 收起 << | Phase 2 Phase 3 | Completed | - | Iran, Islamic Republic of ... 展开 >> Hematology-Oncology & SCT Research Center Tehran, Iran, Islamic Republic of, 14114 收起 << |
NCT01336712 | - | Completed | - | - | |
NCT03198195 | - | Enrolling by invitation | July 10, 2020 | - | |
NCT02806375 | Primary Myelofibrosis ... 展开 >> Myeloproliferative Disorders 收起 << | Phase 1 Phase 2 | Active, not recruiting | June 2019 | Russian Federation ... 展开 >> First Pavlov State Medical University of St. Petersburg Saint-Petersburg, Russian Federation, 197089 收起 << |
NCT00886522 | Hematological Malignancies | Phase 2 | Completed | - | Italy ... 展开 >> Hematology Institute "L. and A. Seràgnoli", S. Orsola-Malpighi University Hospital Bologna, Italy, 40138 收起 << |
NCT02127892 | - | Terminated(Closed due to slow ... 展开 >>accrual. Nine subjects enrolled over 7 years.) 收起 << | - | - | |
NCT00003926 | Brain and Central Nervous Syst... 展开 >>em Tumors Childhood Germ Cell Tumor Chordoma Kidney Cancer Liver Cancer Neuroblastoma Ovarian Cancer Retinoblastoma Sarcoma 收起 << | Phase 1 | Terminated(Withdrawn due to sl... 展开 >>ow accrual) 收起 << | - | United States, Minnesota ... 展开 >> University of Minnesota Cancer Center Minneapolis, Minnesota, United States, 55455 收起 << |
NCT01050439 | Leukemia Lymp... 展开 >>homa Bone Marrow Failure Syndromes Immunodeficiencies Histiocytosis 收起 << | Phase 2 | Terminated(PI left the institu... 展开 >>tion) 收起 << | - | United States, New York ... 展开 >> Columbia University Medical Center New York, New York, United States, 10032 收起 << |
NCT00281879 | - | Terminated | - | - | |
NCT00281879 | Chronic Myeloproliferative Dis... 展开 >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Unusual Cancers of Childhood 收起 << | Phase 2 | Terminated | - | United States, Oregon ... 展开 >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 收起 << |
NCT00927134 | Chronic Granulomatous Disease | Phase 1 Phase 2 | Completed | - | Switzerland ... 展开 >> University Children's Hospital Zürich, Switzerland, CH-8032 收起 << |
NCT02130869 | Neuroblastoma ... 展开 >> Lymphoma High-risk Tumor 收起 << | Phase 1 | Completed | - | United States, Tennessee ... 展开 >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 收起 << |
NCT00564759 | Granulomatous Disease, Chronic | Phase 1 Phase 2 | Unknown | December 2008 | Germany ... 展开 >> University Hospital, Hematology Frankfurt, Germany, 60596 收起 << |
NCT00478244 | - | Terminated(Competing studies) | - | - | |
NCT02127892 | Severe Combined Immunodeficien... 展开 >>cy 收起 << | Phase 1 Phase 2 | Terminated(Closed due to slow ... 展开 >>accrual. Nine subjects enrolled over 7 years.) 收起 << | - | United States, California ... 展开 >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 收起 << |
NCT01810926 | Graft Versus Host Disease | Phase 2 | Unknown | October 2016 | Italy ... 展开 >> University of Cagliari Active, not recruiting Cagliari, Italy, 09126 San Raffaele Scientific Institute Active, not recruiting Milano, Italy, 20132 University of Milano-Bicocca San Gerardo Hospital Active, not recruiting Monza, Italy, 20052 Bambino Gesù Hospital and Research Institute Recruiting Rome, Italy, 00165 Contact: Maria Ester Bernardo, MD mebernardo@gmail.com Principal Investigator: Franco Locatelli 收起 << |
NCT01861106 | GATA2 Immunod... 展开 >>eficiency MDS 收起 << | Phase 2 | Recruiting | December 31, 2021 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 收起 << |
NCT00763490 | Hematological Malignancies | Phase 2 | Completed | - | United States, Michigan ... 展开 >> University of Michigan Cancer Center Ann Arbor, Michigan, United States, 48109 收起 << |
NCT00466674 | Myeloma | Phase 2 | Completed | - | France ... 展开 >> Mohamad Sobh Lyon, France, 69437 收起 << |
NCT00478244 | Epidermolysis Bullosa | Not Applicable | Terminated(Competing studies) | - | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT01049854 | Leukemia Lymp... 展开 >>homa Bone Marrow Failure Immunodeficiencies Histiocytosis Sickle Cell Disease Beta Thalassemia Inborn Errors of Metabolism 收起 << | Phase 2 | Completed | - | United States, New York ... 展开 >> New York Medical College Valhalla, New York, United States, 10595 收起 << |
NCT00763490 | - | Completed | - | - | |
NCT00040469 | Sickle Cell Anemia ... 展开 >> Hemoglobinopathy Thalassemia 收起 << | Phase 2 | Terminated | - | United States, Texas ... 展开 >> Texas Children's Hospital Houston, Texas, United States, 77030 The Methodist Hospital Houston, Texas, United States, 77030 收起 << |
NCT00281983 | Chronic Lymphocytic Leukemia | Phase 1 Phase 2 | Completed | - | Canada, Quebec ... 展开 >> Maisonneuve-Rosemont Hospital Montreal, Quebec, Canada, H1T 2M4 Germany Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin Berlin, Germany, 12200 Universitaetsklinikum Essen Essen, Germany, 45122 Universitaetsklinikum Goettingen Goettingen, Germany, 37075 Asklepios Klinik St. Georg Hamburg, Germany, D-20099 Medizinische Hochschule Hannover Hannover, Germany, 30625 Universitaets-Kinderklinik Heidelberg Heidelberg, Germany, D-69120 Universitaetsklinikum des Saarlandes Homburg, Germany, 66421 Clinic for Bone Marrow Transplantation and Hematology and Oncology Idar-Oberstein, Germany, D-55743 University Hospital Schleswig-Holstein - Kiel Campus Kiel, Germany, 24116 University Hospital of Leipzig Leipzig, Germany, 04103 Klinikum der Universitaet Regensburg Regensburg, Germany, 93053 Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm Ulm, Germany, 89081 收起 << |
NCT02507479 | Non Hodgkin Lymphoma ... 展开 >> Hodgkin Lymphoma Chronic Lymphocytic Leukemia Multiple Myeloma 收起 << | Phase 2 | Recruiting | July 2019 | Israel ... 展开 >> Chaim Sheba Medical Center Recruiting Tel-Hashomer, Israel, 52621 Contact: Arnon Nagler, MD 972 3 530 5830 a.nagler@sheba.health.gov.il Contact: Avichai Shimoni, MD 972 3 530 5303 ashimoni@sheba.health.gov.il Sub-Investigator: Avichai Shimoni, MD Chaim Sheba Medical Center Recruiting Tel-Hashomer, Israel Principal Investigator: Arnon Nagler, MD 收起 << |
NCT02727387 | Ewing's Sarcoma (ES) | Phase 2 | Recruiting | May 2020 | Italy ... 展开 >> Centro di Riferimento Oncologico - Unit of Medical Oncology Not yet recruiting Aviano, Pordenone, Italy, 33081 Contact: Maurizio Mascarin, MD +390434659 ext 536 mascarin@cro.it Principal Investigator: Maurizio Mascarin, MD I.R.C.C. - Unit of Medical Oncology Recruiting Candiolo, Torino, Italy, 10060 Contact: Massimo Aglietta, MD +39.011.9933 ext 628 massimo.aglietta@ircc.it Principal Investigator: Massimo Aglietta, MD Sub-Investigator: Giovanni Grignani, MD Istituto Ortopedico Rizzoli - Unit of Chemotherapy of Muscoloskeletal Tumors Recruiting Bologna, Italy, 40136 Contact: Stefano Ferrari, MD +390516366199 ext 199 stefano.ferrari@ior.it Principal Investigator: Stefano Ferrari, MD Servizio di Oncoematologi Pediatrica Ospedale microcitemico ASL 8 Recruiting Cagliari, Italy, Rosamaria Contact: Rosamaria Mura, MD +39070504208 Principal Investigator: Rosamaria Mura, MD A.O. Universitaria Meyer Recruiting Firenze, Italy, 50139 Contact: Angela Tamburini, MD +3905556 ext 621 a.tamburini@meyer.it Principal Investigator: Angela Tamburini, MD Istituto Giannina Gaslini Recruiting Genova, Italy Contact: Carla Manzitti, MD 0105636 2431 Principal Investigator: Carla Manzitti, MD Fondazione IRCCS INT Milano Recruiting Milano, Italy Contact: Rossella Bertulli, MD +390223903 ext 287 rossella.bertulli@istitutotumori.mi.it Principal Investigator: Rossella Bertulli, MD Fondazione IRCCS INT Milano Recruiting Milano, Italy Contact: Roberto Luksch, MD +390223903 Principal Investigator: Roberto Luksch, MD Ospedale Pediatrico Bambin Gesu' Recruiting Roma, Italy Contact: Raffaele Cozza, MD +39065266919 Principal Investigator: Raffaele Cozza, MD Ospedale Infantile Regina Margherita - Unit of Paediatric Oncoematology Recruiting Torino, Italy, 10126 Contact: Franca Fagioli, MD +39.011.3135 ext 230 franca.fagioli@unito.it Principal Investigator: Franca Fagioli, MD 收起 << |
NCT00005893 | Neutropenia S... 展开 >>ickle Cell Anemia Thalassemia Major Red-Cell Aplasia, Pure 收起 << | Not Applicable | Completed | - | United States, Minnesota ... 展开 >> Fairview University Medical Center Minneapolis, Minnesota, United States, 55455 收起 << |
NCT00801931 | Leukemia Lymp... 展开 >>homa Neuroblastoma Immunodeficiencies Anemia 收起 << | Phase 1 Phase 2 | Terminated(Poor accrual) | - | United States, New York ... 展开 >> Columbia Presbyterian Medical Center New York, New York, United States, 10032 收起 << |
NCT00004899 | Leukemia Myel... 展开 >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases 收起 << | Phase 2 | Completed | - | United States, Illinois ... 展开 >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611 收起 << |
NCT01652092 | SCID Omenn's ... 展开 >>Syndrome Reticular Dysgenesis Wiskott-Aldrich Syndrome Bare Lymphocyte Syndrome Common Variable Immunodeficiency Chronic Granulomatous Disease CD40 Ligand Deficiency Hyper IgM Syndrome X-linked Lymphoproliferative Disease Hemophagocytic Lymphohistiocytosis Griscelli Syndrome Chediak-Higashi Syndrome Langerhan's Cell Histiocytosis 收起 << | Not Applicable | Recruiting | December 2020 | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Angela R. Smith, M.D. 612-626-2778 smith719@umn.edu Principal Investigator: Angela R. Smith, M.D. 收起 << |
NCT01093586 | Acute Myeloid Leukemia With Mu... 展开 >>ltilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Erythroleukemia (M6a) Adult Nasal Type Extranodal NK/T-cell Lymphoma Adult Pure Erythroid Leukemia (M6b) B-cell Adult Acute Lymphoblastic Leukemia B-cell Childhood Acute Lymphoblastic Leukemia Blastic Phase Chronic Myelogenous Leukemia Burkitt Lymphoma Childhood Acute Erythroleukemia (M6) Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Megakaryocytic Leukemia (M7) Childhood Acute Minimally Differentiated Myeloid Leukemia (M0) Childhood Acute Monoblastic Leukemia (M5a) Childhood Acute Monocytic Leukemia (M5b) Childhood Acute Myeloid Leukemia in Remission Childhood Chronic Myelogenous Leukemia Childhood Diffuse Large Cell Lymphoma Childhood Immunoblastic Large Cell Lymphoma Childhood Myelodysplastic Syndromes Childhood Nasal Type Extranodal NK/T-cell Lymphoma Chronic Myelomonocytic Leukemia Chronic Phase Chronic Myelogenous Leukemia Cutaneous B-cell Non-Hodgkin Lymphoma de Novo Myelodysplastic Syndromes Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Juvenile Myelomonocytic Leukemia Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Nodal Marginal Zone B-cell Lymphoma Previously Treated Myelodysplastic Syndromes Prolymphocytic Leukemia Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Small Noncleaved Cell Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Relapsing Chronic Myelogenous Leukemia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Secondary Myelofibrosis Splenic Marginal Zone Lymphoma Stage I Chronic Lymphocytic Leukemia Stage II Chronic Lymphocytic Leukemia Stage III Chronic Lymphocytic Leukemia Stage IV Chronic Lymphocytic Leukemia T-cell Adult Acute Lymphoblastic Leukemia T-cell Childhood Acute Lymphoblastic Leukemia T-cell Large Granular Lymphocyte Leukemia Waldenstrom Macroglobulinemia 收起 << | Phase 2 | Completed | - | United States, Ohio ... 展开 >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 收起 << |
NCT03240861 | HLA-A*0201 Positive Cells Pres... 展开 >>ent Locally Advanced Malignant Neoplasm NY-ESO-1 Positive Unresectable Malignant Neoplasm 收起 << | Phase 1 | Recruiting | September 1, 2022 | United States, California ... 展开 >> UCLA / Jonsson Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90095 Contact: Antoni Ribas 310-206-3928 aribas@mednet.ucla.edu Principal Investigator: Antoni Ribas 收起 << |
NCT02057770 | Leukemia, Myeloid, Acute | Phase 1 | Terminated(Low accrual rate) | - | United States, Missouri ... 展开 >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 收起 << |
NCT02063022 | Ewing's Sarcoma | Phase 3 | Recruiting | December 2018 | Italy ... 展开 >> Centro di Riferimento Oncologico - Unit of Medical Oncology Recruiting Aviano, Pordenone, Italy, 33081 Contact: Maurizio Mascarin, MD +390434659 ext 536 mascarin@cro.it Principal Investigator: Maurizio Mascarin, MD I.R.C.C. - Unit of Medical Oncology Recruiting Candiolo, Torino, Italy, 10060 Contact: Massimo Aglietta, MD +39.011.9933 ext 628 massimo.aglietta@ircc.it Contact: Luisa Gioeni, Pharmacist +39.011.9933 ext 278 luisa.gioeni@ircc.it Principal Investigator: Massimo Aglietta, MD Sub-Investigator: Giovanni Grignani, MD Presidio Sanitario Gradenigo Recruiting Torino, TO, Italy, 10153 Contact: Alessandro Comandone, MD +390118151 ext 211 alessandro.comandone@gradenigo.it Principal Investigator: Alessandro Comandone, MD Istituto Ortopedico Rizzoli Recruiting Bologna, Italy, 40136 Contact: Stefano Ferrari, MD +390516366 ext 411 stefano.ferrari@ior.it Contact: Emanuela Marchesi, PhD +390516366 ext 400 emanuela.marchesi@ior.it Principal Investigator: Stefano Ferrari, MD A.O. Universitaria Policlinico S. Orsola Malpighi di Bologna Recruiting Bologna, Italy, 40138 Contact: Arcangelo Prete, MD +390516363 ext 111 tmoped@aosp.bo.it Principal Investigator: Arcangelo Prete, MD Servizio di Oncoematologi Pediatrica Ospedale microcitemico ASL 8 Recruiting Cagliari, Italy, Rosamaria Contact: Rosamaria Mura, MD Principal Investigator: Rosamaria Mura, MD A.O. Universitaria Meyer Recruiting Firenze, Italy, 50139 Contact: Angela Tamburini, MD +3905556 ext 621 a.tamburini@meyer.it Principal Investigator: Angela Tamburini, MD Istituto Giannina Gaslini Recruiting Genova, Italy Contact: Alberto Garaventa, MD +390105636 ext 694 albertogaraventa@ospedale-gaslini.ge.it Principal Investigator: Alberto Garaventa, MD FONDAZIONE IRCCS Istituto Nazionale dei Tumori Recruiting Milano, Italy Contact: Roberto Luksch, MD Principal Investigator: Roberto Luksch, MD Azienda Ospedaliera di Padova Recruiting Padova, Italy Contact: Gianni Bisogno, MD Principal Investigator: Gianni Bisogno, MD Istituto Nazionale Tumori Regina Elena - Unit of Medical Oncology I Recruiting Roma, Italy, 00144 Contact: Virginia Ferraresi, MD +390652666 ext 773 ferraresi@ifo.it Contact: , MD Principal Investigator: Virginia Ferraresi, MD Ospedale Pediatrico Bambin Gesu' Recruiting Roma, Italy Contact: Raffaele Cozza, MD Principal Investigator: Raffaele Cozza, MD Ospedale Infantile Regina Margherita - Unit of Paediatric Oncoematology Recruiting Torino, Italy, 10126 Contact: Franca Fagioli, MD +39.011.3135 ext 230 franca.fagioli@unito.it Principal Investigator: Franca Fagioli, MD 收起 << |
NCT00145587 | Osteopetrosis | Not Applicable | Terminated(Due to the principa... 展开 >>l investigator having left the institution.) 收起 << | - | United States, Tennessee ... 展开 >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 收起 << |
NCT00778882 | Chronic Granulomatous Disease | Phase 1 Phase 2 | Active, not recruiting | October 2022 | Korea, Republic of ... 展开 >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 收起 << |
NCT00248547 | Cancer | Not Applicable | Completed | - | United States, Oregon ... 展开 >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 收起 << |
NCT03674411 | Acute Myeloid Leukemia ... 展开 >> Acute Lymphocytic Leukemia Biphenotypic/Undifferentiated Leukemia Chronic Myelogenous Leukemia Myelodysplasia Relapsed Large Cell Lymphoma Mantle Cell Lymphoma Hodgkin Lymphoma Burkitt Lymphoma Relapsed T-Cell Lymphoma Lymphoplasmacytic Lymphoma 收起 << | Phase 2 | Not yet recruiting | July 2023 | - |
NCT00004231 | Lymphoma | Phase 2 | Completed | - | United States, Illinois ... 展开 >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611 收起 << |
NCT00145587 | - | Terminated(Due to the principa... 展开 >>l investigator having left the institution.) 收起 << | - | - | |
NCT00002761 | Leukemia | Phase 1 Phase 2 | Withdrawn(PI left institution) | - | - |
NCT02282904 | Chronic Granulomatous Disease | Early Phase 1 | Active, not recruiting | March 1, 2023 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT00055653 | Leukemia Lymp... 展开 >>homa Myelodysplastic Syndromes Myelodysplastic-Myeloproliferative Diseases 收起 << | Phase 2 | Completed | - | - |
NCT00248547 | - | Completed | - | - | |
NCT00454480 | Leukemia Myel... 展开 >>odysplastic Syndromes 收起 << | Phase 2 Phase 3 | Completed | - | - |
NCT00003619 | Chronic Myeloproliferative Dis... 展开 >>orders Leukemia Myelodysplastic Syndromes Thrombocytopenia 收起 << | Phase 1 Phase 2 | Completed | - | United States, Pennsylvania ... 展开 >> Medical College of Pennsylvania Hospital Philadelphia, Pennsylvania, United States, 19129 Medical College of Pennsylvania Philadelphia, Pennsylvania, United States, 19129 收起 << |
NCT00295997 | Chronic Myeloproliferative Dis... 展开 >>orders Kidney Cancer Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms 收起 << | Not Applicable | Unknown | - | United States, California ... 展开 >> UCSF Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 收起 << |
NCT00003414 | Graft Versus Host Disease ... 展开 >> Lymphoma 收起 << | Phase 3 | Completed | - | United States, Maryland ... 展开 >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 收起 << |
NCT00006054 | Immunologic Deficiency Syndrom... 展开 >>es Chediak-Higashi Syndrome Common Variable Immunodeficiency Graft Versus Host Disease X-Linked Lymphoproliferative Syndrome Familial Erythrophagocytic Lymphohistiocytosis Hemophagocytic Lymphohistiocytosis X-linked Agammaglobulinemia Wiskott-Aldrich Syndrome Chronic Granulomatous Disease X-linked Hyper IgM Syndrome Severe Combined Immunodeficiency Leukocyte Adhesion Deficiency Syndrome Virus-Associated Hemophagocytic Syndrome 收起 << | Not Applicable | Terminated | - | United States, Minnesota ... 展开 >> Fairview University Medical Center Minneapolis, Minnesota, United States, 55455 收起 << |
NCT00025402 | Leukemia | Phase 3 | Unknown | - | - |
NCT00002868 | Leukemia | Phase 3 | Completed | - | United States, New Jersey ... 展开 >> Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 Riverview Medical Center - Booker Cancer Center Red Bank, New Jersey, United States, 07701 United Kingdom Royal Infirmary Glasgow, Scotland, United Kingdom, G4 0SF 收起 << |
NCT00006056 | Chediak-Higashi Syndrome ... 展开 >> Graft Versus Host Disease X-Linked Lymphoproliferative Syndrome Familial Erythrophagocytic Lymphohistiocytosis Hemophagocytic Lymphohistiocytosis Virus-Associated Hemophagocytic Syndrome 收起 << | Not Applicable | Unknown | - | United States, Minnesota ... 展开 >> Fairview University Medical Center Minneapolis, Minnesota, United States, 55455 收起 << |
NCT00070174 | Leukemia | Phase 2 | Completed | - | - |
NCT00005641 | Chronic Myeloproliferative Dis... 展开 >>orders Graft Versus Host Disease Leukemia Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes 收起 << | Phase 2 | Terminated(low study accrual) | - | United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 收起 << |
NCT00003913 | Leukemia Lymp... 展开 >>homa Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases 收起 << | Phase 2 | Completed | - | - |
NCT00238368 | Lymphoma | Phase 2 | Completed | - | United States, Maryland ... 展开 >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 收起 << |
NCT00030719 | Neuroblastoma | Phase 3 | Unknown | - | - |
NCT00024193 | Neuroblastoma | Phase 2 | Unknown | - | France ... 展开 >> Institut Gustave Roussy Villejuif, France, F-94805 收起 << |
NCT00003662 | Graft Versus Host Disease ... 展开 >> Leukemia Myelodysplastic Syndromes Thymic Carcinoma 收起 << | Phase 2 | Completed | - | United States, Florida ... 展开 >> University of Florida Health Science Center Gainesville, Florida, United States, 32610-0296 Division of Pediatric Surgery Jacksonville, Florida, United States, 32207 H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, Illinois Rush-Presbyterian-St. Luke's Medical Center Chicago, Illinois, United States, 60612 University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637 United States, Louisiana Children's Hospital of New Orleans New Orleans, Louisiana, United States, 70118 United States, Missouri Cardinal Glennon Children's Hospital Saint Louis, Missouri, United States, 63104 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 New York Blood Center New York, New York, United States, 10021 United States, North Carolina Lineberger Comprehensive Cancer Center, UNC Chapel Hill, North Carolina, United States, 27599-7295 Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 United States, Pennsylvania St. Christopher's Hospital for Children Philadelphia, Pennsylvania, United States, 19134-1095 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425-0721 University of South Carolina School of Medicine Columbia, South Carolina, United States, 29203 收起 << |
NCT00003336 | Leukemia Myel... 展开 >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases 收起 << | Phase 2 | Completed | - | United States, Ohio ... 展开 >> Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-7284 收起 << |
NCT00003270 | Graft Versus Host Disease ... 展开 >> Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes 收起 << | Phase 2 | Completed | - | United States, New York ... 展开 >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 收起 << |
NCT00550992 | Leukemia | Not Applicable | Unknown | - | United States, Massachusetts ... 展开 >> Children's Hospital Boston Recruiting Boston, Massachusetts, United States, 02215 Contact: Lewis B. Silverman, MD 617-632-5285 United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Clinical Trials Office - St. Jude Children's Research Hospital 901-595-4644 United States, Texas M. D. Anderson Cancer Center at University of Texas Recruiting Houston, Texas, United States, 77030-4009 Contact: Clinical Trials Office - M. D. Anderson Cancer Center at the U 713-792-3245 United States, Washington Children's Hospital and Regional Medical Center - Seattle Recruiting Seattle, Washington, United States, 98105 Contact: Blythe Thomson, MD 206-987-2106 Austria St. Anna Children's Hospital Recruiting Vienna, Austria, A-1090 Contact: Georg Mann, MD 43-1-4017-1250 Belgium Hopital Universitaire Des Enfants Reine Fabiola Recruiting Brussels, Belgium, 1020 Contact: Alice Ferster, MD 32-2-477-2678 aferster@ulb.ac.be Czech Republic University Hospital Motol Recruiting Prague, Czech Republic, 150 06 Contact: Jan Stary, MD 420-2-2443-6401 jan.stary@lfmotol.cuni.cz France CHR Hotel Dieu Recruiting Nantes, France, 44093 Contact: Francoise Mechinaud, MD 33-1-4249-9046 Germany University Medical Center Hamburg - Eppendorf Recruiting Hamburg, Germany, D-20246 Contact: Gritta Janka-Schaub 49-404-2803-2580 Medizinische Hochschule Hannover Recruiting Hannover, Germany, D-30625 Contact: Martin Schrappe, MD, PhD 49-511-532-6713 Italy Nuovo Ospedale San Gerardo at University of Milano-Bicocca Recruiting Monza, Italy, 20052 Contact: Andrea Biondi, MD 39-039-233-3661 biondi@galactica.it Netherlands Erasmus MC - Sophia Children's Hospital Recruiting Rotterdam, Netherlands, 3015 GJ Contact: Rob Pieters, MD, MSC, PhD 31-10-463-6691 rob.pieters@erasmusmc.nl United Kingdom Great Ormond Street Hospital for Children Recruiting London, England, United Kingdom, WC1N 3JH Contact: Phil Ancliff, MD 44-20-7829-8831 收起 << |
NCT00334672 | Nonneoplastic Condition | Phase 3 | Unknown | - | United Kingdom ... 展开 >> Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Watford General Hospital Herts, England, United Kingdom, WD18 0HB Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Great Ormond Street Hospital for Children London, England, United Kingdom, WC1N 3JH Royal Manchester Children's Hospital Manchester, England, United Kingdom, M27 4HA Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ 收起 << |
NCT00317408 | Lymphoma | Not Applicable | Unknown | - | - |
NCT00025649 | Neuroblastoma | Phase 2 | Completed | - | Austria ... 展开 >> St. Anna Children's Hospital Vienna, Austria, A-1090 Belgium Universitair Ziekenhuis Gent Ghent, Belgium, B-9000 Denmark Rigshospitalet Copenhagen, Denmark, 2100 France Centre Hospitalier Regional de Purpan Toulouse, France, 31026 Italy Istituto Giannina Gaslini Genoa, Italy, 16148 Norway Rikshospitalet University Hospital Oslo, Norway, 0027 Portugal Instituto Portugues de Oncologia de Francisco Gentil - Centro Regional de Oncologia de Lisboa, S.A. Lisboa, Portugal, 1099-023 Codex Spain Hospital Universitario LA FE Valencia, Spain, 46009 Sweden Ostra Sjukhuset Gothenburg, Sweden, 41685 Switzerland Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 United Kingdom Bristol Royal Hospital for Children Bristol, England, United Kingdom, BS2 8BJ 收起 << |
NCT00253552 | Chronic Myeloproliferative Dis... 展开 >>orders Graft Versus Host Disease Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Sarcoma 收起 << | Not Applicable | Terminated(Terminated at reque... 展开 >>st of PI as study was outdated.) 收起 << | - | United States, Oregon ... 展开 >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 收起 << |
NCT00003661 | Graft Versus Host Disease ... 展开 >> Leukemia Lymphoma Myelodysplastic Syndromes Neuroblastoma 收起 << | Phase 2 | Completed | - | United States, Florida ... 展开 >> University of Florida Health Science Center Gainesville, Florida, United States, 32610-0296 Division of Pediatric Surgery Jacksonville, Florida, United States, 32207 Nemours Children's Clinic Jacksonville, Florida, United States, 32207 H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, Illinois Rush-Presbyterian-St. Luke's Medical Center Chicago, Illinois, United States, 60612 University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637 United States, Louisiana Children's Hospital of New Orleans New Orleans, Louisiana, United States, 70118 United States, Missouri Cardinal Glennon Children's Hospital Saint Louis, Missouri, United States, 63104 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 North Shore University Hospital Manhasset, New York, United States, 11030 New York Blood Center New York, New York, United States, 10021 United States, North Carolina Lineberger Comprehensive Cancer Center, UNC Chapel Hill, North Carolina, United States, 27599-7295 Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 United States, Pennsylvania St. Christopher's Hospital for Children Philadelphia, Pennsylvania, United States, 19134-1095 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425-0721 University of South Carolina School of Medicine Columbia, South Carolina, United States, 29203 收起 << |
NCT00002549 | Leukemia | Phase 3 | Unknown | - | - |
NCT00521430 | Leukemia Lymp... 展开 >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Nonmalignant Neoplasm Unspecified Adult Solid Tumor, Protocol Specific 收起 << | Not Applicable | Completed | - | Korea, Republic of ... 展开 >> Asan Medical Center - University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 收起 << |
NCT00002701 | Leukemia | Phase 3 | Unknown | - | - |
NCT00060255 | Breast Cancer ... 展开 >> Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Testicular Germ Cell Tumor Unspecified Adult Solid Tumor, Protocol Specific Unspecified Childhood Solid Tumor, Protocol Specific 收起 << | Phase 2 | Completed | - | United States, New York ... 展开 >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 收起 << |
NCT01020734 | Leukemia | Phase 2 | Completed | - | Korea, Republic of ... 展开 >> Inje University - Haeundae Paik Hospital Busan, Korea, Republic of, 612-030 Asan Medical Center - University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 收起 << |
NCT01027000 | Leukemia Lymp... 展开 >>homa 收起 << | Phase 2 | Active, not recruiting | - | - |
NCT00004128 | Leukemia | Phase 3 | Unknown | - | - |
NCT00290628 | Chronic Myeloproliferative Dis... 展开 >>orders Diamond-blackfan Anemia Fanconi Anemia Graft Versus Host Disease Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases 收起 << | Not Applicable | Terminated(Replaced with anoth... 展开 >>er study) 收起 << | - | United States, Minnesota ... 展开 >> University of Minnesota Cancer Center Minneapolis, Minnesota, United States, 55455 收起 << |
NCT01027000 | - | Active, not recruiting | - | - | |
NCT00002771 | Leukemia | Phase 3 | Unknown | - | Germany ... 展开 >> III Medizinische Klinik Mannheim Mannheim, Germany, D-68135 收起 << |
NCT00417053 | Neuroblastoma | Phase 3 | Unknown | - | - |
NCT00002792 | Chronic Myeloproliferative Dis... 展开 >>orders Leukemia Myelodysplastic/Myeloproliferative Diseases 收起 << | Phase 2 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 收起 << |
NCT02098512 | Hodgkin Lymphoma | Phase 1 Phase 2 | Recruiting | December 2019 | United States, New York ... 展开 >> New York Medical College Recruiting Valhalla, New York, United States, 10595 Contact: Mitchell Cairo 914-594-2150 mitchell_cairo@nymc.edu Contact: Jessica Hochberg, MD 914-594-2132 jessica_hochberg@nymc.edu 收起 << |
NCT02876679 | Graft vs Host Disease | Phase 2 | Recruiting | February 2020 | France ... 展开 >> Saint Antoine Hospital - Hematology Department Recruiting Paris, France, 75012 Contact: Mohamad MOHTY, PU-PH 01.49.28.26.20 ext +33 mohamad.mohty@inserm.fr Contact: Florent MALARD, CCU-AH 01.49.28.26.20 ext +33 malardf@yahoo.fr 收起 << |
NCT01464359 | Acute Myelogenous Leukemia ... 展开 >> Refractory Acute Myelogenous Leukemia 收起 << | Phase 2 | Terminated(Slow accrual) | - | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT00840684 | Leukemia | Phase 1 Phase 2 | Completed | - | France ... 展开 >> Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Marseille, France, 13273 收起 << |
NCT01252784 | - | Unknown | October 2014 | Korea, Republic of ... 展开 >> Asan Medical Center Recruiting Seoul, Asanbyeongwon-gil, songpa-gu, Korea, Republic of, 138-736 Contact: Yae-Eun Jang, nurse 82-2-3010-6378 redpin75@paran.com 收起 << | |
NCT00170690 | Ovarian Cancer | Phase 3 | Completed | - | Germany ... 展开 >> Charité Campus Virchow-Klinikum Berlin, Germany, 13533 收起 << |
NCT01063647 | Hematological Malignancies | Phase 1 Phase 2 | Completed | - | Finland ... 展开 >> Helsinki University Central Hospital Helsinki, Finland, FIN-00290 Germany Charité University Hospital Berlin Berlin, Germany, 12203 University Hospital Hamburg Eppendorf Hamburg, Germany, 20246 5th Medical Clinic, Clinic North Nuremberg, Germany, 90340 University Hospital Rostock Rostock, Germany, 18057 Poland Silesian Medical University Katowice, Poland, 40-029 Sweden Karolinska University Hospital & Karolinska Institute Stockholm, Sweden, 141 86 收起 << |
NCT01238328 | Mucopolysaccharidosis | Phase 2 Phase 3 | Unknown | December 2012 | Iran, Islamic Republic of ... 展开 >> Hematology-Oncology & SCT Research Center Recruiting Teharn, Tehran, Iran, Islamic Republic of, 14114 Contact: Amir Ali Hamidieh, MD 84902645 ext +9821 aahamidieh@sina.tums.ac.ir Principal Investigator: Amir Ali Hmidieh, MD Sub-Investigator: Ardeshir Ghavamzadeh, MD Sub-Investigator: Kamran Alimoghaddam, MD Sub-Investigator: Mahdi Jalili, MD 收起 << |
NCT01464359 | - | Terminated(Slow accrual) | - | - | |
NCT00129155 | Hematological Malignancies ... 展开 >> Allogeneic Transplantation 收起 << | Phase 2 | Unknown | - | France ... 展开 >> Hôpital Edouard Herriot Recruiting Lyon, France, 69437 Contact: Mauricette MICHALLET, MD 33 472 117 329 mauricette.michallet@chu-lyon.fr Principal Investigator: Mauricette Michallet, MD 收起 << |
NCT00007995 | Multiple Myeloma and Plasma Ce... 展开 >>ll Neoplasm 收起 << | Phase 2 | Completed | - | United States, New York ... 展开 >> Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, New York, United States, 10032 收起 << |
NCT00027937 | Lymphoma Unsp... 展开 >>ecified Adult Solid Tumor, Protocol Specific Unspecified Childhood Solid Tumor, Protocol Specific 收起 << | Phase 2 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 收起 << |
NCT02048800 | - | Unknown | March 2017 | United Kingdom ... 展开 >> Great Ormond Street Hospital for Children Recruiting London, United Kingdom, WC1N 3JH Contact: Robert Chiesa, MD 02078138434 ext 8434 robert.chiesa@gosh.nhs.uk Contact: Praseeda Thaikaloor 02079052346 praseeda.thaikalloor@gosh.nhs.uk Great North Childrens Hospital Recruiting Newcastle Upon Tyne, United Kingdom, NE1 4LP Contact: Mary Slatter, MD 01912823767 mary.slatter@nuth.nhs.uk 收起 << | |
NCT00863460 | Primary Central Nervous System... 展开 >> Lymphoma 收起 << | Phase 2 | Active, not recruiting | May 2026 | France ... 展开 >> Cancérologie Hôpital Sud Amiens, France, 80054 Chu D'Angers Angers, France CHR Argenteuil Argenteuil, France, 95100 CHU de Besancon Besançon, France Institut Bergonié Bordeaux, France, 33076 CHU Hôtel Dieu Clermont-Ferrand, France CHU Michalon Grenoble, France, 38043 Centre Hospitalier Lens Lens, France CHU de Limoges Limoges, France, 87042 CHU de la Timone Marseille, France, 13009 Hôtel Dieu Nantes Nantes, France Centre Antoine Lacassagne Nice, France CHU de Nimes Nîmes, France GH Pitié-Salpétrière Paris, France, 75013 CHG Saint Jean Perpignan, France, 66046 CHU Hôpital Bernard Poitiers, France, 86021 Chu Reims Reims, France Hôpital Pontchaillou Rennes, France, 35033 Centre René Huguenin Saint Cloud, France, 92210 Institut de Cancérologie Saint-Priest en Jarez, France CH de Saint-Quentin Saint-Quentin, France Hôpital Bretonneau Tours, France CHU Nancy - Hôpital Neurologique Vandoeuvre les Nancy, France, 54500 收起 << |
NCT00081055 | Graft Versus Host Disease ... 展开 >> Leukemia Myelodysplastic Syndromes 收起 << | Phase 2 | Withdrawn | - | United States, California ... 展开 >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1678 收起 << |
NCT00093587 | Graft Versus Host Disease ... 展开 >> Leukemia 收起 << | Not Applicable | Unknown | - | United States, California ... 展开 >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1678 收起 << |
NCT01751997 | Acute Myeloid Leukemia | Phase 2 Phase 3 | Recruiting | December 2019 | Korea, Republic of ... 展开 >> Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital Recruiting Seoul, Korea, Republic of, 137-701 收起 << |
NCT02512679 | - | Terminated(Optimal dose obtain... 展开 >>ed for engraftment and minimizing toxicity) 收起 << | - | - | |
NCT00008190 | Leukemia | Phase 2 | Completed | - | United States, New York ... 展开 >> Herbert Irving Comprehensive Cancer Center at Columbia University New York, New York, United States, 10032 收起 << |
NCT00003101 | Brain and Central Nervous Syst... 展开 >>em Tumors 收起 << | Phase 2 | Completed | - | United States, Alabama ... 展开 >> University of Alabama Comprehensive Cancer Center Birmingham, Alabama, United States, 35294 United States, California Stanford University Medical Center Stanford, California, United States, 94305-5408 United States, Illinois Evanston Northwestern Health Care Evanston, Illinois, United States, 60201 Loyola University Medical Center Maywood, Illinois, United States, 60153 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Canada, Alberta Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada, T2N 4N2 Canada, Ontario Cancer Care Ontario-London Regional Cancer Centre London, Ontario, Canada, N6A 4L6 收起 << |
NCT02323867 | Leukemia Lymp... 展开 >>homa Myelodysplasia 收起 << | Phase 2 | Recruiting | June 2020 | United States, Pennsylvania ... 展开 >> The Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19103 Contact: Margaret Tartaglione, RN 215-590-4029 tartaglione@email.chop.edu Contact: Patricia Hankins, RN 215-590-5168 hankinsp@email.chop.edu Principal Investigator: Nancy J Bunin, MD Sub-Investigator: Stephan A Grupp, MD, PhD 收起 << |
NCT02512679 | Stem Cell Transplantation ... 展开 >> Bone Marrow Transplantation Peripheral Blood Stem Cell Transplantation Allogeneic Transplantation Genetic Diseases Thalassemia Pediatrics Diamond-Blackfan Anemia Combined Immune Deficiency Wiskott-Aldrich Syndrome Chronic Granulomatous Disease X-linked Lymphoproliferative Disease Metabolic Diseases 收起 << | Phase 2 | Terminated(Optimal dose obtain... 展开 >>ed for engraftment and minimizing toxicity) 收起 << | - | - |
NCT00002798 | Childhood Acute Erythroleukemi... 展开 >>a (M6) Childhood Acute Megakaryocytic Leukemia (M7) Childhood Acute Monoblastic Leukemia (M5a) Childhood Acute Monocytic Leukemia (M5b) Childhood Acute Myeloblastic Leukemia With Maturation (M2) Childhood Acute Myeloblastic Leukemia Without Maturation (M1) Childhood Acute Myelomonocytic Leukemia (M4) Childhood Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndromes Refractory Anemia Refractory Anemia With Excess Blasts Refractory Anemia With Excess Blasts in Transformation Refractory Anemia With Ringed Sideroblasts Secondary Myelodysplastic Syndromes Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies 收起 << | Phase 3 | Completed | - | United States, California ... 展开 >> Children's Oncology Group Arcadia, California, United States, 91006-3776 收起 << |
NCT02252159 | - | Active, not recruiting | October 2019 | - | |
NCT00077116 | Leukemia Myel... 展开 >>odysplastic Syndromes 收起 << | Phase 2 | Completed | - | Belgium ... 展开 >> AZ Sint-Jan Brugge, Belgium, 8000 Institut Jules Bordet Brussels, Belgium, 1000 Cliniques Universitaires Saint-Luc Brussels, Belgium, 1200 H. Hartziekenhuis - Roeselaere. Roeselare, Belgium, 8800 Germany Ruprecht - Karls - Universitaet Heidelberg Heidelberg, Germany, D-69117 Netherlands Onze Lieve Vrouwe Gasthuis Amsterdam, Netherlands, 1091 HA Leiden University Medical Center Leiden, Netherlands, 2300 CA Universitair Medisch Centrum St. Radboud - Nijmegen Nijmegen, Netherlands, NL-6500 HB Switzerland Universitaetsspital-Basel Basel, Switzerland, CH-4031 收起 << |
NCT00152113 | Sickle Cell Disease | Phase 1 | Completed | - | United States, Tennessee ... 展开 >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 收起 << |
NCT02251821 | Primary Myelofibrosis ... 展开 >> Secondary Myelofibrosis 收起 << | Phase 2 | Recruiting | - | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Rachel B. Salit 206-667-1317 rsalit@fredhutch.org Principal Investigator: Rachel B. Salit 收起 << |
NCT02759822 | - | Recruiting | - | Brazil ... 展开 >> Instituto Nacional de Cancer Recruiting Rio de Janeiro, Brazil, 20230-130 Contact: Leonardo J Arcuri, MD +55(21)3207-1304 leonardojavier@gmail.com Contact: Simone Lermontov +55(21)3207-1261 simonelermontov@globo.com 收起 << | |
NCT00005986 | Leukemia | Phase 2 | Terminated(Principal investiga... 展开 >>tor left the university.) 收起 << | - | United States, Minnesota ... 展开 >> University of Minnesota Cancer Center Minneapolis, Minnesota, United States, 55455 收起 << |
NCT02990819 | Immunodeficiencies ... 展开 >> Immune Dysregulation Syndromes 收起 << | Phase 2 | Recruiting | December 2023 | United States, Pennsylvania ... 展开 >> Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Barbara McGlynn, RN, BSN MCGLYNN@email.chop.edu 收起 << |
NCT03456817 | Graft-versus-host-disease ... 展开 >> Relapse 收起 << | Phase 2 | Not yet recruiting | September 2023 | - |
NCT03602898 | Acute Lymphoblastic Leukemia i... 展开 >>n Remission Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Acute Myeloid Leukemia in Remission Blasts 5 Percent or Less of Bone Marrow Nucleated Cells Chronic Myelomonocytic Leukemia Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Donor Minimal Residual Disease Myelodysplastic Syndrome Myelofibrosis Myeloproliferative Neoplasm Recurrent Acute Myeloid Leukemia Recurrent Hodgkin Lymphoma Recurrent Non-Hodgkin Lymphoma Refractory Acute Myeloid Leukemia Therapy-Related Acute Myeloid Leukemia 收起 << | Phase 2 | Not yet recruiting | September 17, 2023 | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Not yet recruiting Seattle, Washington, United States, 98109 Contact: Masumi Ueda 206-667-4546 Principal Investigator: Masumi Ueda 收起 << |
NCT00818961 | Leukemia Lymp... 展开 >>homa Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases 收起 << | Phase 2 | Terminated(terminated early du... 展开 >>e to meeting end point with fewer patients than anticipated) 收起 << | - | United States, Georgia ... 展开 >> Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States, 30342 收起 << |
NCT00914849 | Hematologic Neoplasms | Phase 2 | Completed | - | United States, Missouri ... 展开 >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 收起 << |
NCT00818961 | - | Terminated(terminated early du... 展开 >>e to meeting end point with fewer patients than anticipated) 收起 << | - | - | |
NCT00458250 | Leukemia, Myeloid, Acute ... 展开 >> Leukemia, Lymphoblastic, Acute 收起 << | Phase 1 | Completed | - | Iran, Islamic Republic of ... 展开 >> Hematology-Oncology & BMT Research Center Tehran, Iran, Islamic Republic of, 14114 收起 << |
NCT02179359 | Sickle Cell Disease ... 展开 >> Transfusion Dependent Alpha- or Beta- Thalassemia Diamond Blackfan Anemia Paroxysmal Nocturnal Hemoglobinuria Glanzmann Thrombasthenia Severe Congenital Neutropenia Shwachman-Diamond Syndrome Non-Malignant Hematologic Disorders 收起 << | Not Applicable | Recruiting | August 2021 | United States, Minnesota ... 展开 >> University of Minnesota Medical Center, Fairview Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Kim Nelson 612-273-2925 knelso62@fairview.org 收起 << |
NCT01099930 | Multiple Sclerosis | Phase 2 | Completed | - | Canada, Ontario ... 展开 >> Ottawa Hospital Research Institute Ottawa, Ontario, Canada, K1H 8L6 收起 << |
NCT00914849 | - | Completed | - | - | |
NCT01338987 | Myelodysplastic Syndrome RAEB ... 展开 >>2 Acute Lymphocytic Leukemia Acute Myelogenous Leukemia Myelodysplastic Syndrome RAEB 1 收起 << | Phase 2 | Active, not recruiting | November 19, 2020 | United States, District of Col... 展开 >>umbia Childrens National Medical Center Washington, District of Columbia, United States United States, Maryland National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, Oklahoma University of Oklahoma Oklahoma City, Oklahoma, United States, 73104 收起 << |
NCT00029380 | Hematologic Diseases ... 展开 >> Anemia, Sickle Cell Beta-Thalassemia Hematopoietic Stem Cell Transplantation 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> Children's Hospital Oakland Oakland, California, United States, 94609 Children's Hospital, Oakland Oakland, California, United States, 94609 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States United States, Florida Nemours Children's Clinic Jacksonville, Florida, United States, 32207 University of Miami Batchelor Children's Research Center Miami, Florida, United States, 33136 United States, Illinois Children's Memorial Hospital Chicago, Illinois, United States, 60614 United States, Louisiana Louisiana State University Children's Medical Center New Orleans, Louisiana, United States United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, North Carolina Duke University Medical Center Children's Hospital Durham, North Carolina, United States United States, Pennsylvania Children's Hospital Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29403 United States, Texas University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States, 75235 Texas Transplant Institute San Antonio, Texas, United States, 78229 Canada, Quebec Hopital Ste-Justine Montreal, Quebec, Canada 收起 << |
NCT00003060 | Melanoma (Skin) | Phase 1 | Unknown | - | United States, Louisiana ... 展开 >> Louisiana State University School of Medicine Shreveport, Louisiana, United States, 71130-3932 收起 << |
NCT01860170 | Hematological Malignancy | Phase 1 Phase 2 | Active, not recruiting | March 2018 | United States, Michigan ... 展开 >> Spectrum Health Grand Rapids, Michigan, United States, 49503 收起 << |
NCT01860170 | - | Active, not recruiting | - | - | |
NCT00024050 | Leukemia Myel... 展开 >>odysplastic Syndromes 收起 << | Phase 2 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 收起 << |
NCT00002789 | Leukemia | Phase 3 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 收起 << |
NCT02938741 | Lymphoblastic Lymphoma | Phase 4 | Recruiting | December 2022 | China, Shanghai ... 展开 >> Shanghai First People's HOSPITAL Recruiting Shanghai, Shanghai, China, 200127 Contact: YANG JUN, master 13564880726 yangjuan74@hotmail.com Contact: wang chun, doctor 13386259777 wangchun2@medmail.com.cn China Shanghai First People's HOSPITAL Recruiting Shanghai, China, 200127 Contact: jun yang, master 18001890183 yangjuan74@hotmai.com Contact: chun wang, doctor 13386259777 wangchun2@medmail.com.cn 收起 << |
NCT01949129 | Acute Lymphoblastic Leukaemia | Phase 2 Phase 3 | Recruiting | April 2023 | - |
NCT00006126 | Breast Cancer ... 展开 >> Kidney Cancer Lung Cancer Melanoma (Skin) Testicular Germ Cell Tumor 收起 << | Phase 1 | Withdrawn(Unable to accrue sub... 展开 >>jects.) 收起 << | - | - |
NCT00003335 | Graft Versus Host Disease ... 展开 >> Leukemia Lymphoma Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases 收起 << | Phase 2 | Completed | - | United States, Ohio ... 展开 >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 收起 << |
NCT00333190 | Hematologic Malignancy ... 展开 >> AML ALL CML Multiple Myeloma NHL Hodgkin's Lymphoma 收起 << | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 << |
NCT00265889 | - | Completed | - | - | |
NCT00513474 | - | Completed | - | - | |
NCT00549835 | Mucositis Pai... 展开 >>n Leukemia 收起 << | Not Applicable | Withdrawn(Inadequate funding) | - | United States, Maryland ... 展开 >> Johns Hopkins Medical Institutions Baltimore, Maryland, United States 收起 << |
NCT00265889 | Lymphoma | Phase 2 | Completed | - | United States, Ohio ... 展开 >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 收起 << |
NCT00513474 | Chronic Myeloproliferative Dis... 展开 >>orders Graft Versus Host Disease Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms 收起 << | Phase 1 | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114-2617 收起 << |
NCT00006363 | Adult Acute Basophilic Leukemi... 展开 >>a Adult Acute Eosinophilic Leukemia Adult Acute Erythroid Leukemia (M6) Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monoblastic Leukemia and Acute Monocytic Leukemia (M5) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Childhood Acute Basophilic Leukemia Childhood Acute Eosinophilic Leukemia Childhood Acute Erythroleukemia (M6) Childhood Acute Megakaryocytic Leukemia (M7) Childhood Acute Minimally Differentiated Myeloid Leukemia (M0) Childhood Acute Monoblastic Leukemia (M5a) Childhood Acute Monoblastic Leukemia and Acute Monocytic Leukemia (M5) Childhood Acute Monocytic Leukemia (M5b) Childhood Acute Myeloblastic Leukemia With Maturation (M2) Childhood Acute Myeloblastic Leukemia Without Maturation (M1) Childhood Acute Myelomonocytic Leukemia (M4) Childhood Myelodysplastic Syndromes de Novo Myelodysplastic Syndromes Untreated Adult Acute Myeloid Leukemia Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies 收起 << | Phase 3 | Completed | - | United States, Illinois ... 展开 >> Cancer and Leukemia Group B Chicago, Illinois, United States, 60606 收起 << |
NCT00003816 | Chronic Myeloproliferative Dis... 展开 >>orders Leukemia Lymphoma Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Nonmalignant Neoplasm Unspecified Adult Solid Tumor, Protocol Specific Unspecified Childhood Solid Tumor, Protocol Specific 收起 << | Phase 2 Phase 3 | Active, not recruiting | December 1, 2019 | United States, New York ... 展开 >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 收起 << |
NCT01422603 | Acute Myeloid Leukaemia ... 展开 >> Myelodysplasia 收起 << | Phase 1 Phase 2 | Completed | - | United Kingdom ... 展开 >> Wessex Blood and Marrow Transplant Unit, Southampton University Hospitals NHS Trust Southampton, Hampshire, United Kingdom, SO16 6YD 收起 << |
NCT00705120 | Osteogenesis Imperfecta | Phase 1 | Completed | - | United States, Tennessee ... 展开 >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 收起 << |
NCT02788201 | Urothelial Carcinoma ... 展开 >> Bladder Cancer Urinary Bladder Neoplasms 收起 << | Phase 2 | Recruiting | July 1, 2020 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 收起 << |
NCT00002768 | Leukemia | Phase 2 | Completed | - | United States, California ... 展开 >> UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States, 94115-0128 United States, Maryland Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States, 21201 United States, New Jersey St. Joseph's Hospital and Medical Center Paterson, New Jersey, United States, 07503 收起 << |
NCT01158118 | Leukemia, Myeloid, Acute ... 展开 >> Myelodysplastic Syndromes Lymphoma, Non-Hodgkin Hodgkin Disease Leukemia, Lymphocytic, Chronic, B-Cell Multiple Myeloma 收起 << | Phase 2 | Completed | - | United States, Missouri ... 展开 >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 收起 << |
NCT00185523 | - | Terminated | - | United States, California ... 展开 >> Stanford University School of Medicine Stanford, California, United States, 94305 收起 << | |
NCT01158118 | - | Completed | - | - | |
NCT01349101 | Hematological Malignancies | Phase 2 | Recruiting | February 2020 | United States, Pennsylvania ... 展开 >> Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: John L Wagner, MD 215-955-8874 Contact: Donna Zuccarello 215-955-6612 Principal Investigator: John L Wagner, MD Sub-Investigator: Neal Flomenberg, MD Sub-Investigator: Seyfettin Onder Alpdogan, MD Sub-Investigator: Matthew Carabasi, MD Sub-Investigator: Beth Colombe, PhD Sub-Investigator: Joanne Filicko-O'Hara, MD Sub-Investigator: Dolores Grosso, DNP, CRNP Sub-Investigator: Margaret Kasner, MD Sub-Investigator: Lisa Kearns, CRNP Sub-Investigator: William O'Hara, PharmD Sub-Investigator: Mark Weiss, MD Sub-Investigator: Maria Werner-Wasik, MD Sub-Investigator: Ubaldo Martinez-Outschoorn, MD Sub-Investigator: Manish Sharma, MD Sub-Investigator: Thomas Klumpp, MD Sub-Investigator: Sameh Gaballa, MD 收起 << |
NCT00919503 | Hematopoietic Cell Transplanta... 展开 >>tion Recipient Non-Malignant 收起 << | Phase 2 | Recruiting | - | United States, Colorado ... 展开 >> Children's Hospital Colorado Active, not recruiting Aurora, Colorado, United States, 80045 United States, Oregon Oregon Health and Science University Completed Portland, Oregon, United States, 97239 United States, Tennessee Vanderbilt University/Ingram Cancer Center Active, not recruiting Nashville, Tennessee, United States, 37232 United States, Washington Seattle Children's Hospital Recruiting Seattle, Washington, United States, 98105 Contact: Lauri M. Burroughs 206-667-2396 lburroug@fhcrc.org Principal Investigator: Lauri M. Burroughs Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Lauri M. Burroughs 206-667-2396 lburroug@fhcrc.org Principal Investigator: Lauri M. Burroughs United States, Wisconsin Children's Hospital of Wisconsin Suspended Milwaukee, Wisconsin, United States, 53226 收起 << |
NCT00860574 | Accelerated Phase Chronic Myel... 展开 >>ogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Blastic Phase Chronic Myelogenous Leukemia Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Chronic Myelogenous Leukemia Childhood Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndromes Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia 收起 << | Phase 2 | Completed | - | United States, Colorado ... 展开 >> University of Colorado Denver, Colorado, United States, 80217-3364 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT00253513 | Leukemia Myel... 展开 >>odysplastic Syndromes 收起 << | Phase 1 Phase 2 | Completed | - | United States, Oregon ... 展开 >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 收起 << |
NCT00253513 | - | Completed | - | - | |
NCT00796068 | Acute Biphenotypic Leukemia ... 展开 >> Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Myelodysplastic Syndrome Blasts Under 5 Percent of Bone Marrow Nucleated Cells Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive Childhood Myelodysplastic Syndrome Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Myelodysplastic Syndrome With Excess Blasts-2 收起 << | Phase 2 | Recruiting | - | United States, Colorado ... 展开 >> University of Colorado Hospital Completed Aurora, Colorado, United States, 80045 United States, Oregon Oregon Health and Science University Completed Portland, Oregon, United States, 97239 United States, Washington Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Filippo Milano 206-667-5925 fmilano@fredhutch.org Principal Investigator: Filippo Milano 收起 << |
NCT01010243 | Multiple Myeloma | Phase 1 Phase 2 | Unknown | October 2016 | Germany ... 展开 >> Schön Klinik Starnberger See Recruiting Berg, Germany, 82335 Contact: Christian Straka, PD MD Principal Investigator: Christian Straka, PD MD Gemeinschaftspraxis Dres. med. J. Wilke u. H. Wagner Recruiting Fürth, Germany, 90766 Contact: Jochen Wilke, MD Principal Investigator: Jochen Wilke, MD Universitätsklinikum Schleswig-Holstein, II Medizin, Sekt. f. Stammzell- u. Immuntherapie Recruiting Kiel, Germany, 24105 Contact: Martin Gramatzki, Prof. MD Principal Investigator: Martin Gramatzki, Prof. MD Klinikum d. Universität München, Med. Klinik u. Poliklinik IV, Abt. H/O Recruiting München, Germany, 80336 Contact: Christian Adam, MD Principal Investigator: Christian Adam, MD Gemeinschaftspraxis Hämato/Onkologie Recruiting München, Germany, 81241 Contact: Burkhard Schmidt, MD Principal Investigator: Burkhard Schmidt, MD University of Regensburg Recruiting Regensburg, Germany, 93053 Contact: Albrecht Reichle, Professor albrecht.reichle@klinik.uni-regensburg.de Sub-Investigator: Matthias Grube, MD Sub-Investigator: Joachim Hahn, MD Sub-Investigator: Stephanie Mayer, MD Sub-Investigator: Martin Vogelhuber, MD Sub-Investigator: Christina Hart, MD Sub-Investigator: Karin Landfried, MD Sub-Investigator: Marco Petronio, MD Sub-Investigator: Dagmar Roll, MD Sub-Investigator: Tanja Zilch, MD 收起 << |
NCT01894477 | Acute Myeloid Leukemia in Remi... 展开 >>ssion Chronic Myelomonocytic Leukemia Minimal Residual Disease Myelodysplastic Syndrome Myelodysplastic/Myeloproliferative Neoplasm Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable 收起 << | Phase 2 | Active, not recruiting | January 2022 | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT03434704 | Transplant-Related Hematologic... 展开 >> Malignancy Leukemia, Acute Myelodysplastic Syndromes Graft Vs Host Disease Fungal Infection 收起 << | Phase 2 | Recruiting | September 15, 2022 | Italy ... 展开 >> Ospedale San Raffaele Recruiting Milano, Lombardia, Italy, 20132 Contact: Fabio Ciceri, MD 0039022643 ext 4289 ciceri.clinicaltrials@hsr.it Sub-Investigator: Raffaella Greco, MD Sub-Investigator: Jacopo Peccatori, MD Sub-Investigator: Maria Teresa Lupo Stanghellini, MD Sub-Investigator: Andrea Assanelli, MD Sub-Investigator: Consuelo Corti, MD 收起 << |
NCT01772953 | Acute Myeloid Leukemia (AML) ... 展开 >> Myelodysplastic Syndrome (MDS) 收起 << | Phase 2 | Completed | - | - |
NCT01894477 | - | Active, not recruiting | - | - | |
NCT01364363 | Severe Aplastic Anemia ... 展开 >> Paroxysmal Nocturnal Hemoglobinuria Acute Myelogenous Leukemia Acute Lymphoblastic Leukemia Myelodysplastic Syndromes Myeloproliferative Syndromes Chronic Myelogenous Leukemia Hodgkin's Lymphoma Non-Hodgkin's Lymphoma Multiple Myeloma Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Large Granulocytic Leukemia 收起 << | Not Applicable | Recruiting | January 2023 | United States, California ... 展开 >> Scripps Green Hospital Recruiting La Jolla, California, United States, 92037 Contact: Carol Burian 858-554-2845 Burian.Carol@scrippshealth.org Principal Investigator: Jeffrey W. Andrey, MD 收起 << |
NCT02551718 | Acute Leukemia of Ambiguous Li... 展开 >>neage Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia 收起 << | Not Applicable | Recruiting | - | United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Pamela S. Becker 206-616-1589 pbecker@u.washington.edu Principal Investigator: Pamela S. Becker 收起 << |
NCT02084563 | Acute Myeloid Leukemia ... 展开 >> Myeloproliferative Neoplasms Myelodysplastic Syndromes Myeloproliferative/Myelodysplastic Neoplasm 收起 << | Phase 2 | Completed | - | Brazil ... 展开 >> Hospital Israelita Albert Einstein Sao Paulo, SP, Brazil, 05651901 收起 << |
NCT03035422 | Refractory Acute Myeloid Leuke... 展开 >>mia 收起 << | Not Applicable | Recruiting | January 2021 | France ... 展开 >> Service d'hématologie Clinique Hôpital Saint Antoine Recruiting Paris, France, 75012 Contact: Rémy DULERY, PH 01.49.28.26.20 remy.dulery@aphp.fr Contact: Mohamad MOHTY, PUPH 01.49.28.26.20 mohamad.mohty@inserm.fr 收起 << |
NCT02852083 | Squamous Cell Lung Cancer ... 展开 >> Non-Squamous Cell Lung Cancer Non-Small Cell Lung Cancer 收起 << | Phase 2 | Recruiting | July 2020 | Germany ... 展开 >> Onkologische Gemeinschaftspraxis Dres. Wilke/ Wagner/Petzoldt Recruiting Fürth, Bavaria, Germany Contact: Traudl Gietl-Drescher 09119792220 info@onkologie-fuerth.de Klinikum Kempten Oberallgäu Recruiting Immenstadt, Bavaria, Germany Contact: Simone Eberl 08323-9108968 pneumologie.studien@kv-keoa.de MVZ am Klinikum GmbH Recruiting Passau, Bavaria, Germany Contact: Margit Schicht 085153002299 studiensekretariat@klinikum-passau.de Universitätsklinikum Regensburg Recruiting Regensburg, Bavaria, Germany Contact: Albrecht Reichle, MD albrecht.reichle@klinik.uni-regensburg.de Kliniken Nordoberpfalz AG, Klinikum Recruiting Weiden, Bavaria, Germany Contact: Gabriele Schulz Contact: Karola Dorner MVZ Weiden GmbH Recruiting Weiden, Bavaria, Germany Contact: Gabriele Schulze 09613033123 gabriele.schulze@kliniken-nordoberpfalz.ag Contact: Karola Dorner 09613033258 karola.dorner@kliniken-nordoberpfalz.ag St. Antonius-Hospital Recruiting Eschweiler, Nordrhein-Westfalen, Germany Contact: Susanne Recker 02403761737 studiensekretariat.onkologie@sah-eschweiler.de Klinik für Innere Medizin Recruiting Homburg/Saar, Saarland, Germany Contact: Thomas Wehler Thomas.Wehler@uks.eu Krankenhaus Martha-Maria Recruiting Halle (Saale), Sachsen-Anhalt, Germany Contact: Sabine Leysring 03455591434 studiensekretariat.schuette@nicsys.de 收起 << |
NCT03079089 | Refractory or Relapsed Lymphoi... 展开 >>d Haemopathy 收起 << | Not Applicable | Recruiting | June 15, 2022 | France ... 展开 >> Service d'hématologie clinique Hôpital Saint Antoine Recruiting Paris, France Contact: Rémy DULERY, PH 01.49.28.26.20 remy.dulery@aphp.fr Contact: Mohamad MOHTY, PUPH 01.49.28.26.20 mohamad.mohty@inserm.fr 收起 << |
NCT01370408 | Chemotherapy-induced Nausea an... 展开 >>d Vomiting 收起 << | Phase 2 | Completed | - | United States, Georgia ... 展开 >> Northside Hospital Atlanta, Georgia, United States, 30342 收起 << |
NCT01370408 | - | Completed | - | - | |
NCT00189488 | Graft Versus Host Disease ... 展开 >> Hematologic Malignancies 收起 << | Phase 2 | Completed | - | - |
NCT00676806 | Leukemia Lymp... 展开 >>homa Multiple Myeloma Aplastic Anemia 收起 << | Phase 2 | Terminated(Slow accrual) | - | United States, Massachusetts ... 展开 >> Tufts Medical Center Boston, Massachusetts, United States, 02111 收起 << |
NCT02333058 | Acute Lymphoblastic Leukaemias... 展开 >> (ALL) Acute Myeloid Leukaemias (AML) Myelodysplastic Syndromes (MDS) Juvenile Myelomonocytic Leukaemias (JMML) 收起 << | Phase 2 | Active, not recruiting | September 2019 | Austria ... 展开 >> St. Anna Children Hospital Vienna, Austria, A-1090 Czechia University Hospital Motol, Charles University, Prague Prague, Czechia, 150-06 Germany University Clinic Düsseldorf Düsseldorf, Germany, 40225 University Clinic Erlangen-Nürnberg Erlangen, Germany, 91054 University Hospital Johann Wolfgang Goethe Frankfurt, Germany, 60590 University Clinic Hamburg-Eppendorf Hamburg, Germany, 20246 Medical University Hannover Hannover, Germany, 30625 University Clinic Heidelberg Heidelberg, Germany, 69120 University Clinic Jena Jena, Germany, 07740 University Clinic München München, Germany, 80804 Univercity Clinic Münster Münster, Germany, 48129 University Clinic Regensburg Regensburg, Germany, 93053 University Clinic Ulm Ulm, Germany, 89075 University Clinic Würzburg Würzburg, Germany, 97080 Italy Ospedale Bambino Gesu Roma Rome, Italy, 00165 Ospedale Infantile Regina Margherita Torino Turin, Italy, 10126 Poland Bydgoszcz Medical University Bydgoszcz, Poland, 85-094 Kraków Medical University Kraków, Poland, 30-663 Lublin Medical University Lublin, Poland, 20-093 Wroclaw Medical University Wroclaw, Poland, 50-368 United Kingdom Birmingham Children's Hospital Birmingham, United Kingdom, B4 6NH Central Manchester University Hospital Manchester, United Kingdom, M13 9WL Sheffield Children's Hospital Sheffield, United Kingdom, S10 2TH 收起 << |
NCT00676806 | - | Terminated(Slow accrual) | - | - | |
NCT03663933 | Lymphoproliferative Disorders ... 展开 >> Autoimmune Lymphoproliferative Primary T-cell Immunodeficiency Disorders Immune System Diseases Common Variable Immunodeficiency 收起 << | Phase 2 | Recruiting | May 1, 2024 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 收起 << |
NCT00810602 | Hematologic Malignancies ... 展开 >> Graft vs Host Disease 收起 << | Phase 1 Phase 2 | Completed | - | United States, Michigan ... 展开 >> University of Michigan Cancer Center Ann Arbor, Michigan, United States, 48109 United States, Missouri Washington University School of Medicine St. Louis, Missouri, United States, 63110 收起 << |
NCT02579967 | Primary T-cell Immunodeficienc... 展开 >>y Disorders Common Variable Immunodeficiency Immune System Diseases Autoimmune Lymphoproliferative Lymphoproliferative Disorders 收起 << | Phase 2 | Recruiting | October 21, 2027 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 收起 << |
NCT00810602 | - | Completed | - | - | |
NCT00560053 | Multiple Myeloma | Phase 3 | Completed | - | - |
NCT00189488 | - | Completed | - | - |
尊敬的 Ambeed 客户您好,
请您选择所在区域,我们将转接对应客服为您服务!